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Abstract
Gene copy number variants (CNVs), which consist of gene deletions and amplifications 
contribute to the great diversity in the Plasmodium falciparum genome. CNVs may influence 
the expression of genes and hence may affect important parasite phenotypes such as virulence, 
drug resistance, persistence and transmissibility. The hypothesis underlying the studies in this 
thesis is that CNVs may be important for adaptation of the parasite to its variable 
environments. To investigate this hypothesis, a population wide survey o f CNVs in 183 fresh 
field isolates from four populations with different transmission intensities was conducted. To 
detect CNVs, comparative genome hybridization was performed using a 70mer microarray. 
This is the first large scale survey for CNVs in natural populations of parasites. A total o f 98 
different CNVs, consisting of 225 genes, were identified. Various systematic aspects that 
could affect detection of CNVs were explored and the population of origin of the isolate was 
found to be the only factor that affects CNV detection. Some of these CNVs showed high 
differentiation in frequency between populations suggestive of the action of directional 
selection. Other CNVs showed no or low differentiation in frequencies between populations, 
indicative of action of neutral evolutionary processes. Validation of the CNVs identified using 
microarrays was done using whole genome sequencing. Very low concordance was observed 
between the CNVs identified by the two technologies. These differences may be attributed to 
technical and analytic differences between the two technologies. Furthermore, the effect of 
CNVs on gene expression levels was analysed. A number of CNVs were found to be 
significantly associated (positively or negatively) with the expression levels of genes located 
inside and also outside the CNVs.
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1 Chapter 1: Introduction
1.1 Background
Malaria is a disease caused by a protozoan parasite, Plasmodium, and transmitted by infected 
female mosquitoes of the genus Anopheles to the human host during blood feeding. The 
species of Plasmodium that infect humans include P. falciparum, P. vivax, P. malariae, P. 
knowlesi and two P. ovale subspecies, i.e., P. ovale curtisi and P. ovale wallikeri. P. 
falciparum causes the most severe form of the disease in tropical regions. The parasite’s life 
cycle involves both the mosquito vector and the human host. The parasite exists in both sexual 
and asexual forms and is known to undergo morphological and metabolic changes throughout 
its life cycle. The parasite genome is approximately 23Mbp in size, with nucleotide content of 
80% AT. It is comprised of 14 chromosomes with approximately 5300 genes covering about 
half of the genome length (Gardner et al. 2002).
1.1.1 Malaria epidemiology
Malaria continues to be a leading contributor to the global burden of disease in developing
countries (Snow et al. 2005, Noor et al. 2014). According to WHO report 2013, an estimated
198 million malaria cases occurred in 2013, with 90% of the 584 000 deaths occurring in Sub-
Saharan Africa (WHO 2014). It is also estimated that 57% of the population in Africa is
resident in regions with at least moderate to high malaria transmission (Figure 1) (Noor et al.
2014). Nonetheless, there is evidence, in some regions, of a decline in prevalence of parasite
positive individuals over the period 1990 to 2010 (Figure 1) (Noor et al. 2014, Murray et al.
2012, WHO 2014). Some of this has been attributed to interventions including the distribution
of insecticide-treated bed nets, the replacement of antimalarial drugs to which P. falciparum
has developed resistance (e.g., sulfadoxine-pyrimethamine) with effective artemisinin
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combination therapy, and better access to treatment (O'Meara et al. 2008, Phillips-Howard et 
al. 2003, Barnes et al. 2005).
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Figure 1.1. The distribution of predicted Plasmodium falciparum parasite rates (/yPR) in 
Africa in 2000 and 2010.
P. falciparum parasite rates (PfPR) predicted from data obtained from surveys of the 
prevalence of P. falciparum infections standardized to the 2-10 years age group in the year A) 
2000 and B) 2010. Darker shades represent regions with high parasite prevalence. Image 
reproduced from Noor et al. 2014 under the terms of the Creative Commons Attribution 
License.
However, in some regions the decline was observed before the introduction of interventions: 
thus the drivers of this decline are poorly understood (Okiro et al. 2010). Despite this general 
decline in malaria, there is ongoing high disease prevalence in many regions (Noor 2014), 
emergence of resistance to the mainstay drug, artemisinin, in the Greater Mekong Subregion 
(Mok et al. 2011, Miotto et al. 2013, Takala-Harrison et al. 2013, Dondorp et al. 2009, Noedl 
et al. 2008), and widespread insecticide resistance in vector populations (Corbel et al. 2012). 
Thus there is still a great need for additional tools for prevention and treatment in order to 
further decrease the burden of malaria.
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1.1.2 Genetic diversity of Plasmodium falciparum
The malaria parasite is highly genetically diverse. This characteristic is thought to enable the 
parasite to survive in its changing environment, including escaping from specific antigenic 
immune responses and resisting antimalarial drug treatment (Volkman et al. 2007, Jeffares et 
al. 2007, Anderson, Patel and Ferdig 2009, Soulama et al. 2011, Mackinnon and Marsh 2010).
The forms of variation in the genome range from large structural variations to single 
nucleotide changes. The structural variations include chromosomal size polymorphisms, gene 
copy number variation (CNVs), inversions and translocations. Other forms of variation 
include small insertions and deletions (indels) and single nucleotide polymorphism (SNPs) 
(Volkman et al. 2007, Kidgell et al. 2006). Genomic variation arises as a result of mutations 
that occur spontaneously or are caused by mutagens e.g., reactive oxygen species (Branzei and 
Foiani 2008). Spontaneous mutations may be caused by errors during DNA replication that 
remain uncorrected and also failure in DNA repair mechanisms to restore a damaged DNA 
strand to its original state. Genetic diversity is also generated by genetic recombination that 
allows exchange of genetic segments affecting phenotype. In P. falciparum, recombination 
hotspots have been identified and are characterized by AT-rich repeats, a 12bp G/C-rich motif 
with 3bp repeat (Jiang et al. 2011) and occur mostly at chromosome ends (Mu et al. 2005).
The rate of recombination is influenced by the diversity of parasite populations and malaria 
transmission intensities (Mu et al. 2010). These different types of genomic variation in a 
population are shaped by selection pressures, population isolation, genetic drift and migration 
(Mackinnon and Marsh 2010). Genetic drift is related to the effective population size. 
Populations with small effective population sizes experience more genetic drift compared to 
those with large sizes. The increase in the number of variants in a population is limited by the 
carrying capacity of the population.
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A number of genomic variants have been linked to parasite phenotypes that are crucial for
survival and spread, and which also contribute to disease pathogenesis. First, genetic
variability in antigens expressed on the surface of the merozoite and on the infected red cell
surface are thought to allow the parasite to evade host immune responses by expressing novel
antigenic types (Amambua-Ngwa et al. 2012, Tetteh et al. 2009, Bull et al. 1998, Wright and
Rayner 2014). Second, erythrocyte invasion, a key determinant of parasite replication rate, is
known to involve multiple parasite ligands that are polymorphic in nature. Third, the parasite
adhesion phenotype that results in obstruction of blood capillaries and prevent clearance of
parasite by the spleen, is caused by a family of highly polymorphic genes referred to as var
genes encoding P. falciparum erythrocyte membrane protein 1 (PfEMPl) (Scherf, Lopez-
Rubio and Riviere 2008). PfEMPl mediates adhesion of infected erythrocytes to endothelial
cells (cytoadherence) (Su et al. 1995) and uninfected erythrocytes (rosetting) and is also
thought to be involved in adhesion of infected erythrocytes to platelets forming clumps
(platelet-mediated clumping) (Rowe et al. 2009). Two other variant surface antigens, RIFINS
and STEVOR are thought to be linked to the adherent phenotype (Niang et al. 2014). Fourth,
production of gametocytes, the asexual forms of the parasite, a key determinant o f malaria
transmission has been shown to be lost, in some studies, during long term in vitro adaptation
of some parasite lines and has been associated with a large deletion on chromosome 9
(Robinson et al. 2011, Cheeseman et al. 2009, Kidgell et al. 2006, Jiang et al. 2008b,
Mackinnon et al. 2009, Mok et al. 2011, Bozdech et al. 2003a, Ribacke et al. 2007, Nair et al.
2008, Pologe and Ravetch 1988, Wellems et al. 1987, Nair et al. 2010, Day et al. 1993).
Lastly, antimalarial drug resistance has been associated with increased copy number in
genomic regions containing three genes (multi drug resistance 1 {pfmdrl), GTP
cyclohydrolase 1 igchl) and falcipain-2) and also SNPs in Kelch 13 gene, chloroquine
resistance transporter gene and dihydrofolate reductase (dhfr) gene (Van Tyne et al. 2011,
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Ariey et al. 2014, Miotto et al. 2013, Plowe, Kublin and Doumbo 1998, Singh and Rosenthal 
2004, Fidock et al. 2000). From these studies, it is evident that the understanding of malaria 
parasite genetic diversity is crucial since it offers insight into genomic loci that affect 
important parasite phenotypes and hence are potential targets for vaccines, therapeutics and 
tools for monitoring of drug resistance.
1,1,3 Gene copy num ber variation as a source of genetic diversity in P. falciparum
The recent interest in CNVs in malaria parasites is driven by increasing evidence of their role
in adaptation, evolution and disease in a number of organisms (Anderson et al. 2009,
Henrichsen, Chaignat and Reymond 2009, Tam et al. 2009, Kirov et al. 2012, Craddock et al.
2010, Angstadt et al. 2013, Palli et al. 2013) and the advances in technologies that enable
high-throughput genome-wide scans of CNVs (Mackinnon et al. 2009, Kidgell et al. 2006,
Ribacke et al. 2007, Cheeseman et al. 2009, Jiang et al. 2008b). In P. falciparum, CNVs have
been identified in long- and short-term cultured lines (Mackinnon et al. 2009, Ribacke et al.
2007, Mok et al. 2011, Carret et al. 2005, Kidgell et al. 2006, Jiang et al. 2008a, Cheeseman et
al. 2009, Dharia et al. 2009, Samarakoon et al. 201 la, Samarakoon et al. 201 lb, Bozdech,
Mok and Gupta 2013) and also in fresh clinical isolates (Robinson et al. 2011, Ribacke et al.
2007). From these CNV studies, it is estimated that between 0.3% -1%  of the parasite’s
genome is subject to variation in gene copy number (Anderson et al. 2009), a fraction of the
genome larger than that represented by SNPs (Volkman et al. 2007, Miotto et al. 2013). This
implies potential significant effects on phenotypic variability. These CNV studies employed
different platforms, parasite strains and CNVs calling strategies (detailed expiation in section
1.2.1.3.1) and hence, as observed (Table 1), their results are expected to vary in the number
and genomic location of CNVs. Furthermore, a number of CNVs have been found to typically
arise during culture adaptation of parasite lines, thus introducing a further source of variation
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in CNVs reported so far (Nair et al. 2010, Mackinnon et al. 2009). None of these studies has, 
on large scale, examined CNVs in natural populations of parasites (Appendix 1.1). Thus there 
is a need for large scale exploration of CNVs in fresh clinical isolates to determine the extent 
of these variants in the genome and their potential role in adaptive evolution of natural 
populations of parasites.
Table 1.1. A summary of published genome wide studies of CNVs in P. falciparum
Platform Type No. of
CNV
genes
No. of
isolates
studied
CNV detection 
analysis method
References
M icroarrays Spotted arrays 
(70mer)
144 1 Difference <50% of 
total intensity
(Bozdech et al. 
2003a)
82 9 limma (B-statistics) (Ribacke et al. 
2007)
324 5 1.5 fold difference (Mackinnon et 
al. 2009)
138 6 R-GADA (Mok et al. 
2011)
Aflymetrix 177 7 % Signal reduction (Carret et al.
arrays 2005)
(25mer) 149 14 MOID algorithm (Kidgell et al. 
2006)
390 4 Partek Genomic suite 
v6.3
(Jiang et al. 
2008b)
186 16 Threshold set at 
absolute log2 ratio > 1
(Cheeseman et 
al. 2009)
-156 4 MOID algorithm (Dharia et al. 
2009)
NimbleGen
arrays
537 37 Nexus Copy Number 
3.0 software
(Samarakoon 
et al. 2011a)
Next
generation
Illumina 7 5 Read depth analysis & 
Paired end mapping
(Robinson et 
al. 2011)
sequencing
Roche 454 7 2 Read depth analysis (Samarakoon 
et al. 2011a)
Illumina >100 5 Read depth analysis 
using 3 tools
(Sepulveda et 
al. 2013)
R-GADA: Genome Alteration Detection Analysis in R. MOID: Match-Only Integral 
Distribution. Limma: Linear Models for Microarray Analysis
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1.2 Methods for detecting CNVs in P. falciparum
CNV detection molecular methods have rapidly evolved in the last decade enabling whole 
genome scans to the resolution level of single nucleotides. The methods are discussed below.
1.2.1 Whole genome/chromosome scan for CNVs
1.2.1.1 Pulse field gradient gel electrophoresis (PFGE)
The early evidence for structural variation in P. falciparum was the detection of chromosome 
size polymorphism in isolates using pulse field gradient (PFG) gel electrophoresis currently 
referred to as pulse field gel electrophoresis (PFGE) (Corcoran et al. 1986, Kemp et al. 1985, 
Van der Ploeg et al. 1985). Variation in chromosome lengths could be as a result of 
loss/addition of whole genes leading to change in the number of gene copies (CNVs) in the 
parasite genome. PFGE involves fractionation of chromosomal DNA in a 1.5% -2% agarose 
gel with a voltage applied across the gel that is constantly changing in direction (Schwartz and 
Cantor 1984) . This enables separation of the chromosomes based on their length ranging from 
30 kilobases to 3000 kilobases. Chromosome sizes were estimated by comparison with known 
yeast chromosome molecular weight sizes.
1.2.1.2 Optical mapping
Optical mapping involves the development of ordered restriction maps of DNA fragments (Cai
et al. 1995). The restriction map of the whole genome of P. falciparum was generated in 1999
by Lai and colleagues and provided a scaffold of the entire genome onto which contigs could
be aligned (Lai et al. 1999). The starting material of the assay was either chromosomal DNA
separated using pulse field gel electrophoresis (PFGE) or randomly fragmented DNA (250bp-
3000kbp) mounted on a surface together with a sizing standard (Lai et al. 1999, Jing et al.
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1999). The mounted DNA was then digested with restriction enzymes o f choice (BamRl and 
Nhel used) to generate fragments that are stained with a fluorescent reagent that intercalates 
into DNA. The image was acquired using microscopy, processed and the maps constructed. 
The restriction maps were assembled to form restriction maps/contigs that were then mapped 
onto the available whole genome optical map. To detect CNVs, the full genome/contig 
restriction maps of test genomes were compared to a reference map which was generated in 
silico using available complete genome sequence (Riley et al. 2011). Riley and colleagues 
generated full maps of four cultured P. falciparum strains and were able to detect deletions, 
duplications and inversions with sizes ranging from 3.5kb to 78kb (Riley et al. 2011).
1.2.1.3 Microarrays
Completion of sequencing of the P. falciparum genome of strain 3D7 in 2002 (Gardner et al. 
2002) facilitated the development of oligonucleotide arrays that have been used to perform 
comparative genome hybridization (CGH) (Bozdech et al. 2003a). CGH involves comparison 
of hybridization o f a labelled test DNA and a reference DNA on a glass slide spotted with 
oligonucleotides. The first published array used to detect CNVs in P. falciparum was a 25- 
mer affymetrix array with 298,752 probes targeting approximately 5,179 genes (Kidgell et al. 
2006, Carret et al. 2005). The major limitation of this array was the large quantity of DNA 
required for the experiment (15 pg) which would not be suitable to assay small quantities of 
genomic DNA (gDNA) obtained from clinical samples. However, this problem has now been 
overcome by the development of whole genome amplification methods that end at the log 
linear phase of amplification thus maintain the relative abundance of genomic content and also 
minimize PCR errors (Petalidis et al. 2003, Carret et al. 2005, Mackinnon et al. 2009).
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Carret and others tested various whole genome amplification methods including multiple 
displacement amplification (MDA) and ligation-mediated PCR (LMP), to overcome this 
problem (Carret et al. 2005). LMP involves attachment of adapter sequence to fragmented 
gDNA and using a primer complementary to the adapter for amplification. MDA, which uses 
random hexamers, had PCR products that were more similar to the non-amplified gDNA as 
compared to LMP products. The CGH intensity signal of genes were observed to be similar 
between the hybridization experiments of MDA products and non-amplified gDNA.
A second 70-mer array developed by Bozdech and others containing 10,680 probes targeting 
5,343 P. falciparum genes, has been used on both non-amplified and randomly amplified 
gDNA samples to detect CNVs in both cultured and fresh clinical samples (Ribacke et al. 
2007, Bozdech et al. 2003a, Mackinnon et al. 2009, Mok et al. 2011, Hu et al. 2007) . Two 
additional studies have used a higher resolution array than the aforementioned two, the 
Affymetrix PFSANGER GeneChip, a 25mer tiling array with about 2.5 million probes 
spanning exons, coding regions, intron/exon junction and intergenic regions. Both studies used 
10-12 pg of non-amplified DNA (Cheeseman et al. 2009, Jiang et al. 2008b).
The main advantages of microarrays are that the assay is cheaper compared to sequencing, the 
arrays can easily be updated for new probes, and less nucleic material is used, especially when 
amplification of gDNA is performed, compared to earlier technologies. The main drawbacks 
of the use of microarray technology in CNV detection include inability to detect rare variants 
in mixed parasite populations, the ability to assay only genomic regions that have been 
previously characterised, that correct mapping of variants in multi-gene families is impossible, 
that the presence of unknown polymorphisms in genes targeted by the probes affects the
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hybridization results and that the boundaries of CNVs cannot be precisely mapped if probes 
are non-overlapping.
1.2.1.3.1 CNVs detection analysis methods for microarray data
A number of CNV detection tools for CGH data are available and differ by the type of array 
platform, input data (log2 intensity ratios or absolute intensity values), the statistical models 
used, detection thresholds applied, ability to detect CNV boundaries, ploidy of genome and the 
way in which the reference genome is used. Some of the tools available that are applicable to 
my study, i.e., compatible with CGH data from two colour arrays (log2 intensity ratio 
calculated against intensity for a reference genome), haploid genome analysis and that are 
freely available will be highlighted.
In an ideal two colour array CGH experiment, the presence of similar copies of a gene 
between the test and reference samples are indicated by log2 intensity ratio, i.e., the difference 
between log2 hybridization signal intensities of a test and reference sample. In the case of a 2- 
fold difference in gene copy number, the log2 intensity ratio is ideally 1 or -1. However, due to 
noise in microarray data, there is uncertainty in the thresholds on which gene copy number 
values can be assigned.
One of the methods used for identifying CNVs in P. falciparum has been to apply thresholds
on the log2 intensities ratios and the minimum number of consecutive probes that meet a set
threshold (Cheeseman et al. 2009). The second method involves identifying array probes that
statistically significantly differ in hybridization between isolates using B-statistics in limma
package in R (Smyth 2004) then applying cut-offs on the number of consecutive probes and
the direction of change (Ribacke et al. 2007). Other tools developed are based on segmentation
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analysis (Pique-Regi, Caceres and Gonzalez 2010, Olshen et al. 2004) and the Smith- 
Waterman algorithm (Price et al. 2005).
In segmentation analysis, the log2 intensity ratio along a chromosome is partitioned into 
segments of equal copy number. The first segmentation algorithm developed for arrays is 
Circular Binary Segmentation (CBS) (Olshen et al. 2004). CBS recursively detects the points 
of change of copy number (start and end of segments) along a chromosome and statistically 
tests whether the means of segments (the mean of log2 intensity ratio of probes within the 
segments) bordering each other differ. A package was later developed in R known as 
DNACopy that uses CBS to detect CNVs (Venkatraman and Olshen 2007). A second 
algorithm, Genome Alteration Detection Algorithm (GADA), also available in R, represents 
log2 intensity ratio along a chromosome as piecewise constant (PWC) vector then uses 
Bayesian learning to identify change-points and segment means along a chromosome (Pique- 
Regi et al. 2010). It then tests for significance of the change-points using t-statistics based on 
the segment means and variance. GADA’s performance was found to be faster than CBS and 
as accurate as CBS (Pique-Regi et al. 2010).
1.2.1.4 Next Generation Sequencing (NGS)
The exploration of CNVs in the parasite genome to single nucleotide resolution has been made 
possible by next generation sequencing (NGS). Whole genome and exome sequencing of 
single-end or paired-end reads has been extensively used to identify CNVs in various 
organisms (Mills et al. 201 la, Yalcin et al. 2011, Zichner et al. 2013). NGS has led to an 
increased accuracy of detecting the breakpoint junctions of CNVs thus making inference of 
mechanisms of CNV formation possible (Carvalho et al. 2013, Hermetz et al. 2014). Another
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major advantage of sequencing over microarrays is its ability to explore a number of genomic 
variants without prior knowledge of the sequence.
1.2.1.4.1 Sequence data analysis tools for CNVs detection
The process of CNV detection from genome sequence date requires initial mapping of reads to 
a reference genome followed by either read depth analysis (normalized depth of coverage 
correlates with copy number), paired end mapping (distance between paired reads that are 
longer/shorter than expected), split-read analysis (reads that span CNVs breakpoint and appear 
to map on two locations on the reference genome) (Karakoc et al. 2012), or a combination of 
these approaches (Zhang et al. 2011). A summary of these analyses methods is illustrated in 
Figure 1.2. In addition, fine mapping of CNV boundaries can be achieved by assembly of the 
short reads, followed by mapping o f contigs to the reference (Le Scouamec and Gribble 2012). 
One of the challenges observed in these analyses methods is that when used on the same set of 
samples, some CNVs can be identified by one method and not the others (Alkan et al. 2009, 
Mills etal. 2011a).
CNV detection using read depth analysis involves calculation of read depth in non­
overlapping window sizes in a chromosome, normalisation and application of statistical 
methods to identifying regions that have excessive or reduced coverage. Ideally, the depth of 
read coverage of a region is proportional to copy number. However, there exist factors other 
than copy number that affect sequence coverage. These include GC content and the ability of a 
region to be uniquely mapped (Quail et al. 2012, Ross et al. 2013). The regions with very low 
and very high GC-content have lower coverage compared to regions with intermediate GC 
content. Most of the CNV calling algorithms correct for these two effects and also perform 
normalisation of read depth across samples. These tools use a variety o f statistical models and
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segmentation analysis methods (Miller et al. 2011, Xie and Tammi 2009, Chiang et al. 2009, 
Abyzov et al. 2011, Xi et al. 2011, Ivakhno et al. 2010, Magi et al. 2011).
SV classes Read pair Read depth Split read Assembly
Deletion Contig/scaffold
Assemble
Novel
sequence Not applicable
Contig/
scaffold
Interspersed
duplication
Contig/
scaffold
Tandem
duplication
Assemble Contig/
r r ;  scaffold
Nature Reviews | Genetics
Figure 1.2. An illustration of the approaches used to detect CNVs using next generation 
sequencing.
CNVs, referred to as structural variation (SV) in the image, can be identified from reads pairs 
that map to the reference at distances shorter/longer than expected read length (first column), 
variation of normalized read depth at a locus compared to the expected (second column), reads 
that map to two locations may span a CNV breakpoint junction (third column) and lastly 
mapping of contigs generated from de novo assembly of reads may identify structural 
variations in the genome (fourth column) Image reproduced from Alkan, Coe and Eichler 
2011 with permission from Nature Publishing Group.
1,2.1,4.2 Challenges of using short read sequence data to detect CNVs
The short reads obtained from NGS present computational challenges during alignment of the
reads to a genome characterized by regions with repetitive sequences, of which P. falciparum
is one (Treangen and Salzberg 2012, Gardner et al. 2002). The reads that map to the repetitive
regions cannot be mapped uniquely and can either be filtered off, assigned to one of the
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possible genomic locations at random or excluded. This still poses limitations on the 
downstream analysis since not all regions in the genome can be assayed, and in the instance of 
random alignment of non-unique reads, copy number estimates are inaccurate.
1.2.2 Targeted loci CNV detection
Laboratory methods for CNV identification at pre-decided (“targeted”) gene loci have been 
used to validate results from whole genome scans and also to map CNV breakpoints. These 
methods are described below.
1.2.2.1 Southern Blot
Southern blot is a technique developed to identify a specific DNA sequence in a mixture of 
DNA fragments (Southern 1975). The fragmented DNA is separated by size in an agarose gel 
then denatured to later enable hybridization of a labelled probe of sequence similar to the 
region of interest. The denatured DNA is transferred from the gel to a membrane where 
hybridization of the labelled probe is performed, and the hybridization results imaged. 
Increased copy number is observed when there is increased signal in the blot. No signal 
indicates a deletion in the test sample compared to the control. The principle was applied to 
the development of microarrays.
1.2.2.2 Fluorescent in situ hybridization (FISH)
FISH is a method developed in the early 1980’s used to detect specific DNA sequence in 
chromosomes in fixed cells (Langer-Safer, Levine and Ward 1982). A labelled probe, with 
sequence complementary to the region of interest, i.e., a CNV region, was generated and 
hybridized to fixed cells which were then visualized using a microscope (Ribacke et al. 2007).
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Both southern blot and FISH are low-throughput, labour-intensive and require a large quantity 
of DNA, and hence are mostly used in small-scale studies.
1.2.2.3 Long range PCR
Long range PCR amplification of the large genomic regions (up to 40kbp) containing CNVs 
has been useful for precise mapping of breakpoint junctions of CNVs through sequencing of 
the PCR products (Carvalho et al. 2013, Winchester et al. 2008). CNVs are identified through 
differences in the size of PCR products in the test and reference samples. The major challenge 
of this method is that prior knowledge of the sequence in the region of interest is required in 
order to design primers.
1.2.2.4 Quantitative real time PCR (qPCR)
Real time PCR has almost completely replaced the methods described above owing to its 
application in high-throughput assays, its less laborious nature and the low quantities of DNA 
template required (Ribacke et al. 2007). To detect CNVs, primers against the regions of 
interest are designed and amplified by PCR in a quantitative assay using an endogenous gene 
(existing as single copy) as a control in order to normalize for variation in input gDNA 
quantity and PCR inhibitors in the samples. Two methods can be used to calculate copy 
number -  the comparative Ct method (in which it is assumed that the efficiency of 
amplification of the test and endogenous genes are similar) or the relative standard curve 
method in which two standard curve generated for a single copy gene and a target gene and 
used to calculate the fold difference in quantity of copies between a test sample and a 
calibrator sample (assumed to contain a single copy of the gene of interest).
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1.3 Mechanisms of CNV formation
The generation of gene copy number changes requires structural changes in the chromosome 
that enable joining of two separate DNA regions. Processes involved in joining these regions 
have been inferred from the DNA sequence at the point of joining, i.e. the CNV’s breakpoint 
junction of the once separate regions (Hastings et al. 2009, Liu et al. 2012, Gu, Zhang and 
Lupski 2008). Investigations on the characteristics of the breakpoint junction have revealed 
that some are found in low copy repeat regions (LCRs) characterized by long stretches of 
sequence homology (>50bp), while others are present in regions of short sequence homology 
of 2bp-15bp (microhomology) (Gu et al. 2008, Liu et al. 2012, Hastings et al. 2009). These 
findings led to the proposition that CNVs may arise through homologous recombination at 
regions with extensive sequence homology enabled by DNA repair mechanisms. Second, short 
homology regions (microhomology) may be subject to template switches during replication 
thereby leading to CNV formation. These two broad mechanisms are further discussed below.
1.3.1 Homologous recombination
In eukaryotes, homologous recombination (HR) underlies DNA repair o f double stranded 
breaks and nicks (Cahill, Connor and Carney 2006). HR also enables exchange o f genetic 
material during meiosis leading to new combinations of DNA sequences (Amunugama and 
Fishel 2012). In a diploid organism, a successful repair event involves the use of alleles to 
repair a broken strand, restoring it to its original sequence. Crossover between non-alleles, a 
process known as non-allelic homologous recombination (NAHR), has been identified as one 
o f mechanisms that generates structural changes in the genome (Gu et al. 2008, Hastings et al. 
2009, Liu et al. 2012). NAHR is seen during repair of double stranded DNA breaks when 
unequal crossover occurs between non-homologous repeat regions. NAHR also occurs during
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repair of collapsed replication forks due to a nick in the template DNA strand, a process 
termed break-induced replication (BIR). In this case, the exposed broken strand may bind to a 
non-homologous region with high sequence similarity. These processes may lead to deletions, 
duplications or inversions of genomic segments. The models of CNV formation by NAHR are 
illustrated below (Figure 1.3).
A) B)
A. Non-allelic homologous recombination
(i) By unequal crossing-over 
a b c  b d
a b b d
(ii) By break-induced replication
a b c  b d
a b
Duplication 
a b c  b c b d
and deletion 
a b d a b
Duplication 
b c b d
Figure 1.3. Models of CNVs formation through non-allelic homologous recombination 
(NAHR)
A) NAHR could occur through homologous recombination between non-allelic repeats 
regions, during meiosis or repair of double stranded DNA breaks resulting in deletions or 
duplications or B) during repair of collapsed DNA replication fork by a process called break- 
induced replication (BIR). Image reproduced from Hastings et al. 2009 with permission from 
Nature Publishing Group.
The malaria parasite DNA is exposed to damage by reactive oxygen and nitrogen species
released during host immune defence (Nathan and Shiloh 2000) and heme metabolism. Errors
during DNA replication also contribute to alteration of DNA sequence. The parasite, in its
haploid state in the human host, uses homologous recombination as one of the mechanisms to
repair double stranded DNA breaks, utilizing regions with high sequence similarity (mostly
segmental duplications) of the genome (Kirkman, Lawrence and Deitsch 2014). NAHR can
also occur when the parasite is in its diploid state in the mosquito. NAHR may be involved in
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CNV generation in P. falciparum as for other eukaryotes since the parasite uses homologous 
recombination to repair double stranded DNA breaks (Samarakoon et al. 201 lb). This is 
supported by the observed association of CNVs with segmental duplications (SDs) and repeat 
regions reported in P. falciparum (Cheeseman et al. 2009). Segmental duplications are 
segments of DNA in the genome, greater than lkb, that exhibit high sequence similarity.
1,3.1.1 Non-homologous recombination (microhomology mediated mechanisms)
The presence of microhomology in some CNV breakpoint junctions has been reported in the 
human genome (Conrad et al. 2010a, Carvalho et al. 2009). There exist DNA repair pathways 
that do not require extensive sequence homology. Instead, they use short sequences of 
homology termed microhomology (l-25bp) or no homology and therefore increase the 
chances of genetic alterations (Symington and Gautier 2011). These mechanisms include non- 
homologous end joining (NHEJ) also referred to as canonical-NHEJ (C-NHEJ) and 
microhomology mediated end joining (MMEJ) sometimes referred to as altemative-NHEJ 
(Symington and Gautier 2011, Fattah et al. 2010). In eukaryotes, C-NHEJ involves binding of 
Ku heterodimer to broken ends, recruiting a protein kinase (DNA PKcs) and forming a 
complex that leads to further recruitment of other proteins (Artemis, LIGIV, XLF and 
XRCC4) that facilitate ligation of the two ends. Chromosomal rearrangements occur as a 
result of joining of two strands that are from different genomic regions. MMEJ differs from C- 
NHEJ in the proteins that bind to the broken ends of DNA. The proteins involved in C-NHEJ 
have not been identified in Plasmodium. Instead, it is thought that the malaria parasite uses 
altemative-non homologous end joining (a-NHEJ) in addition to HR to repair DNA (Kirkman 
et al. 2014). The model of NHEJ is illustrated below (Figure 1.4).
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1.3.2 Replicative mechanisms
The presence of microhomology at breakpoint junctions does not only provide evidence for 
NHEJ but also the involvement of DNA replication in chromosomal rearrangements (Lee, 
Carvalho and Lupski 2007, Zhang et al. 2009, Hastings et al. 2009). From studies in 
Escherichia coli and the human genome, it is proposed that template switching within a 
replication fork results in structural changes in the genome. The presence of short lengths of 
homology in the exposed lagging strand in a replication fork may result in formation of 
secondary structures that prevent replication of certain segments leading to deletion of 
sequences (Hastings et al. 2009). Deletions observed in regions that occur between two sites 
with sequence similarity and a length between them the size of an Okazaki (short fragments 
newly synthesized in the lagging template strand in a replication fork) fragment supports the 
proposition of slippage/template switch in DNA replication within the same replication fork 
(Figure 1.5) (Albertini et al. 1982, Hastings et al. 2009).
In some instances, formation of secondary structures may block continuation of synthesis of 
the lagging strand resulting in the exposed 3’ end annealing to a different exposed single 
strand with short sequence similarity on a different replication fork (Zhang et al. 2009, 
Carvalho et al. 2013, Gu et al. 2008). This results in duplications, deletions or inversion of 
distant genomic regions, a mechanism referred to as Fork stalling and template switching 
(FoSTeS) (Figure 1.5).
A third replicative mechanism known as microhomology mediated break-induced replication 
(MMBIR) is proposed to occur when an exposed single stranded end from a collapsed 
replication fork (due to a nick in DNA template) anneals to any other single strand with
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Figure 1.4. Model for formation of CNVs by non-homologous end joining (NHEJ).
Double stranded breaks in the genome at region c is repaired by binding of the proteins 
involved in NHEJ to the exposed ends (c). This is followed by resection and ligation of broken 
ends. A deletion of region c is observed as a result of the exposed ends ligation to other 
exposed ends (b) with sequence similarity. Image reproduced from Hastings et al. 2009 with 
permission from Nature Publishing Group.
In P. falciparum, DNA secondary structures have been shown to associate with recombination 
sites of var genes (Sander et al. 2014). The secondary structures are thought to promote 
recombination during replication of DNA generating diversity of var genes that encode 
PfEMPl. PfEMPl is a protein important for sequestration of the parasite to host endothelial 
cells and under antigenic variation to evade host immunity.
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Figure 1.5. Models of CNVs formation by replicative mechanisms mediated by 
microhomology
Microhomology mediated mechanisms of CNV formation that occur during DNA replication 
include A) replication slippage as a result of secondary structure formed due to presence of 
regions of single stranded DNA with sequence similarity within a replication fork, B) fork 
stalling and template switching (FoSTeS) caused by formation of hairpins that hinder the 
progress of a replication fork resulting in invasion of the exposed single stranded DNA to 
another replication fork with short sequence similarity and finally C) MMBIR is proposed to 
occur in collapsed replication forks due its encounter of a nick in the DNA template. Image 
reproduced from Hastings et al. 2009 with permission from Nature Publishing Group.
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1.4 Functional impact of CNVs
The impact of CNVs on phenotypic variation has been observed in a number of organisms 
(Henrichsen et al. 2009, Craddock et al. 2010, Hou et al. 2012, Anderson et al. 2009, Chen et 
al. 2012). This has been evaluated by studying the association between gene copy number and 
gene expression levels and also through associations of copy number with important 
phenotypes. Gene expression variation is commonly used as a proxy for phenotypic variation.
1,4,1,1 CNVs and gene expression
CNVs may affect gene expression levels through altering gene dosage, introducing changes in 
regions that regulate gene expression, and possibly by modifying the chromatin environment 
of a gene (Kleinjan and van Heyningen 2005). Studies on the effect o f CNVs on gene 
expression levels in P. falciparum have revealed that certain CNVs influence the transcript 
levels of the genes within the CNV regions and also outside these regions (Mackinnon et al. 
2009, Gonzales et al. 2008). Gene copy number has been shown in P. falciparum to both 
positively and negatively correlate with gene transcription levels suggesting a second 
mfechanism in addition to the direct dosage effect (Mackinnon et al. 2009, Gonzales et al. 
2008). One example of this is an amplification of a region in chromosome 5 containing the 
multidrug resistant gene 1 (mdrl) that has been identified as a ‘hotspot’ for gene expression 
regulation through gene expression quantitative trait loci (eQTL) analysis of the progeny of 
HB3 and Dd2 genetic cross (Gonzales et al. 2008). This region has been shown to associate 
with transcription levels o f269 genes. It was observed that an increase in copy number in 
progeny that inherited multiple copies from Dd2 resulted in subsequent increase in transcript 
levels of 85% of the 269 genes and decrease in transcript levels of 15% of the genes (Gonzales 
et al. 2008). Locus-specific studies on GTP cyclohydrolase 1 gene (gchl) amplification also 
report an increase in gchl expression with increased copy number, gchl amplification has
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been indirectly associated with antifolate resistance in geographic regions that historically use 
antifolates as antimalarial drugs (Nair et al. 2008).
1.4.1.2 Influence of CNVs on phenotypic variation and parasite adaptation
Directional selection on P. falciparum parasites bearing CNVs associated with certain 
phenotypes has been explored in several studies as discussed below.
1.4.1.2.1 Drug resistance
Some of the CNVs associated with malaria treatment failure include the amplification of a 
locus in chromosome 5 containing the multidrug resistance gene (mdrl) (Gadalla et al. 2011, 
Lim et al. 2009) and a region in chromosome 12 containing the GTP cyclohydrolase {gchl) 
gene (Nair et al. 2008). Increased copy number of the region containing mdrl has been linked 
to resistance to mefloquine, halofantrine and artemisinin whereas reduced copy number is 
associated with chloroquine resistance (Sidhu et al. 2006, Price et al. 2004). Amplification of 
gchl, encoding an enzyme involved in the folate synthesis pathway, has been strongly 
associated with a mutation on dihydrofolate reductase (<dhfr-164L) and marginally associated 
with mutations on dihydropteroate synthase (dhps-A436S and dhps A581G)) (Nair et al. 2008, 
Robinson et al. 2011). DHFR and DHPS are enzymes that act downstream of GCH1 in the 
folate biosynthesis pathway and form targets of antifolate drugs. These mutations has been 
linked to resistance to antifolate malaria drugs and found at high frequency in Thailand 
(Sirawarapom et al. 1997, Nair et al. 2008, Plowe et al. 1998). The gchl amplification has also 
been observed to exist at a higher frequency in Thailand, a region with historical use of 
antifolates as first-line treatment, with higher selection of resistant parasites than a second 
region, Laos, where antifolates were second-line treatment at the same period (Nair et al.
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2008). It is thought that increased gchl copy number acts a compensatory mechanism for 
altered function of DHFR and DHPS enzymes as a result of the mutations (Kidgell et al. 
2006).
1.4.1.2.2 Host immunity
Host immunity is thought to be one of the factors involved in selection of parasites bearing a 
deletion at the C-terminal of reticulocyte binding protein homolog 2b (PfRh2b) located in 
chromosome 13 (Ahouidi et al. 2010). The deleted region is thought to facilitate binding and 
erythrocyte invasion of the parasite. This polymorphism has been shown to exist at a higher 
frequency in Senegal, Tanzania and Malaysia as compared to Thailand and Brazil (Ahouidi et 
al. 2010). The difference in frequency is speculated to be as a result o f difference in 
polymorphisms on the host erythrocyte receptors and origin of the deletion in Africa and its 
spread to the rest of the world. It was also observed that antibodies against the C-terminal 
existed in Senegal and Tanzania and increased with age, though the increase was not 
statistically significant. These antibodies are thought to bind to the C-terminal and possibly 
block sialic-acid independent erythrocyte invasion. Therefore, the deletion may be a 
mechanism by which the parasite evades host immunity, thus potentially explaining its 
existence at non-trivial frequencies (Ahouidi et al. 2010, Reiling et al. 2010). This evidence is 
inconclusive since the presence of the antibodies was not tested in the regions with low 
deletion frequencies (Thailand and Brazil). Furthermore, deletions in both homologs (Rh2a 
and Rh2b) have been observed in clinical isolates in other studies (Robinson et al. 2011). 
RH2a and RH2b proteins are involved in erythrocyte invasion through the sialic acid 
independent pathway (Sahar et al. 2011).
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1.4.1.2.3 Adaptation to in vitro environments
Parasites bearing CNVs associated with cell invasion, cytoadherence, and gametogenesis 
among others, have been reported to be selected during in vitro culture propagation. These 
CNVs include large subtelomeric deletions in chromosome 2 and 9 (resulting in loss of a 
number of genes) that have been associated with loss of cytoadherence and loss of both 
cytoadherence and gametogenesis phenotypes respectively (Ribacke et al. 2007, Shirley et al. 
1990, Biggs, Kemp and Brown 1989, Mackinnon et al. 2009, Kemp et al. 1992). Other CNVs 
observed to arise in vitro include an inversion of a region containing a gene encoding ring- 
infected erythrocyte surface antigen (RESA) coupled with a deletion upstream of the same 
gene observed in knobless parasites that do not express the resa gene (Pologe, de Bruin and 
Ravetch 1990). RESA is one of the proteins exported to the erythrocyte surface and thought 
to be involved in blocking additional merozoite invasion of an already infected erythrocyte, 
decreasing deformability of infected host erythrocytes containing the early ring stage of the 
parasite and also protecting the parasite during episodes of high fever of the host (Mills et al. 
2007, Pei et al. 2007). Another important variant observed in cultured parasites is a deletion of 
skeleton binding protein 1 gene (pfsbpl) (Cheeseman et al. 2009), known to be involved in 
erythrocyte membrane protein 1 (PfEMPl) trafficking to the infected red blood cell surface 
(iRBC) (Maier et al. 2007). These gene copy number changes have not been observed in 
clinical samples and therefore may be involved in an otherwise costly mechanism that is 
important to the parasite for maintaining itself in a host.
In culture, the action of immunity and the need for sexual reproduction is diminished and thus
selection for parasites with high growth rates may occur (Ribacke et al. 2007). High growth
rates of parasites in culture have been linked to increased copy number of the gene encoding
reticulocyte-binding protein 1 (RH1) (Ribacke et al. 2007). This CNV has only been seen in
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some culture-adapted parasites and not in fresh clinical isolates and may be a relief of fitness 
cost associated with host immunity or host receptor polymorphisms(Nair et al. 2010, Stubbs et 
al. 2005). RH1 protein is involved in the sialic acid-dependent invasion of the merozoite into 
the host erythrocyte hence the gene amplification is thought to promote the parasite's rate of 
growth in culture.
Drug selection in the laboratory has led to generation of parasite lines resistant to certain 
drugs. Some of the drug resistance traits have been associated with gene copy number 
differences between the resistant and sensitive strains. These include amplification of the 
region containing pfmdrl (Sidhu et al. 2006, Price et al. 2004, Jiang et al. 2008a), which has 
also been reported in clinical isolates, increased copy number offalcipain-2 and falcipain-3 
genes seen in parasite lines resistant to a drug that inhibits cysteine protease (Singh and 
Rosenthal 2004), and deletion of 15 genes (PF3D7 1000900 to PF3D7_1002100) in 
chromosome 10 in parasites bearing mutations in chloroquine-resistant transporter gene (pfcrt) 
exhibiting different drug resistance profiles (Jiang et al. 2008a). Another deletion of 23 genes 
in chromosome 14 was observed in two Dd2 clones selected for fosmidomycin resistance and 
not in the wild type parasite (Dharia et al. 2009). One of the genes deleted is Deoxy-D- 
xylulose 5-phosphate reductoisomerase (pfdxr) which encodes an enzyme involved in the 
isoprenoid synthesis in P. falciparum that is under inhibition by the drug. An amplification of 
dihydrofolate reductase {dhfr) gene was observed in parasites subjected to increased doses of 
pyrimethamine leading to development of resistance (Thaithong et al. 2001). Knowing 
whether CNVs directly cause or are in linkage with causal mutations of drug resistance will be 
useful in monitoring drug resistance and would also offer insight into improving treatments.
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Overall, adaptation of parasites to laboratory culture has been shown to generate non-natural 
gene copy number changes, as seen by considerable lack of overlap in CNVs genes identified 
in fresh clinical and laboratory adapted strains in published studies. Therefore the studies of 
CNVs so far, most o f which have been performed on culture adapted isolates, might not be 
informative for understanding the role of CNVs in natural populations. There is thus a need for 
large scale exploration of CNVs in fresh field isolates to determine the extent of these variants 
in the genome and their potential role in adaptive evolution of the natural population of 
parasites.
1,5 The role of CNVs in P. falciparum
The evidence, so far, points to the contribution of CNVs to the dynamic structure of the 
genome that enables the parasite to adapt to its changing environment. First, the high 
abundance of repeat regions and monomeric A/T tracts in the genome (Gardner et al. 2002, 
Samarakoon et al. 201 lb) increases the chances of recombination events that lead to CNV 
formation that may constantly change the genome structure. The breakpoints of two CNVs, 
i.e., amplification of mdrl and gchl have been observed to consist of monomeric A/T tracts 
(Nair et al. 2007, Nair et al. 2008). Additional evidence for the contribution of CNVs to the 
dynamic genome structure is the observation of CNV regions with multiple copy number 
states, e.g., the number of copies of gchl has been found to vary from 1-11 copies in a 
population (Nair et al. 2008). Differences in CNVs observed between parasite parent lines and 
the progeny lines further illustrates the contribution of CNVs to the dynamic state o f the 
parasite’s genome (Samarakoon et al. 201 la). The growing evidence for the potential adaptive 
relevance of the CNV in the parasite warrants an investigation of the CNVs in nature and their 
potential adaptive role.
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1.6 Scope of the thesis
Most studies of CNVs in P. falciparum have been on a small scale and performed in short­
term or long-term cultured parasite lines which are not representative of natural populations. 
One of the reasons for the small number of clinical isolates previously studied is the low 
quantities of genetic material that are available for the assays: this issue has now been solved 
by use of whole genome amplification techniques. Furthermore, there has been growing 
evidence for the importance and impact of CNVs on disease and evolution in various 
organisms, simultaneous with remarkable improvements in technologies that facilitate high- 
throughput genome-wide scans for CNVs, thereby setting the stage for large-scale studies of 
CNVs in P. falciparum.
In this thesis, it is hypothesised that CNVs are important for the adaptation of the parasite to 
its variable environment. My goal is to establish the distribution of the CNVs in the parasite 
genome, determine frequency of CNVs in three P. falciparum populations in Eastern Africa, 
using microarrays, and identify the CNVs that may be under selection. Some of the differences 
among the three populations include variation in malaria transmission intensity (Noor et al. 
2014, Okiro et al. 2010), antimalarial drug use (Amin et al. 2007), host genetics (Piel et al. 
2010) and vector populations (Mwangangi et al. 2013). Apart from CNV identification, 
validation of the CNVs using a different technology, i.e., sequencing was performed. In 
addition, the influence of CNV on gene expression was investigated. The overall aim of this 
thesis is to identify and characterise CNVs in natural populations of parasites and determine 
whether they are involved in adaptation.
The methodology is described in Chapter 2. Chapter 3 presents results of a genome-wide 
screen for CNVs in four spatially and temporally separated populations of P. falciparum under
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different transmission intensities using microarrays with a view to identifying the CNVs under 
selection. Described in this chapter is the analytic approach of identifying CNVs using 
microarrays, including an investigation of the effects of various parameter settings on CNV 
detectability in order to select the settings that best define CNVs from microarray data. In 
addition, a number of systematic effects relating to experimental design that affect CNV 
detection were explored in order to help isolate the effects of population differences -  the 
main focus of the study - from methodological effects. The distribution of the CNVs in the 
genome is shown and the frequency of each in the populations determined. A number of 
functional gene groups were found to be enriched in the CNV gene list. Using population 
genetics analysis, CNVs with frequencies that appear to be highly differentiated between 
populations and potentially under selection were reported.
Chapter 4 focuses on confirmation of the CNVs detected using microarrays by whole genome 
sequencing of 22 of the 183 samples using PGM Ion Torrent machine. A summary of the 
sequence data output including quality and read coverage is given first. Read depth analysis is 
then used to detect CNVs which involves mapping of reads to a reference genome followed by 
the use of a CNV calling tool that identifies regions that differ in sequence coverage from 
normal. CNVs were detected in different target genomic regions in an effort to understand the 
effect of various aspects of the P. falciparum genome, e.g., low complexity regions, which 
may affect CNV detection. Some correspondence between microarrays and sequencing was 
observed. The chapter mostly highlights the challenges in using whole genome sequence data 
for CNV detection.
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In Chapter 5, the effect o f CNVs on expression of genes within the CNVs and those outside 
the CNV regions was investigated with a view to understanding the functional impact of 
CNVs in P. falciparum.
In Chapter 6, the main findings was summarised and their implications for future research in 
malaria parasite biology discussed with a view to design tools that are useful for the ultimate 
control of this disease.
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Chapter 2 
M aterials and Methods
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2 Chapter 2: Materials and methods
2.1 Population study of CNVs by microarrays
2.1.1 Study population
Patients with malaria attending healthcare facilities in three Eastern Africa regions were 
recruited for the study. Malaria positivity was determined by microscopy. The study 
populations include North Eastern Sudan (Gedaref, Kassab, Medani) and two populations, 
Kisumu (at western Kenya) and Kilifi (at the coast of Kenya with low, high and moderate 
malaria transmission intensities, respectively (Noor et al. 2014, Okiro et al. 2010). The study 
participants in Kilifi were recruited at two time points; (1994-1996) a period with higher 
transmission intensity and 2010 a period with lower transmission intensity (O’Meara et al. 
2008). The participants from Kisumu and Sudan were recruited in 2008 and 2007 
respectively. The populations also differ in antimalarial drug used (Amin et al. 2007), vector 
populations (Mwangangi et al. 2013) and host genetics (Piel et al. 2010). Ethical approval for 
the study was obtained from the Kenyan National Ethical Review Committee (SSC 1292). 
Written consent was obtained from parents/guardians of the study participants if  they were 
below 14 years, or the participants themselves otherwise.
2.1.2 Sample processing
For samples used for Comparative Genome Hybridization (CGH) by microarray, 2-5 ml of
blood was drawn by venepuncture from patients into sterile heparinised tubes (BD) and
placed at 4-8°C before further processing within 12 hours. To minimize contaminating human
host genetic material, whole blood obtained from individuals was centrifuged at 440 x g for 5
minutes and plasma and buffy coat removed. An aliquot of the infected red blood cell pellet
(iRBCs), between 30 pi- 200 pi, of each sample, was stored at -80°C for CGH after washing
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the pellet in IX Phosphate Buffered Saline (PBS) (Oxoid). For some of the samples collected 
from Sudan, the buffy coat was not removed prior to washing and storing.For samples used for 
DNA sequencing, the buffy coat was returned to the tube with the remaining iRBCs pellet 
onto which 5ml of incomplete culture medium was added, mixed and then layered on top o f 3 
ml of sterile Lymphoprep (Axis-Shield Pos AS) contained in a separate 15ml tube in order to 
separate PBMCs for other studies. The incomplete culture medium was made up of 500ml of 
RPMI 1640 (Gibco), 18.75ml of IM HEPES buffer (Gibco), 5ml of 2mM L-glutamine 
(Gibco), 1.25ml of lOmg/ml gentamicin (Gibco), 5ml of 20% glucose (Gibco), 3 ml of 1M 
NaOH. The tube was centrifuged at a speed of 440 x g for 20 min. The layer containing 
peripheral blood mononuclear cells (PBMCs) was removed. Granulocytes were then removed 
from the remaining iRBCs pellet by Plasmion (Bellon) flotation. An aliquot of 100-200 pi of 
these white cell-depleted iRBCs, to be used for whole genome sequencing, was stored in 1ml 
of glycerolyte (42.25% glycerol, 0.1M Sodium Acetate, 4mM KC1, NaFhPCU pH 6.8 (Sigma- 
Adrich)) in cryovials (Thermo Fisher Scientific Inc.) in liquid nitrogen.
The reference parasite line used in CGH, a Kilifi laboratory adapted line, originated from a 
malaria patient at the Kilifi District Hospital (Mackinnon et al. 2009). The parasite line was 
maintained in vitro at 2% hematocrit in complete medium made up of incomplete medium, 
human red cells (O cells) and 10% human serum. The culture medium in the flasks was 
changed every other day and gassed with a gas mixture (BOC) containing 3% carbon dioxide, 
1% oxygen and 96% nitrogen.
2.1.3 Genomic DNA extraction
Genomic DNA was isolated from Kilifi samples by lysis of 30 pi- 200 pi of iRBCs using
saponin. The iRBCs were resuspended in IX PBS to a final volume of 1 ml followed by
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addition of 1 ml of 0.1% of saponin (Sigma) dissolved in IX PBS to obtain a final 
concentration of 0.05% saponin (Sigma).The resuspension was incubated for 3 minutes at 
room temperature and centrifuged for 10 minutes at a speed of 1440 x g. The pellet was 
washed with 3 ml cold IX PBS. Protein digestion and further lysis of the pellet was performed 
by incubation in 75ul Proteinase K (20 mg/ml) (Applied Biosystems) and 425 pi lysis buffer 
(containing 80mM EDTA (Sigma-Aldrich) at pH 8.0, 40mM Tris-HCl (Sigma) at pH 8.0 and 
2% SDS (Sigma)) for 1 hour at 37°C. Finally, separation of DNA from proteins was achieved 
by adding 500 pi of phenol chloroform (Invitrogen) to the lysed material and centrifugation at 
11714xgto separate the aqueous layer containing nucleic acid from the inorganic material. 
Genomic DNA (gDNA) was precipitated from the aqueous mixture using 500 pi isopropanol 
(Sigma-Aldrich) and 0.1 X the total volume (aqueous mixture and isopropanol) of 3M sodium 
acetate (Ambion) at -20 °C overnight. The precipitate was washed with 700 pi 75% ethanol 
(Sigma-Aldrich), dried and resuspended in 20 pi IX TE buffer (Invitrogen). Sudan and 
Kisumu DNA samples were extracted from 100 pi blood pellet using the automated ABI 
PRISM 6100 Nucleic Acid PrepStation (Applied Biosystems) as described in the 
manufacturer’s protocol. The extracted DNA was eluted in 100 pi BloodPrep DNA Elution 
solution 2 (Applied Biosystems). The presence and integrity o f extracted gDNA was 
confirmed using a 1% agarose (Promega) gel electrophoresis.
2,1,4 Multiplicity of infection
The number of distinct parasite clones per isolate was determined by genotyping of P.
falciparum merozoite surface antigen 2 {msp2) using a method developed by Liljander and
others (Liljander et al. 2009). The procedure involves a nested PCR reaction with the primary
PCR amplification of block 3 of msp2 followed by a secondary PCR with fluorescent primers
targeting the msp2 allelic types FC27 and IC. Fragment analysis of the PCR product was
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performed using capillary electrophoresis and the results analyzed using GeneMapper® 
Software version 4.0 (Applied Biosystems). One microliter of the DNA sample, extracted 
using different methods (described in section 2.1.3), was used in the PCR. The samples 
assayed had different parasite DNA quantities per microliter hence could lead to bias in the 
estimation of MOI.
2,1,5 Comparative genomic hybridization (CGH)
2.1.5.1 Microarray design
The microarray used for the study consisted of 70mer oligonucleotides (probes) spotted on a 
glass slide (Bozdech et al. 2003b). The design and printing o f the array was done at Assoc. 
Prof. Zbynek Bozdech’s laboratory, a collaborator, at Nanyang Technological University in 
Singapore. The probes on the array were designed using the available complete P. falciparum 
genome sequence of 3D7 parasite line (Gardner et al. 2002) to target conserved regions of 
approximately 5400 genes with an average of 2 probes per gene (Bozdech et al. 2003b). The 
CGH experiment was carried out in a microarray facility established in the KEMRI-Wellcome 
Trust Research Programme laboratories in Kilifi, Kenya.
2.1.5.2 Whole genome amplification
The CGH experiment was performed on 183 samples, with 8 of these samples with duplicate 
experiments. To increase the amount of DNA available for hybridization to the array, whole 
genome amplification using random nonamers was performed (Petalidis et al. 2003). The 
samples were randomized during amplification and hybridization experiments to minimize 
experimental variability. The whole genome PCR amplification involved three steps. First, 
random priming was performed on lOOng of gDNA (gDNA quantity measured using
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Nanodrop 2000 (Thermo Scientific)) using random nonamers (SMART-Random) consisting 
of 9 random nucleotides with a 23 bp sequence tag (5’-
AAGCAGTGGTATCAACGCAGAGTNNNNNNNNN-3 ’), obtained from Eurofins MWG, at 
95°C for 6 min. The second step, PCR extension of the randomly primed regions, involved 
addition of 2.5 units of Klenow fragment (5U/pl) (3 '—>5' exo-) (New England Biolabs), 1 pi 
of 3X dilution of aa-dUTP/dNTP mix (consisting of 34 pi of lOOmM dATP, 17 pi each of 
lOOmM dCTP, dGTP, dTTP (New England Biolabs), 17 pi of lOOmM amino acyl dUTP 
(aadUTP) (Biotium) and 11.3 pi o f distilled water), 1 pi NEBuffer 2 (New England Biolabs) 
and 2.5 pi ddfbO. The Klenow fragment is a large fragment of DNA polymerase 1 that lacks 
the 3’-5’ exonuclease activity hence facilitates incorporation of aadUTP that enables coupling 
of the Cy3 and Cy5 fluorescent dyes used for DNA labelling (GE Amersham). The 
thermocycling conditions for the Klenow mixture were; 25°C for 10 min, 37°C for 60 min and 
75°C for 20 min. The last step involved a lOOpl PCR amplification reaction containing 10 
units of DNA Taq Polymerase (5U/pl) (New England Biolabs), 6 pi of lOOnM primer 
(SMART-Amplification) complementary to the tag sequence in the random primer (5’- 
AAGCAGTGGTATCAACGCAGAGT-3 ’) (MWG), 10X Buffer, 1.5 pi of aa-dUTPs/dNTP 
mix and 2.5 pi of the Klenow mixture product. The PCR amplification ended at the linear 
phase, after 19 cycles, to maintain the relative abundance of DNA. The thermocycling 
conditions for this step are shown below (Table 2.1).
The PCR product was purified using QIAquick PCR Purification Kits (Qiagen). The 
purification procedure was provided with the kit and it involved addition of 500 pi of PB 
binding buffer to the PCR product then transferred to the spin column. This was followed by 
centrifugation at 15026 x g for 1 min and the flow-through discarded. 750 pi of PE buffer was 
added to the column, centrifuged for 1 minute and flow through discarded. Additional 1 min
Page 50 o f 191
Table 2.1. Thermocycling conditions for PCR amplification of Klenow reaction product
Tem perature Time Number of cycles
95°C 5 min 1
60°C 1 min 1
68°C 10 min 1
95°C 30 sec I
60°C 30 sec 1r 1968°C 5min J
72°C 5 min i
4°C Hold
centrifugation was performed to remove any remaining PE buffer. The column was then 
placed on a clean 1.5ml tube and 14 pi of Elution buffer added and incubated for 5 minutes. 
The spin column was spun for 1 minute to recover the purified PCR product. The DNA was 
then quantified using the Nanodrop 2000 (Thermo Scientific) and run on a 1% agarose gel. 
The size of the PCR product ranged between 100-200bp (Figure 2.1).
1 2 3 4 5 6 8 9 10 11 12 L
# * * Imi tout * * In #  tot tomtto * i  *
■3000 bp 
.1000 bp 
'500 bp
-100 bp
Figure 2.1. Size of amplified DNA using random nonamers
Image of 1% agarose gel containing PCR products from 12 samples (1-12) and sizes indicated 
by ladder (GeneRuler DNA Ladder Mix (Thermo Scientific) run in 2 wells (L). As 
expected,the majority of amplified fragments were between lOObp and 200bp.
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2.1.5.3 Dye labeling
Cyanine dyes, Cy3 and Cy5 dyes, (GE Amersham) were coupled to reference and test DNA 
samples respectively. Dye coupling involved mixing of 10 pi of the purified PCR product, 
with a concentration of at least 3 pg, 2 pi of 0.5M NaHCCb (Sigma) and 2 pi each of Cy3 and
Cy5 dye, containing 3076 pmol of reactive dye, resuspended in DMSO4 (Sigma). This was 
incubated at room temperature, in the dark, for 4 hours followed by removal of the uncoupled 
dye using the QIAquick PCR Purification Kit (Qiagen). The purification procedure was 
similar to that described in section 2.1.5.2 with changes in the volume of PB buffer added to 
700 pi and Elution Buffer of 12 pi. The concentration of the purified labelled material was 
determined using the ‘microarray’ mode on Nanodrop 2000 (Thermo Scientific). The labelled 
material was stored at -20°C awaiting hybridization.
2,1,5,4 Hybridization of sample and reference DNA
The printed slides were hydrated using vapour from 2X saline-sodium citrate (SSC) buffer 
(Sigma-Aldrich) for 20 sec and dried on a heated block at 100°C. This was followed by UV 
crosslinking at an energy level of 80,000 microjoules per cm2 in a HL-2000 HybriLinker™ 
System (UVP) for 1 min. The slides were then fully immersed in blocking buffer for 45 
minutes at 42°C under rotation to reduce non-specific binding to the glass slide. The blocking 
buffer contained 1% bovine serum albumin (PAA), 5X SSC buffer (Sigma-Aldrich) and 0.1% 
SDS (Sigma). The slides were then washed with distilled water and dried on a benchtop rotor 
with slide holders. The microarray chamber known as HX3 mixer (Nimblegen) was assembled 
on each slide, using a slide alignment tool, ready for sample loading.
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Prior to loading the samples, a hybridization master mix, containing 3 pi of 20X SSC buffer, 
0.45 pi of 10% SDS and 0.5 pi of 1M HEPES per sample, was prepared. A volume containing 
2 pg of Cy3 labeled product, 2 pg of Cy5 labeled product and 3.95 pi of the hybridization mix 
was combined and topped up, with distilled water, to a final volume of 20 pi. This procedure 
was carried out in the dark. The tube containing the mixture was placed on a heating block at 
100°C for 5 min, to denature DNA, and allowed to cool at room temperature for 5 min. The 
mix was then loaded to the assembled slides and placed in a MAUI 12-bay hybridization 
station (BioMicro Systems) overnight (at least 12 hours) at 65°C.
The hybridized slides were washed twice in an ArraylT wash bucket with slide holder. The 
first wash was in a solution containing 15ml of 20X SSC buffer, 1.5ml of 10% SDS and 
510ml of distilled water with magnetic stirring. The second wash solution contained 1.5 ml 
20X SSC buffer and 520 ml of distilled water. The slides were then dried by centrifugation.
All these procedures were performed in the dark since the dyes are photosensitive.
2,1,5,5 Image acquisition
The slides were scanned by the GenePix 4000B Microarray Scanner (Molecular Devices) 
using GenePix Pro 4.0 software (Molecular Devices) at optimal wavelengths ranging from 
600-690 nm for the Cy5 dye and 350-420 nm for the Cy3 dye and at a resolution of 10 pm.
The images were saved as TIFF files (Figure 2.2). Using GenePix Pro 4.0, a GenePix Array 
List (GAL) file, containing the sizes, positions and probe identifiers of the spots on the array, 
was overlaid on the images. By visual inspection of the images, poor quality spots and regions 
were marked as bad. The results were saved as GenePix Results (GPR) files.
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2.1.6 Microarray data analysis
2.1.6.1 Pre-processing of microarray data
Analysis of the microarray data was performed using the linear models for microarray analysis 
(ilimma) package (Smyth 2005) in R. The GPR files were imported into R. The quality o f the 
data was assessed using the flag values associated with each spot. Spots with flag values of 
less than zero, i.e., -100, -75 and -50 indicated as ‘bad’, ‘absent’ and ‘not found’ respectively 
were considered of poor quality. The GenePix 4.0 software flagged a spot as ‘bad’, if by 
manual inspection, it was marked of poor quality, ‘absent’ when the GAL file lacked a probe 
identifier associated with the spot or the identifier was indicated as ‘empty’ and lastly ‘not 
found’ if the spot had less than 6 pixels, or its size greatly differed from that in the GAL file.
Spots with the above flag values were weighted as zero and were not included in further 
analyses. To remove any experimental variation, the background intensity was subtracted from 
the foreground by a method known as ‘normexp’ in limma (Ritchie et al. 2007). The method 
uses a normal plus exponential convolution model where the normal distribution reflects the 
background intensities and the exponential distribution reflects the signal intensities. The 
background intensity was calculated from regions outside each spot while the foreground 
intensity was determined from within each spot. Normalization of the data within the array 
was performed using “robustspline” (Smyth and Speed 2003) in limma. This involves, for 
each array, normalization of log2 intensity ratios with respect to the overall intensity values in 
each array. This normalization minimizes the bias in log2 intensity ratios observed at low 
intensities. After this, between-array normalization was performed using the “quantile” 
method which standardizes the intensity means and inter-quartile ranges across arrays.
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3 mm
Figure 2.2. Image of a hybridized array
Image of a single array obtained using GenePix 4000B Microarray Scanner. The array 
contains 16 blocks with red, green and yellow spots. The yellow spots indicate equal 
hybridization of the test and reference to the oligos. The red spots indicate oligos with higher 
amounts of hybridization of the test DNA (Cy5 dye (red)) than the reference DNA (Cy3 dye 
(green)). The green spots indicate oligos with higher amount of hybridization of the reference 
DNA (Cy3 dye (green)) than the test DNA (Cy5 dye (red)).
2,1,6.2 Detection of gene copy number variation using R-GADA
To identify genomic regions that vary in copy number using microarray data, a R package 
called Genome Alteration Detection Analysis (GADA) was used (Pique-Regi et al. 2010). The 
input to this program is normalised microarray log2 intensity data and location of the probes 
and the output is the location and supporting statistics for contiguous segments of genome that
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differ in log2 intensity (amplitude) from their flanking segments. The program includes two 
steps; segmentation analysis and backward elimination. The first step involves the conversion 
of the normalized log2 intensity ratios into piecewise constant vectors. It then employs a sparse 
Bayesian learning (SBL) model to identify the possible breakpoints and the segment average 
log2 intensity ratio (amplitude). The learning is controlled by the array noise level that is 
automatically generated from the data and a second sparseness hyperparameter, aAlpha (aa) 
that is manually set and controls the number of segments generated. When aAlpha is set at a 
high value, the expected number of segments a priori is fewer that when aAlpha is low. In the 
second step, backward elimination, a statistical analysis, t-statistic, is calculated for each 
breakpoint detected based on the mean and variance of the segments. Breakpoints with low 
statistical significance, i.e., with t-statistic less than the set T, are removed. Also included in 
this step is the filtering of segments based on the minimum number of probes within the 
segment. Thus the stringency on CNV detection can be applied by altering T, aAlpha and 
amplitude (magnitude of difference in signal between the putative CNV and its neighbouring 
genes) parameters in the GADA package. It can further be altered by defining the proportion 
o f probes per gene and genes per CNV required to define a CNV.
2.1.7 Statistical analysis
2.1.7.1 Systematic effects of CNVs detection
Once the CNVs were ‘called’, other study-specific systematic effects on their prevalence were 
analysed using mixed effects logistic regression models. The possible effects of population of 
origin, multiplicity of infection (MOI), haemoglobin, age of participant and parasitaemia (5 
fixed effects), experimental batch, isolate (sample) and CNV on the probability o f determining 
the presence or absence of a CNV (dependent variable) were explored. The model was fitted
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to each CNV separately using the ‘glmer’ command with the family as ‘binomial’ in linear 
mixed-effects models using the lme4 package in R. Because of the large number of levels in 
isolate and CNV, these factors, together with batch, were fit as random effects. Least squares 
means were calculated for each level of the fixed effects from the fitted models using the 
Ismeans package in R.
2.1.7.2 Functional gene set enrichment analysis of CNVs
Gene set enrichment analysis was performed on the list of genes identified to be copy number 
variable. The functional gene sets were obtained from Malaria Parasite Metabolic Pathways 
website: http://mpmp.huii.ac.il/. The hypergeometric test was used to identify functional 
groups of genes that were enriched. Hypergeometric test calculates the probability of overlap 
between two gene lists, i.e., genes detected as CNV and those in a functional gene group. The 
‘phyper’ function in the stats package in R was used. Functional groups with p-values of less 
than 0.05 were classified as statistically significantly enriched.
2.1.7.3 Population genetics analysis
The frequency of each CNV in each of the four populations was calculated. To characterize 
the between to within population variability in CNV frequencies, Weir and Cockerham F- 
statistics (F st) were calculated for each CNV using hierfstat as implemented in R (Goudet 
2005).
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2.2 Confirmation of CNVs by whole genome sequencing using the Personal Genome 
Machine (PGM™) Ion Torrent
2.2.1 Samples
Twenty-two out of the 183 samples with CGH data were selected for whole genome 
sequencing. These set o f samples had all the 98 CNVs reported in chapter 3 among them. An 
aliquot of iRBCs in glycerolyte stored in liquid nitrogen, described in section 2.1.2, was used 
for whole genome sequencing.
2.2.2 Genomic DNA extraction
Genomic DNA extraction was performed in two batches. The first batch of 9 samples were 
centrifuged and then the glycerolyte was removed. Then gDNA extraction procedure using the 
saponin lysis method described in section 2.1.3 was used. The second batch were processed 
using the procedure described in section 2.2.4. The presence of DNA after extraction was 
confirmed by 1% agarose gel electrophoresis and the quantity of DNA was measured using a 
Qubit® 3.0 Fluorometer. The DNA quantities ranged between 4-25 ng/pl in a volume of 20pl.
2.2.3 Quantification of the proportions of human and parasite DNA using real time 
PCR
The SYBR green method using primers (below) against parasite DNA and human DNA was 
used to quantify the amount of DNA from each organism in each of the samples. The parasite 
primer set targeted the fructose-bisphosphate aldolase gene (PF3D7_1444800) using the 
forward and reverse primer sequences below. The primer set was used as an endogenous 
control in qPCR by Salanti and colleagues (Salanti et al. 2003).
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PF3D7 1444800 forward primer: 5’-TGTACCACCAGCCTTACCAG-3’ 
PF3D7 1444800 reverse primer: 5’-TTCCTTGCCATGTGTTCAAT-3’
A commercially available human DNA primer targeting the beta hemoglobin gene: HUMAN 
hbb- Hs HBB l SG QuantiTect Primer Assay (Qiagen) was used to amplify human DNA. 
The qPCR assay was performed in 15 pi reaction with 7.5 pi SYBR Green Master Mix 
(Applied Biosystems), forward and reverse primers each at a concentration of 500nM, 1 pi (2- 
40ng) of DNA template and 5 pi DNAse free water. The cycling conditions for qPCR 
amplification on a 7500 Real-Time PCR System (Applied Biosystems) are listed in Table 2.2.
Table 2.2. Thermocycling conditions for qPCR assay for human and parasite DNA 
quantification
Stage Tem perature Time (min) Cycles
Holding 50°C 2.00 1
Holding 95°C 10.00 1
95°C 0.01 " L 45
Cycling 60°C 1.00 J
Melt Curve 95°C 0.15 1
60°C 1.00 1
The standard curve method (Applied Biosystems, User bulletin #2) was used to quantify the 
parasite and human DNA quantities in each sample. The standards were generated from pure 
parasite and human DNA extracted from a lab adapted parasite line and peripheral blood 
mononuclear cells (PBMCs) respectively. The standards consisted of 10-fold serial dilution of 
the DNA with the highest concentration at 50 ng/pl and the lowest at 0.005 ng/pl. The DNA 
quantities were measured using Qubit® 3.0 Fluorometer. The five human and parasite 
standards were included in each plate of the qPCR assays. The parasite and human DNA 
quantities for each sample were interpolated from the standard curves (Figure 2.3). The
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fraction of human and parasite DNA in the first 9 samples ranged from 5-71% (Table 2.3). 
This is comparable to the estimate obtained from next-generation DNA sequencing in most of 
the samples (Table 2.3).
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Figure 2.3. Quantification of parasite and human DNA using the standard curve method.
Plot (from 7500 Real-Time PCR software) of the relationship between C t  (threshold cycle) 
value of each well on the Y axis and the quantity of DNA (ng) in the well. The two standard 
curves, human (upper line) and parasite (lower line), generated from the qPCR measurements 
of the standards (red points), are shown. The samples assayed are indicated in green. The 
quantities of DNA in the standards are known and that of the samples are interpolated from the 
standard curves. The human and parasite standard curves have slopes of -3.38 and -3.31 which 
correspond to amplification efficiencies of 97.5% and 100.4%, respectively (calculated by the 
7500 Real-Time PCR software). The R2 values were 0.99 in both cases. The efficiencies, 
slopes and R values were calculated by the 7500 Real-Time PCR software.
2.2.4 Human DNA depletion by DNase treatm ent
In the first batch of 9 samples parasite DNA consisted of, on average, 37% and 54% of the 
total DNA content as determined by sequencing and qPCR respectively (Table 2.3). As this is 
wasteful of sequencing power, a protocol was developed to further minimize the amount of 
human DNA present in the additional 13 samples to be sequenced. This protocol was based on 
the principle that storage of iRBCs in glycerolyte preserves the integrity of RBCs but not 
PBMCs (Farrugia et al. 1993). If PBMCs, but not iRBCs, are lysed upon thawing, addition of 
DNase to the cells in glycerolyte would be expected to lead to digestion of human DNA but 
not parasite DNA.
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Table 2.3. Proportion of parasite DNA in samples determined by qPCR and also
obtained from whole genome sequence data.
Sample
Identifier
Parasitaemia 
par/p 1 (by 
microscopy)
Proportion of 
parasite DNA in 
sample by qPCR
Proportion of parasite 
sequences in 
sequencing output
pfl299 270,000 0.62 0.58
pfl349 74,000 0.55 0.45
pfl624 460,000 0.71 0.54
pf10676 280,000 0.43 0.42
pf10760 200,000 0.60 0.27
pfl 0814 6,600 0.05 0.13
pfl0836 910,000 0.79 0.63
pfl 0724 290,000 NA 0.22
pfGO 13 NA NA 0.05
Mean 600000 0.54 0.37
NA (first column) - No data on parasitemia due to unreadable microscopy slide of sample 
pfG013 .NA (second column) - Failed qPCR reaction. May be due to presence of PCR 
inhibitors The proportion of parasite sequences in sequencing output was calculated from the 
total sequence reads that mapped to 3D7 (as described in section 2.2.6) divided by the total 
sequence reads obtained for each sample.
The 13 samples stored in glycerolyte were centrifuged at 2156 x g for 3 min and glycerolyte 
removed. To the samples, 10X DNase buffer (Ambion) and 6 pi (12 units) of DNase 
(Ambion) enzyme were added and incubated at 37°C for 30 minutes. The enzyme was 
inactivated by 2 min incubation, at room temperature, with addition of EDTA at a final 
concentration of 15mM. The samples were resuspended in 2.5mM EDTA in 1 X PBS to a 
volume of 1 ml. gDNA extraction was undertaken as described in section 2.1.3 using the 
saponin lysis method. The percent of parasite DNA sequences after whole genome sequencing 
ranged between 5 and 98% in the 13 samples (Table 2.4). Unfortunately, no controls were 
tested in the human DNA depletion experiment to assess its success. However, the observation 
of comparable proportions of parasite DNA between blood samples from Sudan (pfM007 and 
pfM004) and Kisumu (pfK007, pfK020, pfK071) that were not subjected to prior removal of
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white blood cells (section 2.1.2) and Kilifi samples (pfl212, p fl0770, pfl 590, p f l0820 and 
pfl 0495) that had white blood cells removed (section 2.1.2) is promising.
Table 2.4. Proportion of parasite DNA sequences in whole genome sequence data of 
samples after DNase treatm ent
Sample
identifier
Proportion of parasite 
DNA sequences in 
sequence output
pfl 212 0.93
pfl 0770 0.62
pfl 590 0.18
pfl 895 0.98
pfK007 0.90
pfK020 0.94
pfK071 0.43
pfM004 0.70
pfM007 0.96
pfK065 0.05
pfl 0820 0.87
pfl0578 0.08
pfl 0495 0.98
2,2.5 L ibrary preparation of gDNA for sequencing
Library preparation of gDNA was performed using the Ion Xpress™ Plus Fragment Library 
Kit (Part No. 441269) according to the Ion Torrent protocol. 20 ng -100 ng of gDNA was 
fragmented using Ion Shear™ Plus reagents (Part No. 441248) to a median fragment size of 
between 200-300bp. The fragmented product size was assessed using Agilent Bioanalyzer™ 
2100 (Agilent Technologies, Inc) (Figure 2.4A). Adapters were ligated to the fragmented 
DNA, nick repaired and purified using Agencourt AMPure beads (Beckman Coulter). The 
target fragment size of approximately 330bp was selected for using E-Gel SizeSelect™ 2% 
agarose gel (Life technologies). Five cycles of PCR amplification of the size-selected DNA 
was performed (Figure 2.4B).
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Figure 2.4. Distribution of DNA fragment sizes
Graphs from Agilent Bioanalyzer™ 2100 showing the distribution of fragment sizes A) after 
enzymatic shearing of gDNA of sample loaded on well 11 and read as sample 11 by the 
machine (pfl 299) B) after size selection of fragmented DNA, for a 200bp library, and 5 cycles 
of PCR amplification of sample loaded on well 1 (pfl 299). The fluorescence units (FU) on the 
y axis represents the quantity of DNA fragments and the sizes of the fragments, in base pairs 
(bp) are shown on the x axis. The peaks at 35bp and 10380 are the sizing marker peak.
The quantity of the amplified product for use in emulsion PCR on the Ion One Touch 
Instrument (Life Technologies) was assessed using Ion Library Quantitation Kit on the 7500
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real time PCR machine (Applied Biosystems). A volume of the amplified products that 
corresponded to a concentration of 13pM of molecules were taken to emulsion PCR step. 
Emulsion PCR involves clonal amplification of individual DNA templates on magnetic beads 
in droplets formed in water-oil emulsion. The Ion PGM OneTouch Two Template Kit (Part 
No. 4480974) was used in the emulsion PCR. After the PCR, the percentage of templated ion 
spheres was assessed using Ion Sphere Quality Control Kit in order avoid sequencing of 
samples with insufficient templated Ion Sphere Particles or samples with multiple templates 
per Ion Sphere Particle. Enrichment of Ion Spheres with templates was then carried out on the 
Ion OneTouch ES. The enriched templated spheres were loaded onto an Ion 318 Chip (Part 
No. 4469497) with a capacity of up to 2 Gbp and sequenced. Signal processing and base 
calling was performed in the Ion Torrent Server. Trimming of 3’ end of reads based on base 
quality was turned off during base calling. The raw files in Standard Flowgram Format (SFF 
files) were converted to FastQ files using a plugin known as FastQCreator in the Torrent 
Server. The FastQ files were then exported for analysis.
2.2.6 Sequence data analysis
2.2.6.1 Mapping of reads to reference genome
The sequence reads contained in the FastQ files were mapped to a reference genome using the 
Burrows Wheeler Aligner (BWA) (Li and Durbin 2010). The reference genome used was 3D7 
version 3, available from GeneDB (Logan-Klumpler et al. 2012). The BWA-MEM option 
suitable for mapping of reads greater than 70bp was used and output to files in Sequence 
Alignment/Map (SAM) format. These files were converted to compressed binary versions 
(BAM format) using SAMtools (Li et al. 2009). Alignments with low alignment quality
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scores, i.e., less than 30 ,and reads mapping to multiple locations in the genome together with 
non-mapped reads were excluded from further analysis using SAMtools (Li et al. 2009).
2.2.6.2 CNV detection using sequence data
To detect CNVs in the sequence data, Copy Number estimation by Mixture Of PoissonS 
(cn.MOPS), in R, was used (Klambauer et al. 2012). Using cn.MOPS package, the BAM files 
were imported in R from which the read coverage across non-overlapping genomic windows 
was calculated. Normalization of read counts across all samples was performed using the 
‘quantile’ method to correct for differences in sequencing depth of the samples. To identify 
CNVs, cn.mops employs a mixture of Poisson distributionsmodel at each window across the 
samples. The model assumes that the read coverage for a specific copy number across samples 
has a Poisson distribution and in instances of presence of different copy numbers, the model is 
a mixture of Poisson distributions. An initial CNV call is made when there exists variation in 
coverage across the samples, e.g., a log2 fold difference of less than -0.8 (loss) or greater than 
0.8 (gain) between sample and the mean normalized coverage in the window. A second CNV 
call is made when consecutive initial calls along a chromosome are joined by segmentation 
analysis using the ‘fastseg’ method and called as a single CNV.
2.3 Transcriptome profiling using microarrays
Transcription profiling experiment was performed by Rono, M., Nyonda, M., Ngoi, J., Simam, 
J., Mackinnon, M. J. (unpublished). Below are the procedures that were undertaken in 
generation o f transcriptome data.
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2.3.1 RNA extraction
An aliquot of blood sample processed as described in section 2.1.2 was used for transcription 
profiling. Prior to storage, each fresh blood aliquot, 200 pi-1000 pi was subjected to 
laboratory culture to obtain parasites at all the 48 hr asexual stages, i.e., ring, trophozoite and 
schizont stages. Seven aliquots, of equal volume, were obtained from culture at an interval of 
10 hours each and the iRBCs pellet stored in TRI Reagent® (Sigma-Aldrich) at -80°C. I was 
involved in the culture of some of the parasites and set up of the sample database. To extract 
RNA from blood, the stored aliquot was thawed and TRI Reagent® (Sigma-Aldrich) was 
added to a total volume of lOOOpl and mixed. 240pl of Chloroform (VWR) was then added 
mixed and centrifuged at 2000 x g for 10 minutes at 4°C. The aqueous layer containing nucleic 
acid was separated, 500pl of Isopropanol (Sigma-Aldrich) added to it and stored at -20°C 
overnight to enable precipitation of the nucleic acids. The sample was spun at a speed of 
12000 x g for 1 hr at 4°C and the supernatant removed. The pellet was then washed with 500pl 
of ice-cold 75% Ethanol (Sigma-Aldrich) and dried. The pellet was resuspended in 20pl o f 
RNAsecure (Invitrogen) and incubated at 60°C for 10 minutes. The RNA quality and quantity 
was assessed by Nanodrop and 1% Agarose gel.
2,3.2 cDNA synthesis, amplification and hybridisation
First, reverse transcription reaction was performed on 500ng of RNA. To a volume of RNA 
containing 500ng, 2 pi o f a mixture of primers containing SMART-dT (MWG), SMART- 
Random (section 2.5.1.2), SMART-TS (MWG) at concentrations of 25pM, 25pM and 50pM 
respectively was added and the total reaction volume made up to 8 pi by adding distilled 
water. The primer sequences for SMART-dT and SMART-TS are shown below. The reaction 
mix was incubated at 65°C for 5 minutes and at 4°C for 10 minutes. Secondly, cDNA
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synthesis was carried out using the Superscript II Reverse Transciptase kit (Life 
technologies). It involved making a reaction mixture containing 4 pi of 5X First-Strand, 2 pi 
of lOOmM DTT, 2 pi of 3mM dNTPs, 1 pi of 40U/ pi RNAse OUT (Invitrogen) and 2 pi 
distilled water to the first reaction. The mixture was mixed and incubated at room temperature 
for 2 minutes. 1 pi of 200U/pl Superscript II (Invitrogen) was added then incubated at 42°C 
for 50 minutes and then 70°C for 15 minutes. The third step involved amplification of the 
cDNA, a method similar to the amplification step of gDNA (section 2.1.5.2). 2 pi 5U/pl Taq 
polymerase ( New England Biolabs), 10 pi 10X Taq thermopol buffer (New England Biolabs), 
1.5pl aa-dUTP/dNTP mix (described in section 2.1.5.2 ), 6pl SMART-amplification primer 
(section 2.5.1.2), 5pi of cDNA synthesis product and 75.5 pi of ddFbO were mixed and placed 
in a thermocycler under the following conditions below (Table 2.5).
SMART TS primer sequence: 5’-AAGCAGTGGTATCAACGCAGAGTACGCGGG - 3’ 
SMART dT primer sequence: 5’-AAGCAGTGGTATCAACGCAGAGTACTTTTTTTTTTT 
TTTTTTTTTTTTTTTTTTT AGCN-3 ’
Table 2.5. Thermocycling conditions for PCR amplification of cDNA
Temperature Time Number of cycles
95°C 5 min 1
60°C 1 min 1
68°C 10 min 1
95°C 30 sec 1
60°C 30 sec Su .  22
68 °C 5min J 1
72 °C 5 min 1
4°C Hold
The reference parasite line used for hybridisation was an isolate similar to that of CGH 
experiment; Kilifi isolate adapted to lab culture, ‘P 4 \ The amplified product used as reference
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for microarrays was prepared by pooling, at equal concentrations, the RNA from different 
lifecycle stages of the reference parasite line prior to cDNA synthesis and amplification.
The amplified product was purified, labelled with dyes and hybridized using the procedure 
described in section 2.1.5.2, section 2.1.5.3 and section 2.1.5.4 respectively. The image 
acquisition and microarray data pre-processing was performed as described in sections 2.1.5.5 
and 2.1.6.1, respectively.
2,3,3 Statistical analysis
The effect of CNVs on the expression of genes located within them was assessed by 
performing a Pearson correlation between the mean CGH ratio per gene and ‘Mean’ 
expression data obtained from Rono, M., Nyonda, M., Simam, J., Mwongeli, J., Mok, S., 
Marsh, K., Bozdech, Z. and Mackinnon, M J .  (unpublished work). The p-value for assessing 
significant differences from the expected correlation of zero under the null hypothesis of no 
relationship between gene copy number and expression levels was calculated using the cor. test 
function in R.
To investigate whether the correlation obtained from the analysis may have been by chance, a 
permutation test was performed. 100 random permutations of the expression data o f each gene 
were generated and the correlation between mean CGH ratio of each gene and each of the 100 
randomized expression data per gene was calculated. A test for significant differences 
between the distribution of observed correlations and distribution of correlations from the 
permuted data was applied using the Kolmogorov-Smimov test implemented in the ks.test 
function in R.
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To analyse the relationship between gene expression (of genes in the whole genome) and the 
CNVs detected, a linear regression model was applied using the Im function in R. The mean 
log2 expression ratio of each gene was the dependent variable while the copy number state 
(fitted as a fixed effect factor with levels for loss, gain or normal) was the independent 
variable. The significance of the difference in gene expression between samples with a gene 
copy number difference and those without was assessed from the p-value of the regression 
coefficient from the same model.
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Chapter 3
Population-wide survey of gene copy number variation in Plasmodium falciparum 
isolates from Africa
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3 Chapter 3: Population-wide survey of gene copy number variation in P. falciparum 
isolates from Africa
3.1 Introduction
Genome-wide scans for gene copy number variants (CNVs) in P. falciparum have led to the 
discovery that CNVs contribute to up to 1% of the genetic differences between parasite 
genomes (Anderson et al. 2009). CNVs have been linked to differences in gene expression 
among parasite strains (Mackinnon et al. 2009, Gonzales et al. 2008, Nair et al. 2008) and 
have also been associated with important phenotypes including drug resistance (Nair et al. 
2008, Price et al. 2004, Dharia et al. 2009), erythrocyte invasion (Jiang et al. 2008b), 
cytoadherence and gametogenesis (Shirley et al. 1990, Biggs et al. 1989, Kemp et al. 1992). 
However, most of these surveys have taken place in laboratory-cultured isolates and only a 
small fraction of parasite isolates studied so far are direct from infected individuals. Certain 
CNVs are known to arise in vitro (Nair et al. 2010) and for this reason parasites subjected to in 
vitro culture for long periods of time are not a good representation of naturally occurring 
CNVs. The main goal of this study was to investigate the potential adaptive role of CNVs in 
nature through the largest CNV survey to date of natural populations of parasites.
A genome wide survey o f CNVs in 183 parasite isolates from three populations in Eastern 
Africa with different malaria transmission intensities was conducted. The CNVs were detected 
by comparative genomic hybridization using a 70mer oligonucleotide microarray. First, the 
microarray data were subjected to normalisation and quality screening to remove effects of 
technical variation. This was followed by CNV calling using Genomic Alteration Detection 
Analysis (GADA) package in R. In order to choose suitable thresholds that would maximize 
the number and accuracy of CNVs detected, a range of parameters for quality filtering and
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CNV calling and their impact on CNV detection were explored. In addition, to rule out any 
possible systematic bias, including sample and patient characteristics, other than population 
effects on the chances of detecting a CNV, a mixed effects logistic regression model was used 
to examine these potential influences on CNV detection. A summary o f the CNVs identified 
including their genomic locations, gene content, sizes and frequencies in each populations was 
generated. Furthermore, population differentiation in CNV frequencies was determined, using 
Weir and Cockerham’s F st estimates, to identify those CNVs that show strong differentiation 
between populations indicative of directional selection. Lastly, functional enrichment of gene 
groups in the genes located within the CNVs was investigated.
3.2 Methods
3.2,1 Experimental strategy
Comparative genomic hybridization (CGH) was performed in order to detect CNVs (described 
in section 2.1). DNA extracted from infected blood of 183 patients was amplified using random 
nonamers and competitively hybridized on an oligonucleotide array against a common 
reference genome. The reference parasite line originated from a patient resident in Kilifi, 
Kenya, and had undergone adaptation to in vitro culture (Mackinnon et al. 2009). The parasite 
line was in culture for approximately 100 cycles. Randomization of the samples was carried out 
during whole genome amplification and microarray hybridization to minimize any 
experimental bias. The 70mer oligonucleotide array used contained probes targeting 
approximately 5500 genes (Bozdech et al. 2003b). Each gene was targeted by, on average, 2 
probes. The microarray data were pre-processed using linear models for microarray data limma 
in R (Smyth 2005) and CNVs were identified using GADA (Pique-Regi et al. 2010). The 
experimental design is illustrated below.
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Genomic DNA extraction of 183 samples
Whole genome amplification and 
labeling
Competitive hybridisation of test and 
reference sample on a 70mer array
Quality assessment of microarray data
Normalisation and background 
correction using limma
Segmentation analysis using GADA
CNVs definition
Figure 3.1. Overview of the process of CNV detection using microarrays.
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3.2.2 Sample populations
A total of 183 P. falciparum isolates were obtained from individuals living in three 
geographical regions in Eastern Africa, i.e., Kilifi and Kisumu in Kenya and in Sudan, that 
differ in malaria transmission intensity (Noor et al. 2014, Okiro et al. 2010). The samples from 
Kilifi were obtained at two time points: 1994-1996, a period with higher transmission 
intensity, and 2010 when transmission intensity was lower (O'Meara et al. 2008). These two 
Kilifi populations will be referred to as “Kilifi pre-malaria decline” and “Kilifi post-malaria 
decline” respectively. Characteristics of each population are shown in Table 3.1. The age of 
the malaria patients significantly differed among the four populations (p-value < 0.05 by 
Mann-Whitney-Wilcoxon Test). Its effect on CNV prevalence is investigated in section 3.3.5.
Table 3.1. Characteristics of the four sample populations.
Population Kisumu Kilifi
Pre-malaria
decline
Kilifi
Post-malaria
decline
Sudan
M alaria transmission 
intensity
High Moderate Low Low
Number of samples 49 33 49 52
Year of sample collection 2008 1994-1996 2010 2007
Median age in months 
(range)
36
(6-72)
30
(11-37)
53.5
(14-147)
84
(12-612)
logio median 5.3 4.7 5.1 5.1
parasitaemia (par/pi) (4.9-5.8) (4.0-5.8) (2.5-6.1) (4.4-5.8)
(range)
Median haemoglobin in 9.9 9.4 10.6 9.6
g/dl (range) (5.2-15.2) (5.3-13.2) (3.4-12.1) (3.2-12.9)
Median number of clones 2 2 2 2
(range) (1-6) (1-7) (1-5) (1-5)
Monoclonal infections
(percentage) 10.2 33.3 18.4 26.9
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3.2.3 Quality control of microarray data
Quality o f hybridisation of the spots on the microarray was measured by the consistency in red 
intensity (test sample) and green intensity (reference sample) across a spot. The correlation 
between red and green fluorescence intensity of each pixel in a spot was determined by the 
image acquisition software, GenePix. From this, the square o f the correlation coefficient, 
termed ‘Rgn R2’, with values between 0 and 1, was used as an indicator of its quality, with 
values of less than 0.6 flagged as ‘bad’. In addition, microarray spots were also automatically 
and manually flagged as bad by visual inspection using the GenePix software (described in 
Chapter 2.1.6). Poor quality spots were assigned a weight of 0 and good quality spots given a 
weight of 1.
Furthermore, data from probes in the microarray targeting highly polymorphic gene families 
including variant surface antigens (vars, rifins and stevors) and also genes with known SNPs 
located within the probe sequences based on all SNPs data available in PlasmoDB version 9.1 
(SNPs information available for 37 isolates) were excluded. These polymorphic probes 
constituted 17% of probes on the microarray. The presence of 7 mismatches was found to lead 
to, on average, a reduction of 64% of the microarray hybridisation intensity (Bozdech et al. 
2003b) which could be called as a CNV. Probes targeting more than one gene location (6% of 
the total number of probes) were filtered out.
3.2.4 Pre-processing of microarray data
The total red and green fluorescence intensity of a spot, i.e., the foreground intensity, 
correlates with the amount of hybridization of the test sample and the reference sample 
respectively. Included in spot intensity measurement is signal from non-specific hybridization
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known as background signal estimated from regions surrounding the spots by the GenePix 
software. The background intensity was subtracted from the foreground intensity using linear 
models for microarray data limma package in R (Smyth 2005). To further minimize technical 
variation as a result of poor hybridization in part of a slide due to a bubble or poor printing, 
within array normalisation of microarray data was performed using limma (Smyth 2005). 
Technical variation between arrays due to, for example, differences in printing quality and dye 
concentrations was adjusted for using the ‘quantile’ normalisation method in limma. Detailed 
explanation of these analysis methods are in section 2.1.6
3.2.5 CNV detection using Genome Alteration Detection Analysis (GADA)
To detect CNVs, Genome Alteration Detection Analysis (GADA) package in R was used 
(Pique-Regi et al. 2010). This performs segmentation analysis to detect adjacent regions in the 
genome that differ in gene copy number. The input to GADA is the normalised log2 intensity 
ratios for each probe ordered by genomic position. The output is a list of chromosomal 
segments which differ in their average log2 intensity ratios from those in adjacent regions 
(Figure 3.2). CNV calling is restricted by certain parameter threshold settings including the 
amplitude (A) of segment (the average log2 intensity ratios of probes in a segments), T value 
(the t-statistic above which breakpoints are excluded) and aAlpha (aa) (a measure of the 
degree of segmentation). These are described in detail in chapter 2 section 2.1.6.2.
3.2.6 CNV definition
For the remainder of the analyses, the cut-offs at the segmentation analysis step in GADA 
were set at T= 3.5 and aa=0.2, a low stringency, on the basis that prior knowledge of the 
expected degree of segmentation was unavailable and also to maximize on the number of
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probes
Figure 3.2. CNV detection using GADA
An illustration of CNV detection using GADA. The log2 intensity ratio of probes (+ sign) 
ordered by genomic positions. The segments detected by GADA are indicated by horizontal 
lines. The amplitudes (A) of these segments indicated by log2 intensity ratio of cl, c2 and c3. 
The breakpoints of the segments indicated by probes al, a2, a3 and a4. Image reproduced from 
Pique-Regi et al. 2010.
CNVs identified. The stringency was increased by defining a segment to be copy number 
variable if it contained a minimum of two consecutive probes with an absolute average log2 
intensity ratio greater than 1, i.e., a two-fold increase or reduction in copy number. Due to 
measurement error in the data, the boundaries, i.e. the start and end of segments identified by 
GADA, may not be precise and thus appear to vary among isolates thus making it difficult to 
distinguish artefactual from real (Figure 3.3). Therefore, segments that overlapped in genomic 
position among samples, but had different start or end genomic locations, were considered to 
be the same CNV (Figure 3.3). Lastly, CNVs that appeared in less than 2% of the isolates 
studied were excluded from further analysis to allow for the possibility that they were 
artefactual. Each CNV was assigned a unique identifier that included the chromosome 
number, e.g., cnvl3_473, indicates that the CNV is on chromosome 13 and has unique number 
identifier 473.
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Figure 3.3. A schematic representation of the definition of CNVs breakpoints
3.2.7 Analysis of systematic effects on CNV detection
In order to determine whether there was systematic bias in the probability of detecting CNVs 
that may distort comparisons of CNV frequencies between populations, The effects of 
multiplicity of infection (MOI), parasitaemia, patient characteristics (age and haemoglobin), in 
addition to population, were analysed using generalized linear mixed effects model under a 
binomial model in the lme4 package in R. The aforementioned factors were classified as fixed 
effects. Three further effects - experimental batch, sample and individual CNV - were also 
included in the model as random effects. The response variable was binary, i.e., 
presence/absence of a CNV. Least-squares means were estimated from the fitted model for 
each category of the fixed effects using the Ismeans package in R. The overall effect of each 
factor was determined using ANOVA.
3.2.8 Assessing reproducibility of microarrays
Included in the set of samples for this CNV survey were 8 isolates that had been independently 
assayed twice. The 8 isolates were randomly chosen. To assess reproducibility of the
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microarray in identification of CNVs, the correlation between duplicates of the log2 intensity 
ratios of only the probes falling inside the detected CNVs was calculated for each o f the 8 
pairs. Also calculated was Cohen’s kappa value that measures the agreement between two 
replicates.
3.2.9 Gene set enrichment analysis of CNVs
Gene set enrichment analysis was performed on the list of genes identified to be copy number 
variable. The functional gene sets were obtained from Malaria Parasite Metabolic Pathways 
website: http://mpmp.huii.ac.il/. The hypergeometric test was used to identify functional 
groups of genes that were enriched. The ‘phyper’ function in the stats package in R was used. 
Functional groups with p-values of less than 0.05 were classified as statistically significantly 
enriched.
3.2.10 Population genetics analysis
The frequency o f each CNV in each of the four populations was calculated. To characterize 
the between to within population variability in CNV frequencies, Weir and Cockerham F- 
statistics (F st)  were calculated for each CNV using hierfstat as implemented in R (Goudet 
2005).
3.3 Results
3.3.1 Quality of microarray data
A large proportion, 87%, of the microarray data was of good quality (Figure 3.4A). The 
majority of the spots had weights of 1 and Rgn R2 values greater than 0.7. The proportion of
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data finally retained for further analysis after applying quality filters described in section 3.2.3 
was greater than 65% in most arrays (Figure 3.4B).
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Figure 3.4. Summary of quality of microarray data
A) Histogram showing the distribution of Rgn R2 and the weights (1, blue; 0, red) of spots in 
the array data generated from 183 samples. Rgn R2 value of 0 and weight of 0 indicate the 
worst quality and 1 is the best quality data from a microarray spot. B) Distribution of the 
proportions of arrays ( in percentage), y-axis, with the proportion (percentage), x-axis, of 
microarray data retained for further analysis after quality filtering and removal of probes 
targeting highly polymorphic gene families including variant surface antigens, and probes with 
known SNPs within their sequences.
3,3,2 Background correction and normalisation of m icroarray data
Technical variation among the arrays was minimized as follows. Firstly, the foreground 
fluorescence intensity values that are used for calculation of the log2 intensity ratios were 
corrected for background noise (Figure 3.5A vs. 3.5B). Secondly, bias in log2 intensity ratios 
(M) (M = log2 (Red intensity (test sample)/Green Intensity (reference)) observed at low 
average intensity values (A) (A= 1/2 log2 (Red*Green intensities) observed within an array 
was removed (Figure 3.5C vs. 3.5D) and lastly, between array normalisation was not 
necessary because it did not have major effect on the distribution of intensities between the
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arrays after the data was corrected for background noise and within array normalisation 
performed (Figure 3.5E vs. 3.5F).
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Figure 3.5. Pre-processing of m icroarray data.
Box plots of average log2 intensity values of a subset of 20 arrays of A) raw data B) 
background corrected data. Plot of relationship between log2 ratio (M) (Y axis) and average 
log2 intensity (A) (X axis) of a single array C) before within array normalisation D) after 
within array normalisation using the ‘robustspline’ method. Boxplot of the average intensity 
ratios (M) E) before between array normalisation and F) after within array normalisation using 
the ‘quantile’ method. The log2 intensity ratio (M) is calculated from the equation M = log2 
(Red intensity/Green intensity). Average log2 intensity (A) is calculated as A = 1/2 log2 
(Red*Green intensities), i.e., the geometric mean of the red and green intensities.
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3.3.3 CNV detection using Genome Alteration Detection Analysis (GADA)
An example of a CNV segments generated in chromosome 13 using GADA in one of the 
samples is illustrated below (Figure 3.6). The number of probes within each segment and the 
amplitudes of the segments was different from the consecutive segment. Later, the effects of 
different cut-offs on the number of probes and amplitude size in defining a CNV were 
examined. In this study, the stringency in ‘calling’ CNVs at both the pre-input stage and at the 
GADA analysis stage was altered. At the pre-input stage, the threshold quality control filter, 
Rgn R2, was varied and found that this parameter did not greatly affect the number of 
segments detected by GADA regardless of the chosen amplitude, A (Figure 3.7A). At the 
GADA analysis stage, increasing the absolute amplitude cut-off (Figure 3.7A) and the value of 
‘T’ leads to fewer segments identified (Figure 3.7B).
By contrast, increasing aa (degree of segmentation) results in a decrease in the number 
segments detected (Figure 3.7B). Additionally, the cut-off can be set at the minimum number 
of probes within a segment for it to be considered as a CNV. Thus, as expected, the use of less 
stringent parameters results in more ‘noisy’ CNV ‘calls’. On the other hand, use of high 
stringency parameters causes some CNVs to be missed. Thus there is an optimal stringency 
which ought to be determined.
3.3.4 Reproducibility
High correlation was observed between duplicates of the log2 intensity ratios of only the 
probes falling inside the detected CNVs with values ranging from 0.46 to 0.91 across 
duplicates (Figure 3.8). The highly correlated log2 intensity ratios were greater than 1 or less 
than -1 in both duplicates of a sample (Figure 3.8). Due to less accurate identification of CNV
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Figure 3.6. Segmentation using GADA on a region on chromosome 13 (CNV: cnvl3_473)
Illustration of segmentation on a region on chromosome 13 in a single isolate (pf10882). Each 
point is a log2 intensity ratio of a given probe. A cut-off of a minimum of 2 consecutive probes 
in a segment was set. The probes are ordered according to genomic location. On the X-axis are 
the genes targeted by the probes. The genes that appear more than once are targeted by more 
than one probe. The red horizontal lines are the CNV segments detected by GADA with their 
amplitudes indicated on the Y axis, delineated by blue dashed lines. This CNV was assigned 
the name “cnvl3_473” which indicates that it is a CNV on chromosome 13 and has unique 
identifier 473.
breakpoints, some probes within CNVs (red points) that had log2 ratios between 0, 1 and -1 
were observed (Figure 3.8). The reproducibility of CNV detection was assessed using Cohen’s 
kappa statistic. The kappa values for the replicate pairs ranged between 0.1-0.5 (Table 3.2).
Poor concordance was observed in the CNVs detected between some replicate pairs (Kappa 
value <0.20). Fair (kappa value 0.21-0.40) and moderate (kappa value 0.41-0.60) concordance 
was observed in other replicate pairs. The eight isolates had multiple parasite clones. The low 
concordance observed may be as a result of noise in microarrays that contribute to uncertainty 
in the threshold for calling a CNV. A threshold of log2 ratio of 1 would miss calling some of 
the segments that have values close to 1, e.g., 0.9 that may be true CNVs.
[Amplitude
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Figure 3.7. Effect of different stringency measures on CNV calling
A) The relationship between total number of segments called (y-axis) against average intensity 
values of the segments (x-axis) of 183 arrays. The different coloured lines represent different 
quality filters (Rgn R2) on the data input to GADA. B) The effect of a combination of all the 
possible GADA settings of T (range from 1 to 17) and aa (range from 0.2 to 2.7) on the 
number of segments identified, with absolute amplitude A >0.8 and a minimum of 2 probes 
within the segment, of a single array.
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Table 3.2. Table showing the kappa value of each replicate pair of samples.
Sample kappa value
0.29
0.49
0.35
0.49
0.27
0.21
8 0.10
Sample 1 r=0.46 Sample 2 r=0.57 Sample 3 r=0.84 Sample 4 r=Q.71
o
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Figure 3.8. Reproducibility of m icroarray data and CNV detection
A) Plots showing the correlation between technical duplicates of 8 samples of log2 ratios for 
only the microarray probes within the total CNVs detected (red and black points) (352 out of 
approximately 8800 probes in the array). The correlation coefficient is indicated by the value 
‘r’. The red points are the log2 ratios of the probes within the CNVs identified in each 
individual sample and the black points are the log2 ratios of non-CNVs microarray probes.
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3.3.5 Systematic effects on CNV detection probabilities
The only strong effect on the prevalence of CNV was population (p value < 0.001 by 
ANOVA). Specifically, across all CNVs, the prevalence of CNVs was lower in the Kilifi 
populations (1 and 2) than in Kisumu and Sudan (populations 3 and 4 respectively) (Figure 
3.9). The lack of significance of the other factors, i.e., MOI, parasitaemia, haemoglobin and 
patient’s age, on prevalence of CNVs (p value >0.05 by ANOVA) is reassuring because only 
the factor of interest, i.e., population, had significant effect on CNV detection probabilities. 
The presence of multiple genotypes (MOI) in an infection is a common phenomenon in P. 
falciparum infections and tends to vary with age (Ntoumi et al. 1995) and malaria 
transmission intensity (Konate et al. 1999). MOI may interfere with the average intensity in a 
given probe if a CNV is present in the sample and thereby mask its detection. The number of 
clones detected in the isolates ranged from 1 to 7 with the distribution of MOI varying in the 
four populations. The analysis here showed that MOI did not have an effect on the 
detectability of CNVs (p value > 0.05 by ANOVA).
V a r ia b le
A g e
H em o g lo b in
MOI
P a r a s ite m ia
P o p u la tio n
Hemoglobin Parasitemia Population
N  CD
m io m o  
t t  i n  cm  i n  
w  in
Variables
Figure 3.9. Systematic effects on CNV prevalence.
Least-squares means are indicated by points, with upper and lower 95% confidence limits 
represented by whiskers. Population 1 is Kilifi pre-malaria decline, population 2 is Kilifi Post­
malaria decline, population 3 is Kisumu and population 4 is Sudan.
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3.3.6 CNVs detected in field isolates
3.3.6.1 General characteristics of CNVs
A total of 98 different CNVs with minor allele frequency (MAF) greater than 2.2% (i.e., 
occurring in 4 or more isolates) were detected among the 183 field isolates studied. 34 of 
these were deletions and 64 were amplifications in gene copy number. These CNVs were 
distributed throughout the 14 chromosomes of the genome (Figure 3.10A). The number of 
CNVs per sample ranged from 1 to 20 with an average at 8 CNVs per isolate (Figure 3.10B). 
The majority of CNVs contained less than 3 genes within each, with the largest CNV on 
chromosome 9 consisting of approximately 20 genes (Figure 3 .10C). The estimated CNV 
lengths were between 400bp and 90kb (Figure 3.10D).
3.3.7 Population genetics of CNVs
Most CNVs were observed at low frequencies in the population studied with majority of the 
CNVs occurring in less than 10% of the isolates (Figure 3.11 A). To assess levels of population 
differentiation of CNVs frequencies, Weir and Cockerham F-statistics (F st)  for each CNV 
were calculated for pairs of populations using the hierfstat package in R (Goudet 2005). The 
average estimates of F st are a sign of the background levels of population differences that are 
expected to arise through neutral processes including drift and population isolation and affect 
all loci in the genome to a similar manner (Anderson et al. 2005, Beaumont and Balding 2004, 
Akey et al. 2002). The average F st estimates across all CNVs ranged between 0.02 and 0.11 
across the 6 pairwise population comparisons (Figure 3.1 IB). The greatest difference was 
exhibited by the comparison of Kilifi Pre-malaria decline and Sudan followed by Kilifi Pre­
malaria decline and Kisumu (Figure 3.1 IB). The Kisumu vs. Sudan comparison showed the 
least average F st.
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Outliers from these average F s t  estimates are CNVs that show unexpectedly low or high 
population differentiation thus potentially indicating that they are maintained by balancing and 
directional selection forces, respectively, that are locus specific (Figure 3.1 IB). These 
differences in CNV frequencies between populations may have arisen as a consequence of
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Figure 3.10. General properties of CNVs detected using microarrays.
A) A chromosome map showing the location of the CNVs in the 14 chromosomes of P. 
falciparum  genome (deletions in blue and amplifications in red (MAF>2%). White vertical 
bars represent regions that are not targeted by the microarray probes. Black vertical bars are 
locations of centromeres. The distribution of the B) length of the CNVs (in kilobase pairs) C) 
number of genes per CNV and D) number of CNVs detected in each of the 183 samples in the 
four populations studied. Within each box, the horizontal line represents the median number 
of CNVs per sample, top and bottom boundaries show the 75th percentile and 25th percentile 
values respectively. The end of the whiskers show the minimum and maximum number of 
CNVs per sample and the data points above and below the end of the whiskers show the 
outliers.
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local adaptation to population-specific selection pressures. The high differentiation may also 
be as a result of population bottlenecks, e.g., change in antimalarial use, vector populations 
among others and migration that leads to introduction on new variants to a population. These 
CNVs were classified into three groups, discussed below, based on the populations affected.
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Figure 3.11. F st estimates obtained from pairwise population comparisons
A) The distribution of CNV frequencies in the study population B) Boxplot showing the 
distribution of F s t  estimates of each CNV obtained from six pairwise population comparisons, 
i.e., Kilifi Post and Kisumu, Kilifi Post and Sudan, Kilifi Post and Kilifi Pre, Kilifi Pre and 
Kisumu, Kilifi Pre and Sudan and Kisumu and Sudan. The horizontal line within each box 
represents the median F s t  estimates. The top and bottom boundaries of the box shows the 75th 
percentile and 25th percentile respectively. The end of the whiskers show the extreme values 
(minimum and maximum values) and the data points above and below the end of the whiskers 
show the outliers.
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In the first category are four CNVs with the greatest population differentiation observed, i.e., 
top 7% in F s t  estimates, in the comparison between the two Kilifi populations and Sudan and 
between Kisumu and Kilifi Pre-malaria decline populations. These CNVs occur at lower 
frequencies in the Kilifi populations than in Sudan and Kisumu (Figure 3.12). These 4 CNVs 
show great variance in CNV frequencies between populations and thus are likely to indicate 
differential directional selection between populations or population bottlenecks. One weakness 
of the evidence of high differentiation is the small sample size of Kilifi Pre compared to the 
other populations that may affect the chance of CNV detection. They include three 
amplifications on chromosome 5, 12, and 9 and a deletion on chromosome 13. The 
frequencies of each of these CNVs were found to statistically significantly different in at least 
one of the populations at 95% confidence level using binomial test (prop.test function in R). 
The genes located within these CNVs and their functions are indicated in table 3.3.
Table 3.3. Genes and gene functions of CNVs that exhibit the greatest population 
differentiation
CNV No. of Gene ID Putative function
identifier genes in 
CNV
cnv5 101 3 PF3D7 0507900 Unknown
PF3D7 0508000 Exposed to host immunity 
(Sanders et al. 2005)
PF3D7 0508100 gene expression regulation 
(Cui et al. 2008)
cnvl2 413 1 PF3D7 1248600 Unknown
cnvl3_478 3 PF3D7 1348800, 
PF3D7 1348900, 
PF3D7 1349000
Unknown
cnv9_242 2 PF3D7 0908000 DNA repair
(Nishino and Morikawa 2002)
PF3D7 0908100 Unknown
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Figure 3.12. Population frequencies of CNVs with top 4 highest F st values
Barplot showing CNV frequencies in the four populations of 4 CNVs A) cnv5_101 on 
chromosome 5 consisting of PF3D7 0507900 - PF3D7 0508100 b) cnvl2_413 consisting of 
PF3D7 1248600 on chromosome 12 c) cnvl3_478 on chromosome 13 containing 
PF3D7 1348800- PF3D7_1348900and d) cnv9_242 on chromosome 9 consisting of 
PF3D7 0908000 and PF3D7 0908100PF3D7 0908100.
A  second set of CNVs appear to be under positive selection in the Kilifi populations ( F s t  
>0.20) as compared to Kisumu or Sudan. They comprise deletions on chromosome 6 and 11 
and amplifications on chromosome 3, 9 and 12 (Figure 3.13). The frequencies of each of these 
CNVs were found to be statistically significantly different in at least one of the populations. 
The genes found in these regions are shown in table 3.4.
A third set are CNVs that appear to be under purifying selection in one of the four populations 
(Figure 3.14). Seven CNVs were not detected in the Kilifi pre-malaria population but found to 
exist in the other three populations (Figure 3.14). The CNV frequencies were found to be
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Table 3.4. Genes and gene functions of CNVs that appear to be under positive selection
in Kilifi populations
CNV No. of genes Gene ID Putative function
identifier in CNV
cnv9 254 3 PF3D7 0925400 Gametocytogenesis (Li and Baker 1997)
PF3D7 0925500 protection from reactive oxygen species 
(Nickel et al. 2006, Kehr et al. 2010)
PF3D7 0925700 Transcriptional regulation (Cui and 
Miao 2010)
cnv3_051 1 PF3D7 0315200 ookinete motility and infectivity 
(Dessens et al. 1999, Templeton, 
Kaslow and Fidock 2000)
cnvl2_388 3 PF3D7_1229400 modulation of host immunity (Augustijn 
et al. 2007)
PF3D7 1229500 Protein trafficking (Mbengue et al. 
2015)
PF3D7 1229300 Unknown
cnv6 129 4 PF3D7 0606200 Protein degradation
PF3D7 0606500 RNA splicing
PF3D7 0606300 Unknown
PF3D7 0606400 Unknown
cnvll_354 PF3D 7J 148700 Exported to erythrocyte (Sargeant et al. 
2006)
P F 3 D 7 J148800 Exported to erythrocyte (Sargeant et al. 
2006)
statistically significantly different in at least one of the populations at 95% confidence level. 
The genes that were located in these CNVs and their functions are listed in table 3.5. The 
amplification of PF3D7 1149000 was at a lower frequency in Kisumu (high transmission) 
compared to the low transmission populations (Kilifi post-malaria decline and Sudan) and also 
in Kilifi pre-malaria decline compared to the low transmission period (Kilifi Post-malaria 
decline). A large deletion on chromosome 9, previously observed in laboratory adapted lines 
(Mackinnon et al. 2009, Cheeseman et al. 2009, Kidgell et al. 2006, Ribacke et al. 2007) and 
linked to loss of cytoadherence (Kemp et al. 1992, Trenholme et al. 2000) and gametocyte 
production (Day et al. 1993) was observed in 24 out of 183 isolates from all the populations
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except the Kilifi pre-malaria decline population. A CNV on chromosome 7 (PF3D7 0710100
and PF3D7 0710200PF3D7 0710200) was found to be absent in Sudan only.
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Figure 3.13: Population frequencies of CNVs showing signs of selection in Kilifi 
population
Barplots showing frequencies of CNV A) cnv9_254 on chromosome 9 containing 
PF3D7 0925400PF3D7 0925400 - PF3D7 0925700PF3D7 0925700 B) cnv3_051 on 
chromosome 3 containing PF3D7 0315200 C) cnvl2_388 on chromosome 12 containing 
PF3D7 1229300 - PF3D7 1229500 D) cnv6 129 on chromosome 6 containing 
PF3D7 0606200 - PF3D7 0606500 and E) cnvl 1 354 on chromosome 11 containing 
PF3D7 1148700- PF3D7_1148900.
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Table 3.5. Genes and gene functions of CNVs that appear to be under purifying selection
in one of the four populations
CNV
identifier
No. of 
genes in 
CNV
Gene ID Putative function
cnv7_169 2 PF3D7 0710100, 
PF3D7 0710200 Unknown
cnv9_269 18 PF3D7 0935400 Gametocytogenesis(Eksi et al. 2012)
PF3D7_0935500 Gametocyte stage (Silvestrini et al. 2010)
PF3D7_0935600 Gametocytogenesis (Gardiner et al. 2005)
PF3D7 0935700 Unknown
PF3D7 0935800 Cytoadherence (Trenholme et al. 2000)
PF3D7 0935900 Protein trafficking (Dixon et al. 2011)
PF3D7_0936000 Exported protein (Spielmann et al. 2006b)
PF3D7 0936100 Located at host-parasite interface (Spielmann 
et al. 2006a)
PF3D7 0936400 Exported protein (Spielmann et al. 2006b)
PF3D7 0936500 Host cell adhesion (Nacer et al. 2015)
PF3D7 0936200, 
PF3D7 0936600, 
PF3D7 0936800, 
PF3D7 0936900, 
PF3D7 0937000, 
PF3D7 0937100
PHIST gene family (Sargeant et al. 2006)
PF3D7 0936700, 
PF3D7 0937200
lysophospholipase
cnvl4_573 2 PF3D7 1460700 A ribosomal subunit
PF3D7 1460800 Unknown
cnvl4_564 2 PF3D7 1452700, 
PF3D7 1452800
Unknown
cnvl4_549 3 PF3D7_1438800 Unknown
PF3D7 1438900 Antioxidative activity (Nickel et al. 2006)
PF3D7 1439000 Copper transporter (Choveaux, Przyborski and 
Goldring 2012)
cnv4_076 3 PF3D7 0409500, 
PF3D7 0409700
Unknown
PF3D7 0409600 DNA replication (Voss et al. 2002)
cnv3_036 3 PF3D7 0301600, 
PF3D7 0301700, 
PF3D7 0301800
Exported proteins (Sargeant et al. 2006)
cnv ll 355 1 PF3D7 1149000 iRBCs remodelling (Glenister et al. 2009)
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gure 3.14. Frequencies of CNVs showing signs of purifying selection in single populations
irplots of frequencies of CNV A) cnv7_169 containing PF3D7_0710100- PF3D7_0710200 B) cnv9_269 containing PF3D7 0935400 - 
r3D7_0937200 C) cnvl4_573 containing PF3D7_1460700- PF3D 7J460800 D) cnvl4_564 containing PF3D7J452700- PF3D7_1452800 E) 
vl4_549 containing PF3D7_1438800- PF3D 7J439000 F) cnv4_076 containing PF3D7_0409500 - PF3D7_0409700 G) cnv3_036 containing 
r3D7_0301600 - PF3D7_0301800 and H) cnvl 1_355 containing PF3D7_1149000.
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3.3.8 Comparison with published literature
There was considerable overlap of CNVs identified in our study with already published CNVs 
from genome-wide scans of P. falciparum. Out of the 225 genes located within the 98 CNVs 
detected, 20% of these genes (50 genes in 25 CNVs) have been previously identified to be 
copy number variable (Figure 3.10 and Appendix 3.1). These include a CNV on chromosome 
11 containing an amplification of three adjacent genes (PF3D71148700PF3D7 1148700- 
PF3D7 1149000) identified in four other studies (Jiang et al. 2008b, Sepulveda et al. 2013, 
Samarakoon et al. 2011a, Cheeseman et al. 2009). and PF3D7_0423500, identified herein 
have also been previously identified (Samarakoon et al. 201 la). These genes encode three 
proteins thought to be exported to the erythrocyte surface including a gene belonging to the 
PHISTc gene family. A deletion of a second PHISTc gene (PF3D7 0202100) on chromosome 
2 was also detected in three other studies (Cheeseman et al. 2009, Mackinnon et al. 2009, 
Carret et al. 2005). Two genes within a CNV, PF3D7_0423400 and are thought to play a role 
in erythrocyte invasion and anchoring o f the cytoskeleton to the inner membrane (Bullen et al. 
2009) respectively. An additional copy number variable gene PF3D7 0424400 also known as 
SURFIN 4.2 has been reported (Samarakoon et al. 201 la, Jiang et al. 2008b, Kidgell et al. 
2006). The gene product was found to be exposed at the surface of an infected erythrocyte and 
merozoite hence is thought to be under selection by host immunity or involved in merozoite 
invasion (Winter et al. 2005, Chan, Fowkes and Beeson 2014).
Evidence of deletion of one or two members of the cytoadherence linked asexual gene i.e. clag
3.1 and clag 3.2 (Robinson et al. 2011) has been previously reported. In this study a deletion of 
clag 3.1 was detected. A clag 3 hybrid, made up of the clag 3.2 sequence at 5’ UTR and the
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clag 3.1 sequence at the 3’UTR, has also been observed (Iriko et al. 2008). The clag gene 
family is thought to be involved in erythrocyte invasion (Kaneko et al. 2005) and 
cytoadherence (Trenholme et al. 2000) of the infected erythrocyte. Recently, clag 3.1 has been 
implicated in transport of solutes across the infected erythrocyte membrane (Nguitragool et al. 
2011).
Interestingly, a large deletion was observed on the right arm of chromosome 9 in field isolates, 
a phenomenon that has previously been observed only in laboratory adapted isolates 
(Mackinnon et al. 2009, Shirley et al. 1990, Kemp et al. 1992, Cheeseman et al. 2009, Ribacke 
et al. 2007, Kidgell et al. 2006) and thought to arise due to reduced selection pressures, e.g. 
host immunity, antimalarial drugs and the need for sexual reproduction, in vitro.
3.3.8.1 Novel CNVs
Seventy-five potentially novel CNVs out of the 98 CNVs detected (Appendix 3.2) were found. 
These included a gene rad51 (PF3D7_1107400) coding for protein involved in homologous 
recombination during DNA repair and recombination events that may lead to DNA 
rearrangements that enable antigenic variation (PF3D7_1107400) (Bhattacharyya et al. 2005). 
Interestingly, the rad51 human homolog has been found to be amplified in cancer cells 
(Mathews et al. 2011). Two additional genes adjacent to rad51, identified to vary in copy 
number, are thought to play a role in regulation of stimulation of translation (PF3D7_1107300) 
(Ochoa, Llinas and Singh 2011, Martineau et al. 2008) and protein folding (PF3D7_1107500). 
A number of novel CNVs containing genes with unknown functions were also detected 
(Appendix 3.2).
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Figure 3.15. Overlap between CNVs identified in this study and published studies.
Chromosome map showing the location of CNVs identified in this study (pink) and CNVs 
detected in earlier published work (green) in the 14 chromosomes of P. falciparum  genome.
3,3,9 Functional gene set enrichment of CNVs
Enrichment of 15 out of 205 functional categories (obtained from the Malaria Parasite 
Metabolic Pathways website: h t t p : / / m p m p . h u i i . a c . i l / ) of genes in the list of genes located 
within CNVs were found (Table 3.3). The groups that showed statistically significant 
enrichment (p-value < 0. 05), using the hypergeometric test, included genes coding for 
proteins that are exported to the surface of infected erythrocytes and may be exposed to 
selection pressure from the host immunity. These include PHISTs, Maurer cleft proteins and 
genes encoding proteins exported to the infected erythrocyte and classified as
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Table 3.6. Functional gene categories showing significant enrichment
Gene set No. of No. of genes P value
genes in present in a 
________________________gene set CNV_________________
Maurer’s clefts proteins 98 14 4.00E-05
Exported PHISTs 51 9 9.66E-05
Glycolysis 27 5 0.001266
ER to Golgi translocation and quality control 13 3 0.002385
Asparagine and Aspartate metabolism 8 2 0.004747
Rab proteins in intracellular traffic 16 3 0.005435
Pentose Phosphate Cycle 9 2 0.006877
Thioredoxin glutaredoxin and peroxiredoxin 18 3 0.008491
Cotranslational.cleavage of.N terminal. 10 2 0.009489
Methionine residues and N terminal acetylation
Exported ‘Immunoreactive’ proteins 
(Crompton et al. 2010)
19 3 0.010368
Methionine and polyamine metabolism 20 3 0.012494
Tubulin and microtubules 20 3 0.012494
Utilization of phospholipids 42 5 0.012508
Anaphase promoting complex ubiquitin ligase 11 2 0.012603
Double strand break repair and homologous 
recombination
11 2 0.012603
Mitochondrial electron flow 21 3 0.01488
Mitochondrial antioxidant system 12 2 0.016232
Compartmentation of redox metabolism 24 3 0.023685
f Histone chaperones 36 4 0.024691
Lipoic acid metabolism 6 1 0.028841
Skpl Cullin.F box biquitin ligase 15 2 0.030278
Dolichol metabolism 7 1 0.039148
Ubiquinone metabolism 7 1 0.039148
Initiation of translation 41 4 0.040707
Biogenesis of cytochrome oxidase 17 2 0.042259
‘immunoreactive’ by Crompton and colleagues after probing 1,200 P. falciparum antigens for 
antibody reactivity using protein arrays (Crompton et al. 2010). This suggests that varying 
gene copy number is one of the different strategies the parasite uses to escape host immunity. 
Increased copy number would facilitate immune escape by increasing the chances of
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mutations which could lead to increased antigenic diversity. Alternatively, some of these 
genes exposed to host immunity may be selected for sequence variability, and detected as 
CNVs but are not real CNVs because of the effect of sequence polymorphism on 
hybridisation. Significant enrichment was also observed for genes involved in key functional 
processes including glycolysis, DNA repair, transcriptional and translation regulation, 
intracellular trafficking and antioxidative processes.
3,4 Discussion
The results of this study confirm the high prevalence of CNVs in the P. falciparum genome 
and are consistent with earlier work (Mackinnon et al. 2009, Cheeseman et al. 2009, Kidgell et 
al. 2006, Ribacke et al. 2007, Mok et al. 2011, Dharia et al. 2009). On average 8 CNVs were 
observed per isolate and approximately 4.5 % of the genes in the genome were identified to be 
copy number variable. 20% of the CNV genes identified in this study have been previously 
reported in other studies. The results further highlight their high prevalence in natural 
population, something not previously studied. The CNVs found in nature appear to be 
distributed throughout the genome, contrary to some findings that CNVs tend to occur at the 
subtelomeric regions (Cheeseman et al. 2009, Jiang et al. 2008b). This discrepancy is most 
likely explained by exclusion from analysis in this study of probes targeting genes encoding 
variant surface antigens, mostly located in the subtelomeric regions and highly polymorphic, 
because of their reduced hybridization to the microarray and hence propensity to generate 
false CNV ‘calls’.
The CNVs identified here are mostly small in size (average of 7.4 kilobase pairs and 2 genes)
with the exception of a chromosome 9 deletion covering about 18 consecutive genes. This
may indicate that large-sized CNVs could be at a selective disadvantage because of the cost
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associated with the DNA replication of the extra copies and likely impact on epigenetics due 
to the large structural changes that they may cause. The amplifications outnumbered deletions 
at a ratio of 1.9:1. This deficit in deletions supports the idea that CNVs are adaptive since 
purifying selection would act to remove deletions which, if important to function, are expected 
to be deleterious.
The enrichment of key parasite functional gene groups within the CNVs, e.g., DNA 
replication, gametogenesis, cytoadherence, transport and DNA repair reflects the potential 
impact o f CNVs on the survival of the parasite. Importantly, the observation of enrichment of 
CNV genes belonging to groups with environmental responsiveness functions, such as those 
that are exposed to host immunity and may be involved in immune escape and also those that 
respond to oxidative stress arising from glycolysis, could reflect an adaptive role of CNVs to 
the environment. None of the P. falciparum published CNV studies to date have investigated 
the functional enrichment of genes with CNVs. Further analysis of the functional impact of 
these CNVs is assessed in Chapter 5 by investigating the influence of CNVs on gene 
transcriptional levels.
Overall, low population frequencies of CNVs with most occurring in less than 10% of the 183 
field isolates studied was observed. The abundance of low frequency CNVs may suggest that 
some variants may be favoured in a fraction of host or vector conditions, e.g., host red cell 
polymorphism and co-infection, offering short term adaptation that enabled the parasite to 
survive and transmit to the next host, after which they revert back to normal copy when the 
environmental pressure ceases to exist.
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Applying population differentiation analysis by calculating F st estimates of CNV frequencies, 
CNVs that may be under selection pressure in the populations were identified. Among the 
CNVs that were found to be potentially adaptive (F st estimates of greater than 0.20) were 
genes that encode proteins involved in gene expression regulation (Cui et al. 2008), 
gametogenesis (Dessens et al. 1999, Templeton et al. 2000, Li and Baker 1997), protection 
from reactive oxygen species (Kehr et al. 2010, Nickel et al. 2006) and some exposed to host 
immunity (Sanders et al. 2005, Sargeant et al. 2006). The high F st observed between 
populations could be reflective of the differences in environmental selection between 
populations including vector populations, antimalarial drug used, ethnicity, host genetics and 
climatic conditions. The background levels of differentiation between populations, which may 
be due to neutral processes, were further established. Some of the CNVs are likely to exist in 
the population under no selective pressure. These variants may be present in the population 
until they become advantageous to the parasite when environmental conditions change. By 
having a flexible genome that allows for the random generation of genetic variation including 
CNVs, the parasite is able to adapt to current conditions and also even future changes in 
environmental conditions.
This study has some limitations. First, though high stringency was applied on calling CNVs by 
filtering out probes targeting highly polymorphic genes, probes with known SNPs within the 
probe sequences, poorly hybridizing probes and low frequency CNVs, the presence of 
additional sequence variation in field isolates, not able to be ruled out using these filters, is 
likely. The presence of sequence polymorphism is expected to cause false positives in CNV 
calls using microarray data. Second, the array could only assay genes present in the 3D7 
parasite line since the array probes were designed against the complete 3D7 genome. Any 
gene that is absent in 3D7 could not be assayed by the array. Lastly, microarray data provides
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low resolution of CNV breakpoints and hence the genes located at the start and the end of a 
CNV may be incorrectly called.
This study shows that CNVs contribute to genetic variation in the genome of the parasite in 
nature. It also provides evidence of the adaptive role of specific CNVs under current selection 
pressures in the populations. Population differences in specific CNV frequencies may be due 
to differences in environmental conditions including a change in the dominant vector species 
and feeding behaviour reported in Kilifi during the period of 1990-2010 (Mwangangi et al. 
2013), differences in antimalarial drug used and differences in host immunity.
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Chapter 4
Confirmation of CNVs detected using m icroarray by whole genome sequencing
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4 Chapter 4: Confirmation of CNVs detected using microarray by whole genome 
sequencing
4.1 Introduction
Next generation sequencing has, in theory, the potential for high resolution identification and 
characterization of CNVs. It may also facilitate understanding of mechanisms of CNV 
formation through more accurate identification of CNV boundaries (Carvalho et al. 2009, 
Dittwald et al. 2013, Samarakoon et al. 201 lb) and in the detection of translocation events to 
new positions in the genome (Ma et al. 2013). However, comparisons between CNVs 
detected using sequencing vs. microarrays have shown some discrepancies (Retterer et al. 
2014, Sepulveda et al. 2013). Methodology for detecting CNVs in NGS data has not yet 
stabilised with many new methods for analysis being published in recent years (Zhao et al. 
2013, Yoon et al. 2009, Xie and Tammi 2009, Miller et al. 2011, Abyzov et al. 2011, Magi et 
al. 2011, Boeva et al. 2012, Alkan, Coe and Eichler 2011). One of the strategies for detection 
of CNVs from sequencing data is based on the assumption that read depth in a genomic region 
correlates with genome copy number. However, certain biases including GC content and 
uniqueness (the number of times a sequence appears in the entire genome) of a region affect 
read depth thus making estimation of copy number from read-depth analysis problematic. Of 
particular relevance to P. falciparum are the long stretches of A and T nucleotides in its 
genome which pose a challenge to CNV identification for both the above reasons.
In P. falciparum, most studies of CNVs have used DNA microarrays to detect CNVs. Three 
recent studies, however, have used next-generation sequencing to detect CNVs in P. 
falciparum (Sepulveda et al. 2013, Robinson et al. 2011, Samarakoon et al. 201 lb). Robinson 
and colleagues reported 7 CNV genes in 5 clinical samples using read depth and paired end 
analysis of Illumina sequence data. Using 7 publicly available whole genome sequence data,
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i.e., 2 samples from Robinson and others and 5 laboratory lines, Sepulveda and others tested a 
CNV detection method they had developed against two other published tools. A third study 
identified 5 CNVs in 5 laboratory lines using read depth analysis on 454 sequence data 
(Samarakoon et al. 201 lb) .
In Chapter 3, it was described that 98 different CNVs, containing a total of 225 genes, were 
identified in 183 field isolates using microarrays. In this chapter, whole genome sequencing of 
a subset of 22 of these isolates was performed with the aim of comparing the results of 
detection using sequencing vs. microarrays and confirming some of the CNVs. Analysis of 
sequence data involved mapping the sequence reads to a reference genome, calculating and 
normalising for read coverage, followed by identification of CNVs using the Copy Number 
estimation using the Mixture Of PoissonS (cn.MOPS) package in R (Klambauer et al. 2012).
4,2 Methods
4.2.1 L ibrary preparation
Whole genome sequencing of 22 out of the 183 P. falciparum clinical isolates was performed
using the Personal Genome Machine (PGM) Ion Torrent sequencing platform at the KEMRI-
Wellcome Trust Research Programme laboratories in Kilifi, Kenya. These samples were
selected based on the CNVs identified. All the 98 CNVs (identified in chapter 3) were
represented in these samples sequenced. Ion Torrent 200bp library preparation involved
enzymatic fragmentation of gDNA, ligation of adaptors to the fragments, selection of
fragments of appropriate size, PCR amplification (5 cycles), clonal amplification o f fragments
(emulsion PCR) and finally performing the sequence run on an Ion Torrent 318 chip which
has a capacity of up to 2Gbp (Chapter 2, section 2.2). To achieve successful runs, several
quality control steps in the library preparation were undertaken including assessment of
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fragment size and quantification of the proportion of templated ion spheres after emulsion 
PCR. Human DNA quantification of the samples was assessed prior to sequencing using 
quantitative real time PCR (qPCR). A summary of the experimental procedure is shown below 
(Figure 4.1).
4.2.2 Sequence data processing for CNV detection
4.2.2.1 Quality assessment and read mapping of sequence data
The sequence data were obtained from the Ion Torrent Suite software in FastQ format and the 
quality was assessed using FastQC software
(http://www.bioinformatics.babraham.ac.uk/projects/fastqc/). The sequence reads were
mapped to a reference genome from the 3D7 parasite line (Version 3) available at GeneDB
(Logan-Klumpler et al. 2012). The mapping was performed using the Burrows-Wheeler
Aligner (BWA) (Li and Durbin 2009) with the BWA-MEM option. This option is suitable for
mapping reads longer than 70bp, and was implemented with the ‘-M ’ option for marking
secondary read alignments (reads mapping to more than one location). Non-mapped reads,
PCR duplicates and reads with mapping quality of below 30, i.e., non-uniquely mapped reads,
were filtered out using SAMtools (Li et al. 2009). Filtering of reads mapping to more than one
location would lead to exclusion from analysis of genes that are amplified in reference genome
(3D7) but exist in different copy number state in the test genome..To minimize mapping errors
that may result in bias in read coverage and hence accuracy of identification of CNVs, I
performed analyses that targeted different sets of specific regions of the genome. First, I
filtered out genes that are known to be highly variable including the variant surface antigens
(VSAs) iyar, rifins and stevors) (Gardner et al. 2002, Cheng et al. 1998) and low complexity
noncoding regions, i.e., intergenic regions and introns: this targeted genome is referred to as
the ‘exome’. The second target genome was the ‘probome’, which consisted of the regions
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targeted by the probes in the microarray used for the CGH experiment described in Chapter 3 
(Bozdech et al. 2003b). Third, all the genes in the genome, including their introns 
weretargeted, filtering out the VS As. This was referred to as ‘genes’. Fourth, the whole
GeneExons Probe regions
Genomic DNA extraction
Comparison with microarray results
Whole genome excluding VSAs
Quality assessment of sequence data
P. falciparum infected blood depleted of white blood cells
Sequencing of 200bp library using a 318 
chip on the PGM Ion Torrent machine
Mapping of sequence reads to a reference 3D7 
version 3 using BWA (Li and Durbin 2009)
Quality filter of duplicate reads, non-mapped reads and reads 
with multiple alignment hits using SAMtools (Li et al. 2009)
CNV detection using cnMOPS software on targeted subsets 
of the genome shown below (Klambauer et al. 2012)
Library Preparation
• gDNA fragmentation for 200bp library
• PCR amplification (5 cycles)
• Emulsion PCR
Figure 4.1. Overview of the process of CNV detection using whole genome sequencing
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genome (genic and non-coding regions) was targeted with VSAs filtered out for comparison 
(the ‘genome’).
GC content and presence of repetitive sequence/non-unique regions have been previously 
reported to affect the read mapping in genomes known to be AT rich and also with repetitive 
regions (Quail et al. 2012, Ross et al. 2013). To examine these issues prior to the main 
analysis to detect CNVs, uniqueness and GC content were calculated using a function in the 
ReadDepth software (Miller et al. 2011). For this, the reference genome was split into lOObp 
sequences which were then mapped back to the reference genome. The number of times a 
sequence, if found in the genome, was calculated and then normalised to give a ‘uniqueness’ 
score of between 0 and 1 such that a score of 0 indicated a lOObp sequence that occurs more 
than four times in the genome and that of 1 indicated a sequence that appears only once. The 
GC content (the proportion of the G and C nucleotides) in the lOObp windows was also 
calculated using the same software.
4,2,2,2 Copy number estimation and segmentation
Read depth in the targeted regions was calculated in lOObp non-overlapping windows and
normalised across the samples using the ‘quantile’ method in cn.MOPS package in R
(Klambauer et al. 2012). The method adjusts the distribution of read depth in the samples such
that they are similar. To identify CNVs, cn.MOPS applies a mixture of Poisson models at each
window across the samples. The model assumes that the read coverage for a specific copy
number across samples has a Poisson distribution and, in the case of there being different copy
numbers among the samples, the model assumes a mixture of Poissons with different means.
In this analysis, a copy number difference was considered by cn.MOPS to be present when the
normalised read depth for a sample in a lOObp sequence window showed a fold-difference
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from the mean read depth of all the samples for that window corresponding to a log2 value of 
greater than 0.8 (> 1.7-fold, i.e., a gain) or less than -0.8 (<0.6-fold, i.e., a loss). Thus the 
outputs of cn.MOPS were the segments identified to be copy number variable in each of the 
samples, their estimated copy number, their fold difference and their location in the genome. 
For subsequent analyses, the cut-off of defining a CNV was set at a minimum of 50% of the 
gene length called as CNV in ‘gene’, ‘genome’ and ‘exome’ methods and a cut-off of a 
minimum of 50% of the probes identified to be copy number variable in ‘CGH (GADA)’, 
‘CGH (cn.MOPS)’ and ‘probome’ methods.
To ensure a fair comparison between CNVs identified in sequence and CGH data, cn.MOPS 
was also applied to log2 intensity ratio data from microarrays. The normalized log2 ratios were 
transformed to a scale similar to read depth by calculating the base 2 antilog of the log2 ratio 
and multiplying the result by 30 (average sequence coverage) (designated ‘CGH (cn.MOPS)’). 
Finally, for comparison with the results from Chapter 3, the CGH data were reanalysed for 
CNVs using GADA, as in Chapter 3, except that the log2 ratio cut-off of 0.8/-0.8 was used 
instead of 1/-1 so as to be comparable to the analyses here using cn.MOPS. This analysis was 
designated ‘CGH (GADA)’.
To evaluate the consistency between CNV calling using sequence and CGH data, for each 
CNV genes, the positive and negative predictive value (PPV and NPV) of each of the methods 
was calculated using CGH (GADA) as the ‘gold standard’. PPV gives the proportion of CNVs 
detected in a method that are also detected in CGH (GADA). The NPV gives the proportion of 
CNVs not identified in a method that are not detected in CGH (GADA). The values of the two 
measures range between 0 and 1. A PPV of 1 indicates that all samples identified to have a 
specific CNV gene in one method were also identified to have the same CNV gene in CGH
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(GADA) and 0 indicates that none of the samples identified to have a specific CNV gene in 
one method had CNVs detected in CGH (GADA). A NPV of 1 indicates that all samples 
without a CNV in one method did not have the CNV detected in CGH (GADA) and 0 
indicates that all the samples without a CNV gene in one method had the CNV detected in 
CGH (GADA). PPV and NPV were used instead of sensitivity and specificity because they 
take into account the prevalence of the CNVs.
4.3 Results
4.3.1 Sequence quality
The majority of sequenced bases were of good quality with Phred quality scores of greater
than 20, i.e., a 1 in 100 probability that a base is incorrectly called. The mean read length
ranged between 160bp and 235bp in the 22 samples. The average genome coverage differed in
the samples sequenced. The genome coverage ranged between 7.8 - 47.7 in the 18 samples
analysed and from 1.6 - 5.1 in the four samples excluded from analysis (Table 4.1).
The quality of the bases decreased with increasing sequence read length above 200bp (Figure
4.2A), a characteristic commonly observed with most sequencing platforms. This
phenomenon is thought to be due to some templates on the bead lagging behind or ahead in
sequence of other templates on the bead as a result o f lack of complete extension or leftover
nucleotides in the well (Bragg et al. 2013, Salipante et al. 2014, Margulies et al. 2005). The
average nucleotide content observed was 20% GC which is similar to the expected value in P.
falciparum based on Sanger sequencing (Gardner et al. 2002) (Figure 4.2B) and the proportion
of the nucleotide content varied greatly after the 250bp position. Four samples with the lowest
average sequence coverage, due to presence of high proportion of human DNA sequences
relative to parasite sequences, of up to 95% (Table 2.3 and 2.4), were excluded from further
analysis. A summary of the sequence output for each of the samples is shown in Table 4.1
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Figure 4.2. Plots of quality scores and nucleotide content of sequenced reads
A) Boxplots of quality scores (y-axis) by position in read (x-axis) in a samples. Yellows boxes 
show the inter-quartile range, 25th -75th, the red line-median, upper and lower whiskers are the 
10th and 90th values and the blue line-mean. The poor quality bases are in red, good quality 
bases are in green and moderate quality in orange background. B) Mean proportion of each 
nucleotide (y-axis) by position in sequence reads (x-axis) in a sample.
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able 4.1 Summary statistics of whole genome sequence data of 22 P. falciparum  field isolates
Sample
Identifier
Population 
o f origin
Number of 
reads
Mean read 
length (bp)
Number of 
reads
mapped to 
3D7
Final read 
count after 
filter
Percent o f genome with coverage values 0, >0- 
<=5, >5-<=10, >10-=<20 and >20
=0 =<5
>0
>5
<=10
>10
=<20
>20
pf!299 Kilifi Pre 5,814,179 192 3,343,322 2,634,034 8.4 11.7 10.1 17.4 52.4
pfl624 Kilifi Pre 4,768,102 181 2,584,197 1,903,046 12.0 15.3 11.7 24.0 37.0
pfl349 Kilifi Pre 6,117,359 200 2,752,578 2,172,391 10.0 13.2 11.1 20.7 45.0
pfl0676 Kilifi Post 6,516,576 195 2,726,767 2,158,002 10.8 16.0 12.3 21.8 38.1
pfl0724 Kilifi Post 7,212,289 235 1,579,785 1,199,707 10.8 19.8 17.2 37.2 14.9
pf!0836 Kilifi Post 4,221,534 204 2,642,321 1,882,187 9.0 15.6 12.0 19.4 44.0
pfl0760 Kilifi Post 4,469,713 206 1,192,910 984,949 14.2 27.0 25.5 31.0 2.3
pfl212 Kilifi Pre 6,151,974 188 5,715,908 4,868,604 9.4 12.4 7.9 11.0 59.3
pfl0770 Kilifi Post 7,325,789 190 4,558,838 3,776,892 10.9 15.2 9.4 12.0 52.5
pfl590 Kilifi Pre 6,966,753 205 1,239,892 972,995 17.2 27.3 19.8 31.5 4.2
pfl895 Kilifi Pre 7,282,318 178 7,112,587 6,151,059 8.3 5.9 4.9 8.9 71.9
pfK007 Kisumu 6,673,824 183 6,021,604 5,068,212 7.6 11.6 8.3 12.0 60.5
pfK020 Kisumu 6,161,420 160 5,761,970 4,647,383 8.5 12.0 9.8 15.7 54.0
pfK071 Kisumu 6,661,003 189 2,882,086 2,365,500 13.7 22.1 10.3 12.4 41.5
pfM004 Sudan 6,674,924 204 4,651,427 3,953,732 8.8 6.8 6.0 11.7 66.7
pfM007 Sudan 6,718,825 192 6,430,355 5,428,351 9.9 7.9 5.2 8.8 6.8
pfl0814 Kilifi Post 6,620,382 190 883,916 672,578 24.5 36.5 22.4 15.6 1.0
pfK065 Kisumu 6,699,194 200 332,760 209,049 35.3 61.5 3.2 0 0
pfG013 Sudan 6,716,879 162 366,073 237,561 3.5 61.5 3.3 0 0
pfl0820 Kilifi Post 4,593,168 199 4,267,905 3,501,088 21.7 15.0 6.7 9.2 47.4
pfl0578 Kilifi Post 5,690,616 233 496,494 375,707 55.5 36.0 5.1 2.0 1.5
pfl0495 Kilifi Post 4,369,272 225 5,387.450 4,184,087 22.9 14.4 6.4 8.6 47.6
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4.3.2 Challenges in mapping of whole genome sequence data of P. falciparum
As in previous studies (Quail et al. 2012, Ross et al. 2013), GC content in a region was found 
to positively affect read coverage at GC content below 50% (Figure 4.3A). This effect has 
been linked to the PCR amplification step during sequencing (Quail et al. 2012): in this study, 
5 rounds of amplification per sample were performed. Low sequence complexity also affects 
the ability o f reads to unambiguously map to the reference thus biasing read coverage 
estimates in these regions (Treangen and Salzberg 2012). In this study, low or no coverage in 
non-unique regions was observed since the reads that aligned to multiple locations on the 
genome were filtered out (Figure 4.3B).
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Figure 4.3. Effect of GC content and uniqueness of a region on sequence coverage
The relationships between A) GC content and coverage, and B) uniqueness and coverage 
calculated in lOObp non-overlapping windows. A uniqueness value of 1 indicates a lOObp 
sequence window that is not similar to any other region in the genome while a value of 0 
represents a lOObp sequence that appears more than four times in different locations in the 
genome.
Page 114 of 191
4.3.2.1 Normalisation of read depth across the samples
The read depth was normalised across the samples by applying the ‘quantile’ method in 
cn.MOPS package in R (Klambauer et al. 2012). Quantile normalisation adjusts the 
distribution of read depth such that they are similar among the samples. Normalisation 
minimized the variation in read coverage that is due to the differences in number of reads 
sequenced among the samples (Figure 4.4A vs 4.4B).
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Figure 4.4. Normalisation of read coverage across samples
A) The raw coverage of 18 samples across a region in chromosome 1. The coverage of the 
sample with the highest overall coverage indicated by the red line and the coverage of the 
sample with the lowest overall coverage indicated in green. B) Normalised coverage of the 
same region on chromosome 1.
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4.3.2.2 CNV detection using cn.MOPS
Genomic regions that vary in copy number were identified using cn.MOPS. The example 
illustrated in Figure 4.5 shows the normalised read coverage (black lines), the CNV segments 
detected (pink bars) in 11 out of the 18 samples and their genomic positions in the ‘genes’ 
method. The length and location of the CNV segments detected varied across the 11 samples 
(Figure 4.5). Only three samples had CNV segments spanning a whole gene. Most of the 
samples contained CNV segments that spanned very small portions of genes, and may be 
noise or short repeat regions located within genes. For this reason, a cut-off on the minimum 
length of CNV segments within a gene for it to be called a CNV was later applied.
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Figure 4.5. CNV calling using cn.MOPS
A region on chromosome 8 identified to contain CNV regions in the ‘genes’ method. The line 
plot shows the normalized read depth of the 18 samples. The CNV segments identified by 
cn.MOPS in 11 samples are shown by the pink horizontal bars. The three genes located in this 
region are shown by grey rectangles.
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Overall, the total number and length of the CNV segments varied across the six methods 
(sequencing and CGH) and 18 samples (Appendix 4.1 A-F). The ‘genome’ had the highest 
number of segments owing to the inclusion of intergenic regions in the analysis (Appendix 
4.1C). The ‘probome’ had the lowest number of segments among the sequence methods since 
only regions targeted by probes, ~ 10000 regions of 70bp width, were analysed (Appendix 
4. ID). The number of CNV segments detected in the CGH data was higher when using the 
GADA method than cn.MOPS due to the inability of cn.MOPS to analyse data of probes with 
missing values in any one sample whereas GADA could analyse data of the same probes 
ignoring the sample with missing values (Appendix 4. IF vs. 4. IE). The number o f probes 
analysed by GADA was 9615 whereas 4749 probes were analysed using cn.MOPS. The 
majority of the CNV segments were observed to be shorter than 500bp in the ‘exome’, ‘genes’ 
and ‘genome’ methods (Appendix 4.1A-C). The ‘probome’, ‘CGH (GADA)’, and ‘CGH 
(cn.MOPS)’ had most of the CNV segments above lOOObp (Appendix 4.1 D-F).
4,3.3 Gene copy number variation definition
The genes that lie in the CNV segments were identified and found to differ in number between 
the samples in a method and also between the 6 analysis methods (Appendix 4.2).The fraction 
of the gene lengths detected to be copy variable were calculated for each of the methods 
(Appendix 4.2). In the sequence-based methods, the majority of the genes had less than 20% 
of the gene length identified to be copy number variable except in the case of the ‘probome’ 
which had a majority greater than 80% (Appendix 4.2 A-D). The majority of CNV genes 
identified in CGH data had a copy number difference in at least 80% of the probes (Appendix 
4.2E-F). For subsequent analysis, a CNV gene was defined as those with greater than 50% of 
their gene length/probes within identified CNV segments.
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There were differences between the sequence and the probe based methods. First, a number of 
lOObp windows per gene were assessed sequence methods (‘exome’, ‘genes’ and ‘genome’) 
whereas on average two 70bp windows per gene were assessed in CGH data and ‘probome’ 
methods. Second, the total number of genes assayed by the two methods varied. A total of 
5179 genes per genome were assayed in sequence methods (‘exome’, ‘genes’ and ‘genome’) 
whereas 5031genes were assayed in CGH methods (‘GADA’, ‘probome’) and 3121 genes in 
‘CGH (cn.MOPS)’.
4.3.4 CNVs detected by next-generation sequencing
The CNV genes identified in both sequence and microarray data , defining CNV genes as 
those with greater than 50% of gene length/probes in a gene identified to be copy number 
variable, are distributed throughout the parasite’s genome (Figure 4.6). There was poor 
overlap in the CNV genes identified from the sequence and microarray methods (Figure 4.6). 
The reason for the higher number of CNV genes detected in CGH data using GADA than in 
Chapter 3 is that low stringency was used in CNV definition in this analysis. The number of 
different genes showing copy number gain, loss or both gain and loss ranged from 191 to 828 
in the six methods (Figure 4.7A). Many CNV genes identified were exclusive to each method 
with approximately 300 CNV genes shared between any two methods (Figure 4.7B). The 
CNV genes identified using the three sequence methods, ‘exome’, ‘genes’ and ‘genome’, were 
significantly shorter (p-value < 0.0001 using t-test) than those identified in CGH data and the 
‘probome’ method (Figure 4.7C). The length of the CNV genes identified on CGH data using 
the two methods (‘cn.MOPS’ and ‘GADA’) were statistically similar (p-value=0.37 using t- 
test). Also, the CNV genes length identified using ‘probome’ method was statistically similar 
to ‘GADA’ method (p-value 0.05).
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Figure 4.6. Genomic location of CNVs identified in CGH and sequence data in 18 
isolates.
The location of CNV genes are shown as coloured vertical bars. The CNVs detected by CGH 
(GADA) method in green, CGH (cn,MOPS) in maroon, ‘exome’ in blue, ‘genes’ in red, 
‘probome’ in magenta and ‘genome’ in orange. The regions targeted by the microarray probes, 
the exons and the full genome are shown in grey in the top, middle and bottom row of each 
chromosome, respectively. Regions excluded from the analysis are shown in black.
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Figure 4.7. The number and length of CNV genes detected by five methods using 
cn.MOPS.
A) Barplot showing the number of CNV genes in six methods and the proportions of genes 
with increased copy number (gain) in grey and decreased copy number (loss) in pink and CNV 
genes with both gain and loss in green. B) Barplot showing the number of CNV genes 
exclusively detected in a single method, or detected in two or more methods. C) Boxplot 
showing the distribution of the length of CNV genes in the six methods.
4.3.4.1 Comparison between CNV genes identified in m icroarray and sequence data
The PPV and NPV of each method in detecting a CNV gene identified in CGH (GADA) were 
determined across the 18 samples. These calculations were based on less than 100 CNV genes 
because less than 100 CNV genes were detected by both CGH (GADA) and either one of the 
methods. Less than 10 CNV genes in each of the methods had a PPV of 1, i.e., all samples
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with the CNV in a method also had the CNV detected using CGH (GADA) (Figure 4.8 A, B, 
C, D and E). However, the majority of the CNV genes detected by each of the methods had 
low PPV of 0 and high NPV of 1. The low PPV indicates that the CNVs identified in one of 
the five methods were not identified in the same samples in CGH (GADA) (Figure 4.8 A, B,
C, D and E). High NPV observed shows that CNV genes that were not identified in a method 
were also not detected in CGH (GADA) (Figure 4.8 F, G, H, I and J). CGH (cn.MOPS) was 
found to have a higher proportion of genes with high PPV than the other methods indicating 
that CNV genes that were detected in this method were also detected in CGH (GADA) (Figure 
4.8H).
4.3.5 CNVs detected by both microarrays and sequencing
Examples of CNV genes identified in the same samples in both CGH (GADA) and sequence 
methods are listed below (Table 4.2). Some of the genes are involved in regulation of gene 
expression (PF3D7_0925700, PF3D7 1105000). One gene encodes proteins that form part of 
the 60S ribosomal subunit of the ribosome (PF3D7 1351400). Two genes are involved in 
gametogenesis, PF3D7_1038400 (Scherf et al. 1992) and PF3D7_0935400 (Eksi et al. 2012).
4.3.6 CNVs exclusively detected in sequence data or microarray data
One of the CNVs detected in sequence data and not in CGH data of the 18 sequenced samples 
was an amplification of three consecutive genes in chromosome 12 (Figure 4.9A). However, 
this amplification was observed in one sample of the 183 samples with CGH data that was not 
sequenced (Figure 4.8B). One of the genes in this CNV, PF3D7 1224000, known as GTP 
cyclohydrolase 1 (gchl) has been previous reported to be amplified in field populations of P. 
falciparum (Nair et al. 2008, Mackinnon et al. 2009, Robinson et al. 2011) as well as in culture
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gure 4.8. Positive and negative predictive values (PPV and NPV) of CNVs genes detection in five genome sequences analysed by 
.MOPS and CGH (cn.MOPS) with CGH (GADA) as the gold standard. Histogram of the positive predictive value (PPV) CNV gene 
tection in the five method A) ‘genes’ B) ‘exome’ C) ‘genome’ D) ‘probome’ and E) CGH (cn.MOPS). The negative predictive value (NPV) of 
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(Kidgell et al. 2006, Jiang et al. 2008b). The presence of up to 11 copies of the gchl identified 
in field isolates (Nair et al. 2008) is consistent with the extremely high sequence coverage of 
this region for the isolate displaying the amplification (Fig. 4.9A). The estimated copy number 
of the region in our analysis was 4. gchl codes for the first enzyme in the folate synthesis 
pathway. Its amplification has been observed to occur together with a SNP (dhfr-164L) present 
in an enzyme, dihydrofolate reductase (dhfr), which occurs in the same metabolic pathway and 
which is targeted by antifolate antimalarial drugs. The amplification is thought to be a 
compensatory mechanism as a result of presence of the antifolate resistance SNP mutation 
(Nair et al. 2008, Kidgell et al. 2006).
A large deletion at the right end of chromosome 9 observed in CGH data, in 3 of the 19 
samples sequenced, was observed to contain sequence coverage in sequence data (Figure 
4.10). However, four genes in the region (PF3D7 0935400, PF3D7 0936000,
PF3D7 0936400 and PF3D7 0936500) were observed to be copy number variable by 
sequencing in reference to the mean of all the samples sequenced (Table 4.2). The reference 
sample in CGH experiment is known to have the deletion (Mackinnon et al. 2009), and 
therefore clinical isolates with similar copies to the reference, i.e., a log2 ratio close to zero, 
indicate a deletion in the samples. Of interest to this study of field isolates is that this deletion 
has previously only been detected in laboratory cultured lines and thought to be an adaptation 
mechanism to growth in vitro (Kemp et al. 1992, Shirley et al. 1990, Mackinnon et al. 2009).
Another interesting CNV gene, clag 3.1 identified as PF3D7_0302500, belonging to the 
cytoadherence-linked asexual gene family {clag genes) was detected in one sequence method 
(‘probome’) and microarrays. One or both of the clag 3 genes (PF3D7_0302200lclag3.2 and
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Table 4.2. A list of CNV genes detected in CGH (GADA) and at least one sequence 
method with the fraction of the number of samples with CNV in a method that had the 
CNV detected in both the method and CGH (GADA)
Gene Product Exome Gene Genome Probome
PF3D7 0 107200 Carbon catabolite repressor 1/1
protein 4 putative
PF3D7 0302500 Cytoadherence linked asexual 1/1
protein 3.1 (CLAG3.1)
PF3D7_0312000 Conserved Plasmodium protein 1/6 1/6
unknown function
PF3D7 0315200 Circumsporozoite-and TRAP- 1/5
related protein (CTRP)
PF3D7 0422300 Alpha tubulin 2 1/5 1/5 1/5
PF3D7 0522800 G10 protein putative 1/1
PF3D7 0915300 Conserved Plasmodium protein 1/8
unknown function
PF3D7 0925600 Zinc binding protein (Yippee) 2/7 1/7
putative
PF3D7 0925700 Histone deacetylase (HDAC1) 1/7
PF3D7 0935400 Gametocyte development 1/14
protein 1 (GDV1)
PF3D7 0936000 Ring-exported protein 2 1/3
(REX2)
PF3D7 0936400 Ring-exported protein 4 2/13
(REX4)
PF3D7 0936500 Plasmodium exported protein 1/8
unknown function
PF3D7 1038400 Gametocyte-specific protein 1/16 1/16 1/16
(Pfll-1)
PF3D7 1105000 Histone H4 (H4) 5/7 5/7 3/7 5/7
P F 3D 71107100 Nucleic acid binding protein 1/1
putative
PF3D7 1107400 Rad51 homolog (RAD51) 1/4 1/4 1/4
PF3D7_1114200 GTPase activator putative 1/1
PF3D7 1245200 Conserved Plasmodium 1/6
membrane protein unknown
PF3D7 1333100 Conserved Plasmodium protein 1/3
unknown function
PF3D7 1351400 60S ribosomal protein L I7 1/3
putative
PF3D7 1479000 Acyl-CoA synthetase (ACSla) 1/1 1/1 1/1 1/1
Total 12 11 12 17
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Figure 4.9. Amplification of GTP cyclohydrolase gene 1
A) Plot of normalised coverage of a region on chromosome 12 containing three CNV genes 
identified in the ‘exome’ method. B) Plot of the CGH ratio of the same region of all the 183 
samples with CGH data. The coverage and CGH ratio of the sample with the amplification in 
among the sequenced isolates is indicated by the red line.
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Figure 4.10. A CNV identified in chromosome 9 using microarrays but not using 
sequencing.
Plot of A) CGH ratio along a CNV region on chromosome 9. B) Plot of the normalised 
sequence coverage in the ‘genome’ method across the same region. The blue lines indicate 
CGH ratio/normalised coverage of samples with the chromosome 9 deletion observed in CGH 
data.
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PF3D7_0302500) have been previously reported as CNVs in both clinical isolates (Robinson 
et al. 2011) and laboratory lines (Jiang et al. 2008b, Mackinnon et al. 2009, Iriko et al. 2008). 
However, in one of the studies, clag 3.1 was reported to be amplified (Jiang et al. 2008b). The 
two clag 3 genes are known to exhibit a sequence similarity of greater than 90% (Kaneko et al. 
2005). Therefore, only a small proportion of each gene can be uniquely mapped to two genes 
in the reference genome. For the clag 3.1 gene, CNV segments were detected using the 
sequence methods ‘exome’, ‘gene’ and ‘genome’, but for the above reason, the criterion of 
CNV segments constitution at least 50% of the gene length for it to be designated as a CNV 
gene were not met (Figure 4.11 A). Closer inspection of the raw sequence coverage of only the 
regions that differed in sequence between the two genes shows that some of the samples had 
no coverage in these regions in the clag 3.1 gene but had sequence coverage in clag 3.2, thus 
suggesting that there may be a true deletion of this gene (Figure 4.11 C vs. B).
4.4 Discussion
Array CGH has been widely used to detect CNVs in P. falciparum genome (Cheeseman et al. 
2009, Kidgell et al. 2006, Ribacke et al. 2007, Mackinnon et al. 2009, Mok et al. 2011, Jiang 
et al. 2008b). Recently, there has been an attempt to apply whole genome sequencing to detect 
CNVs in the expectation that its higher resolution might yield more accurate results (Robinson 
et al. 2011, Samarakoon et al. 201 lb, Sepulveda et al. 2013). A total of 7 CNV genes were 
identified in 5 clinical isolates in one of these studies, of which 2 have been previously 
reported (Robinson et al. 2011). In a second study, 4 out of 7 isolates sequenced had publicly 
available CGH data (Sepulveda et al. 2013). In the four laboratory parasite lines, the 
proportion of CNV hits (lOObp windows detected to be copy number variable) detected in
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Figure 4.11. Deletion of clag 3.1 gene (PF3D7 0302500) on chromosome 3
A) Plot of the CNV segments (deep pink, green, blue and orange rectangles) identified in the 
region containing the two clag 3 genes, clag 3.2 (PF3D7_0302200) and clag 3.1 
(PF3D7 0302500), on chromosome 3 in the ‘exome’ method. The blue vertical lines show the 
regions that have sequences unique to each gene. Plot of raw per base coverage of only the 
sequences unique to each gene B) the clag 3.2 and C) clag 3.1. The samples with very low 
coverage/no coverage in the unique regions of clag 3.1 are shown by green, orange and blue 
lines and may be real deletions. The CNV segments detected in these samples are shown in 
similar colours in A.
The main goal of this chapter was to confirm the CNVs identified using microarrays by whole 
genome sequencing. Comparison of the two technologies of CNV detection has its challenges. 
First, CNVs detection in P. falciparum using sequencing data is still new and the analysis 
remains a challenge hence complicates the comparison with microarrays. Second, most
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analysis tools used in the two technologies were developed to suit each of the individual 
technologies, therefore comparing CNVs detected by different algorithms may be problematic. 
Third, the two technologies differ in the regions of the genomes targeted with sequencing 
covering the whole genome whereas microarrays target specific regions of genes. Fourth, the 
reference upon which copy number was calculated differ. In microarrays, the number of gene 
copies in the samples is in reference to a single parasite genome while in sequencing, the 
number of copies is in reference to the mean of all the samples. Lastly, the forms of ‘noise’ 
(measurement error) differ in the two technologies: whereas microarrays average out the 
signal, sequencing generates high base to base variability in read depth.
These challenges were overcome by employing various strategies in CNV detection analysis. 
First, regions with less accurate mapping in P. falciparum, i.e., low complexity regions 
(introns and intergenic regions) and highly polymorphic genes (vars, rifins and stevors), were 
excluded prior to CNV calling. The ‘genome’ target, with low complexity regions included in 
analysis, had the highest number of CNV segments detected in the samples ranging from 
1000-3000 per sample (which did not correspond to high numbers of CNV genes) compared to 
the target genomes (‘genes’, ‘exome’, ‘probome’) range (5-1200 segments) which had the 
low complexity regions excluded. Most of these CNV segments in the ‘genome’ were located 
in the intergenic and intron regions.
Second, to analyse similar targets in the two technologies, a sequence genome target, 
‘probome’, made up of the genomic regions targeted by the microarray probes were analysed 
in sequence data. Also, a target genome o f only coding regions of the genome named the 
‘exome’, which are targeted by the array, was included in the comparison. The number of
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overlapping CNV genes detected in the samples was greatest between the ‘probome’ and CGH 
(GADA).
Differences in CNV detection in the two technologies is also contributed by the differences in 
the reference used in copy number estimation. In sequencing, copy number was calculated 
from the normalised coverage of the region in an isolate against the mean of the all the isolates 
whereas in microarrays it was calculated against one reference isolate. Another major 
difference in the microarrays and sequencing technology is measurement used. In microarrays, 
an average intensity signal is obtained for a 70bp sequence whereas in sequencing the read 
depth of each base is obtained. The read depth is biased by GC content and uniqueness of a 
region. The choice of window size and regions over which read depth is calculated and 
normalised to minimize variation is a critical step. Though the read depth, calculated in lOObp 
windows and normalised in lOObp windows, a number of very short fragments of genes/exons 
were detected as CNVs, reflective of the high amount o f variability in sequence data. To 
minimize the technology-specific noise, a cut-off was set on the minimum length of sequence 
and the number of probes required for a gene to be called a CNV.
After accounting for some of these variables, concordance was found in 21 CNV genes with 
the ‘probome’ method proving to be the most concordant. This is because its genomic targets 
were similar to CGH (GADA).
Two clear examples of major discrepancies between microarray and sequencing were found.
A large deletion in chromosome 9 was found by microarray in three isolates but sequencing 
data showed presence of sequence reads in these same samples. Second, a high copy number 
amplification of three consecutive genes in another region of chromosome 12, one of which
was gchl, was found in sequence data but no amplification was observed in the same sample 
by microarrays but was instead was observed in another sample by microarrays that was not 
sequenced. One possible reason for these observed differences is that microarrays have a 
limited dynamic range and, unlike sequencing, may not accurately quantify the massive 
deletions and amplifications. A further possibility is that the presence of subpopulations of 
parasites in the isolate with the CNV were undetected by microarray but became amplified 
during library preparation and visible by sequencing. These examples illustrate that one 
technology cannot replace the other yet for the purpose of CNV detection.
The two dag 3 genes best illustrates the difficulty of detecting CNVs in multiple regions of 
sequence homology in the genome. Focussing on the unique regions of these genes is one way 
to overcome the mapping problem, though mapping in the short unique regions may still be 
affected by sequencing errors and the stringency applied during read mapping to the reference. 
Increasing the sequence read length coupled with de novo assembly may help solve this 
problem (Zhao et al. 2013, Nijkamp et al. 2012).
Improvement of CNV detection methods using sequence data is still needed. One of the 
challenges of comparing CNV detection methods is the lack of a gold standard. Every 
technology has its challenges and even the analysis tools used for CNV detection in each of 
the technologies have shown to yield different results (Pinto et al. 2011, Mills et al. 201 lb).
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Chapter 5
Effects of CNVs on gene expression levels
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5 Chapter 5: Effects of CNVs on gene expression levels
5,1 Introduction
In P. falciparum, a number of CNVs have been identified: however, the functional impact of 
these CNVs on gene expression has not been widely studied. In many organisms, it has been 
shown that CNVs alter gene expression levels and hence affect phenotype (Henrichsen et al. 
2009, Stranger et al. 2007). CNVs have been shown to affect the levels of expression of genes 
within the CNVs (‘direct effects’) and also genes located outside the CNVs (‘indirect effects’). 
In P. falciparum, an example Of a direct effect of a CNV is an amplification of the GTP- 
cyclohydrolase 1 (gchl) gene that leads to increased levels of gchl expression which has been 
associated with antifolate drug resistance (Nair et al. 2008). An example of an indirect and 
global effect of a CNV is the ‘super CNV’ on chromosome 5 comprising an amplification of 
the region containing the P. falciparum multidrug resistance gene 1 (Pfmdrl) associated with 
multidrug resistance gene. This CNV was found to be either positively or negatively 
associated with the level of expression of 269 genes (Gonzales et al. 2008). A number of P. 
falciparum CNVs have also been observed to influence the levels of expression of genes 
within and outside CNV regions (Mackinnon et al. 2009).
In this chapter, the impact of gene copy number variation on the levels of gene expression was 
assessed. Gene expression/transcriptome data were generated by Rono M et al. (unpublished). 
The relationship between gene expression and CNVs discovered in the same set of isolates 
described in Chapters 3 and 4 was investigated. The direct effect o f alteration of gene copy 
number on gene expression and the global effect o f these CNVs were investigated by 
correlation and linear regression analyses of CGH data in relation to expression data.
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5.2 Methods
5.2.1 Samples
Seventy-two isolates out of the 183 isolates used for CNV identification in Chapter 3 had 
expression data and were used in this analysis. The 72 parasite isolates selected had complete 
maturation ex vivo and good quality array data of all the parasite stages. These isolates were 
from Kilifi pre-malaria decline, Kilifi post-malaria decline, Kisumu and Sudan, as described in 
Chapter 2. Twelve out o f the 72 isolates had sequence data (chapter 4).
5.2.2 Gene copy num ber variation
The CGH data (log2 CGH ratio) used in this Chapter were pre-processed as described in 
Chapter 3. The mean CGH ratio was calculated for each gene from CGH ratio of probes 
targeting the genes and used for association analysis. Ninety-five different CNVs comprising 
221 genes were detected in the 72 samples with both CGH and transcriptome data. The mean 
CGH ratio of probes contained in the CNVs (mean amplitude of CNVs) provided an indication 
of the size and direction of gene copy number differences between the test and reference 
isolates.
5.2.3 Gene expression data
Transcriptome data were generated by Rono. M et al. using a similar microarray to that used in
CGH (Chapter 2). Parasite isolates were obtained straight from the arm of infected individuals
at the ring stage of development and were matured ex vivo to obtain samples at all the stages
of the parasite’s 48-hour intraerythrocytic development. This step is required since levels of
expression of most of the parasite’s genes are known to vary across this cycle (Bozdech et al.
2003a). I was involved in maturation experiments of some of the parasites and set up of
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sample database. Preparation of cDNA and amplification from extracted RNA, at each of the 
parasite stages, were carried out (section 2.3.1 and 2.3.2). The amplified product was labelled 
and hybridized against a reference line, a Kilifi laboratory-adapted strain designated as ‘P4’, 
as for CGH. The reference cDNA consisted of a pool of cDNA from all the intraerythrocytic 
developmental stages of the parasite.
Prior to analysis, Loess curves were fitted to the data for each gene across all isolates and the 
residual values were computed. For each gene and for each isolate, these residual values were 
used to calculate the mean value across all stages of development (‘Mean’), and the mean 
value of data 6 hours each side of the time of maximum expression of the gene (‘Max’).
These isolate means were then used for the analyses described below.
5.2.4 Analysis of expression in relation to gene copy num ber
The effect of CNVs on the expression of genes located within them was assessed by 
performing a Pearson correlation between the mean CGH ratio per gene and ‘Mean’ 
expression data of each gene across the 72 isolates. The p-value for assessing significant 
differences from the expected correlation of zero under the null hypothesis of no relationship 
between gene copy number and expression levels was calculated using the cor.test function in 
R.
To investigate whether the correlation obtained from the analysis may have been by chance, a 
permutation test was performed. 100 random permutations of the expression data o f each gene 
were generated and the correlations between mean CGH ratio of each gene and each of the 
100 randomized expression data per gene were calculated. A Kolmogorov-Smimov test for
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significant differences between the distribution of observed correlations and distribution of 
correlations from the permuted data was applied using the ks.test function in R.
To analyse the relationship between gene expression (of genes in the whole genome) and the 
CNVs detected, a linear regression model was applied using the Im function in R. The mean 
log2 expression ratio of each gene was the dependent variable while the copy number state (fit 
as a fixed effect factor with levels for loss, gain or normal) was the independent variable. The 
difference in gene expression between samples with a gene copy number difference and those 
without was indicated by the regression coefficient (effect size). The significance of the 
difference was assessed from the p-value of the regression coefficient from the same model.
5.3 Results
5.3.1 Direct dosage effect of CNVs
The relationships between gene copy number and expression of 221 genes located within the 
95 CNVs was determined by calculating the correlation between the CGH ratio and the log2 
expression ratio in the 72 samples. Both positive and negative correlations between 
expression and copy number were observed (Figure 5.1 A). Significant correlations were 
detected in 41 CNV genes located in 30 different CNVs (p value < 0.05 and absolute 
correlation > 0.23) (Table 5.2). These represent direct dosage effects of CNVs on gene 
expression levels. To test whether the observed distribution of correlations may have been 
obtained by chance, the expression data for each gene were randomized, 100 times per gene, 
among the 72 isolates and the correlation re-calculated, 100 times per gene (Figure 5. IB). The 
observed (Fig. 5.1 A) and empirical (from randomized data, Fig. 5.IB) were found to differ, 
thus showing that the observed correlations between CGH and expression data were not as
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expected by chance (Kolmogorov-Smirnov test with p value < 2.2e-16). These distributions 
differed in that there were unexpected peaks at strong negative and positive correlation values 
of r = -0.3 and r = 0.2-0.3 respectively (Figure 5.1 A).
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Figure 5.1. Correlation between CGH log2 ratio of 221 CNV genes within 95 CNVs and 
their corresponding log2 expression ratio
A) Histogram showing the distribution of correlation coefficient of CGH log2 ratio and log2 
expression ratio of 221 CNV genes in 95 CNVs detected in 72 samples. B) Histogram 
showing the correlation between CGH data and 100 permutations per gene of expression data 
of the 221 genes.
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5.3.2 Direction of CNV effects on expression
Some of the genes shown to have gains or losses in copy number by CGH showed 
correlations with gene expression that varied from strongly negative to strongly positive while 
others showed very low correlations (Figure 5.2A). For genes showing gains in copy number, 
there was an approximately equal number that showed significantly higher (i.e., positive 
correlations) vs. significantly lower expression levels (negative correlations) (15/31 vs. 16/31, 
p-value=l using binomial test). For genes showing loss in copy number, slightly more genes 
showed significant positive relationships with expression (i.e., decreased expression) than 
significant negative relationships, though the difference in proportions between the two 
correlations was not significant (6/10 vs. 4/10, p value = 0.75 using binomial test).
Surprisingly, expression was observed in genes identified to be deleted (Figure 5.2A). This is 
possibly because some of the observed loss in gene copy number may not necessarily mean 
complete absence of the gene, but rather presence of reduced number of copies of the gene in 
the test isolates compared to the reference parasite line.
Also surprising is that, in some instances, genes located within the same CNV exhibited 
opposite directions of the CNV effect. An example of this is the largest CNV on chromosome 
9 with a mean amplitude of 2.5 and containing the highest number of genes (15 genes) which 
showed both positive and negative correlations with expression of some of the genes 
contained within it. However only five genes with positive correlations were statistically 
significant (p value < 0.05) (Table 5.1).
Examples of genes showing positive correlations , i.e., an increase or decrease in copy number
associated with an increase or decrease in gene expression levels, respectively, are genes
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PF3D7 0508100 and PF3D7 1207000 (Figure 5.2D and E). An example of a CNV gene 
showing a negative correlation with expression upon loss of copy number is PF3D7_1149000 
(Figure 5.2B). An example of a negative correlation upon gain in copy number is gene 
PF3D7_0925400 (Figure 5.2C). The direction of CNV effects for all the 41 CNV genes 
showing significant correlations between CGH and expression are shown in Table 5.2.
Table 5.1. Genes in a CNV showing both negative and positive associations between
CGH and expression data
Gene ID Correlation P value
PF3D7 0935500 Positive 0.315833
PF3D7 0935600 Positive 0.010319
PF3D7 0935700 Positive 0.734123
PF3D7 0935800 Negative 0.507444
PF3D7 0935900 Positive 0.036364
PF3D7_0936000 Positive 0.027061
PF3D7 0936100 Positive 0.600683
PF3D7 0936400 Positive 0.028079
PF3D7 0936500 Negative 0.200308
PF3D7_0936700 Positive 0.460633
PF3D7 0936800 Positive 0.008986
PF3D7 0937000 Negative 0.172866
PF3D7 0937100 Negative 0.25637
Among the 41 genes that showed significant correlations between copy number and 
expression were 5 genes located in a region of chromosome 9 that contained a large deletion at 
low frequency in the populations. All the 5 genes within this CNV, PF3D7 0935600,
PF3D7 0935900, PF3D7_0936000, PF3D7_0936400 and PF3D7_0936800, showed 
significant positive correlations between copy number and expression (Figure 5.3).
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Figure 5.2. Direction of CNV effects on levels of gene expression 
A) Plot showing relationship between the amplitude of 95 CNVs (mean log2 CGH ratio of 
probes within CNV) on the x axis and the correlation coefficient of each of the 221 CNV 
genes in the CNVs. Each spot represents the correlation coefficient obtained from the 
correlation between CGH and expression value in each of the 72 samples, of each CNV gene 
(x axis) and the amplitude of the CNV that contains the gene (y axis). Some of the 95 CNVs 
have more than two 2 genes located within them thus a single y value (amplitude) may have 
more than two different correlation coefficients (x axis). Box plots show ‘Mean’ gene 
expression data (a single ‘mean’ value, calculated from all the time points per gene, of an 
isolate (explained in section 2.3.3)) in samples with the CNV gene and those with normal copy 
number of the gene. A positive correlation between CGH and expression data was observed in 
gene PF3D7 1207000 B) and PF3D7 0508100 C) while a negative correlation was observed 
in PF3D7_1149000 C) and PF3D7 0925400 D).
This deletion has been previously reported in the reference parasite (Mackinnon et al. 2009): 
thus parasites bearing similar gene copies to the reference would have CGH log2 ratios close 
to zero, and those without the deletion will have higher CGH log2 ratios. The deletion was 
observed in 7 of the 72 isolates. Low levels of gene expression were observed in some of the
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Table 5.2. Genes showing direct dosage effect of CNVs on expression
Gene ID Protein Annotation CNV
state
Correlati
on
PF3D7_1129000 Spermidine synthase Gain Positive
PF3D7 1412400 Conserved protein, unknown function Gain Positive
PF3D7 1212300 Conserved protein, unknown function Gain Positive
PF3D7 1212400 Tetratricopeptide repeat family protein Gain Positive
PF3D7 0423400 Asparagine-rich protein Gain Positive
PF3D7 0936800 Plasmodium exported protein (PHISTc) Gain Positive
PF3D7 0935600 Gametocytogenesis-implicated protein Gain Positive
PF3D7 0322700 Conserved protein, unknown function Gain Positive
PF3D7 1329300 Chromatin assembly factor 1 subunit Gain Positive
PF3D7 0928000 Cytochrome c oxidase subunit 6B Gain Positive
PF3D7 0936000 Ring-exported protein 2 Gain Positive
PF3D7 0936400 Ring-exported protein 4 Gain Positive
PF3D7 0935900 Ring-exported protein 1 Gain Positive
PF3D7 1128700 GPI-anchor transamidase Gain Positive
PF3D7 0515200 Conserved protein, unknown function Gain Positive
PF3D7 0925400 Protein phosphatase-beta Loss Positive
PF3D7 0925600 Zinc binding protein (Yippee) Loss Positive
PF3D7 1008900 Adenylate kinase Loss Positive
PF3D7 0822600 Protein transport protein SEC23 Loss Positive
PF3D7 0826000 Conserved protein, unknown function Loss Positive
PF3D7 0804700 Conserved protein, unknown function Loss Positive
PF3D7 1143400 Translation initiation factor eIF-1 A Gain Negative
PF3D7 1313000 Ubiquitin-like protein nedd8 homologue Gain Negative
PF3D7 1244800 Cytoplasmic translation machinery associated 
protein
Gain Negative
PF3D7 1201900 Conserved protein, unknown function Gain Negative
PF3D7 0213600 Conserved protein, unknown function Gain Negative
PF3D7 1316800 Protein transport protein SEC20 Gain Negative
PF3D7 1312800 Conserved protein, unknown function Gain Negative
PF3D7 1317300 Conserved protein, unknown function Gain Negative
PF3D7 0602200 MYND finger protein Gain Negative
PF3D7 0915300 Conserved protein, unknown function Gain Negative
PF3D7 0407100 Methyltransferase Gain Negative
PF3D7 0203100 Protein kinase Gain Negative
PF3D7 1245200 Conserved protein, unknown function Gain Negative
P F 3 D 7 1 128900 Conserved protein, unknown function Gain Negative
PF3D7 0302900 Exportin-1 Gain Negative
PF3D7_1329200 Conserved protein, unknown function Gain Negative
PF3D7 1149000 Antigen 332, DBL-like protein Loss Negative
PF3D71207200 Conserved protein, unknown function Loss Negative
PF3D7 0309600 60S acidic ribosomal protein P2 Loss Negative
PF3D7_1114800 Glycerol-3-phosphate dehydrogenase Loss Negative
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Figure 5.3. Association between the CGH ratio and expression ratio of genes located in 
chromosome 9 region containing a deletion
Plot of the relationship between CGH ratio (x axis) and expression ratio (y axis) of five genes 
PF3D7 0935600 (black), PF3D7 0935900 (red), PF3D7 0936000 (blue), PF3D7 0936400 
(green) and PF3D7 0936800 (orange) located in the right arm of chromosome 9 contained 
within a CNV. The coloured linear regression lines fitted to the corresponding coloured data 
points are generated using Im function in R with the CGH ratio of the genes as the independent 
variable and the expression ratio as the dependent variable. All the fitted lines were found to 
be statistically significant (p value < 0.05).
isolates with CGH ratios close to zero or below 1 (i.e., with the deletion) (Figure 5.3). This 
CNV of interest, observed using CGH data (Chapter 3) but not confirmed using sequencing 
(Chapter 4), has previously been reported only in laboratory-adapted lines but not from 
clinical isolates. The low expression levels observed at low CGH ratios in some isolates may 
support the observation of a deletion of these genes. Alternatively, it may have resulted from a 
result of presence of polymorphism in the isolates which may interfere with microarray 
hybridization. This seems unlikely given that SNP-containing probes were excluded prior to 
CNV analysis (Chapter 3) and that all five genes contained within the region exhibited similar 
reductions in signal in both CGH and expression in some isolates.
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5.3.3 CNV effects on the expression of genes located outside CNV intervals
Previously, CNVs have been associated with not only changes in expression of genes with
altered copy number, but also genes outside the CNV boundaries (Mackinnon et al. 2009,
Gonzales et al. 2008). In this study, the potential CNV regulation of expression of genes
neighbouring the CNVs and also genes on different chromosomes was examined. The effect of
the 95 CNVs on expression of approximately 4000 genes outside CNV regions was assessed
using linear regression models. Gain and loss in copy number showed both negative and
positive effects on expression of genes outside the CNVs (Figure 5.4A). For the majority of
genes the level of expression was not affected by CNVs, indicated by high density observed at
zero (Figure 5.4A). CNV effects on expression were more extreme for deletions than for
amplifications, especially in causing a reduction in expression (Figure 5.4A). Five percent of
these CNV effects on expression were found to be significant (loglO (p value) < -1.30) (Figure
5.4B).
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Figure 5.4. CNV effects on expression of genes located outside the CNVs 
The violin plot shows the results from a linear regression model that was used to explore the 
relationship between changes in expression of approximately 4000 genes with changes in gene 
copy number in 95 CNVs. Violin plot showing the distribution of the A) regression 
coefficient of the CNVs (gain and loss) on gene expression compared to normal copy B) log 10 
(p value) indicating the significance of the CNV effect. The log 10 of the p value of 0.05 is - 
1.30. In the violin plots, the median value is indicated by the white spot, and the interquartile 
range is indicated by the short black lines. The outer line shows the density estimations at each 
value.
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5.3.3.1 Intra-chromosomal effects of CNVs on gene expression
CNV effects on expression were observed in some genes located in close proximity to the 
CNVs (Figure 5.5). The estimated proportions of genes neighbouring the CNVs that showed 
significant influence of the CNV on their expression were highest at 30-50kb and 100-200kb 
from CNV boundaries (defined as the end of the last gene and the start of the first gene in the 
CNV). The lowest proportion was at an interval of 10-20kb from the CNV boundaries.
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Figure 5.5. Effect of CNV on expression of genes at a distance from CNV
Barplot showing the proportion of genes as a function of their distance from the CNV 
boundaries that had expression levels significantly affected by CNVs. The CNV boundaries 
include the start of the first gene in the CNV and the end of the last gene in the CNV. 
Proportions were calculated as the fraction of those genes whose expression levels were found 
to be significantly affected by the CNV out of the number of genes located within these 
intervals for which data were available. The CNV effect was assessed using the linear 
regression model described above.
5.3.3.2 Inter-chromosomal effect of CNVs on expression
CNVs were also found to affect the levels of expressions of genes on different chromosomes.
The example in Figure 5.6 shows expression values of genes in samples with and without a
CNV (cnvl2_413) on chromosome 12. The CNV consists of an amplification of
PF3D7 1248600, a gene coding for a conserved Plasmodium protein of unknown function.
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The CNV was found to significantly affect the expression of 170 genes located in all 14 
chromosomes of the parasite genome. This CNV is located approximately IMbp downstream 
from another CNV (gchl amplification) region in chromosome 12 associated with expression 
of 269 genes (Gonzales et al. 2008).
The isolates with the CNV (cnvl2_413) showed two patterns of expression of the genes under 
CNV regulation. Some of the genes had high expression (expression values >0) in some of the 
isolates while others showed low expression (expression values<0). The isolates without the 
amplification (columns under black bar) exhibited a single pattern of gene expression in most 
of the isolates that was similar to a subset of isolates with the CNV (the first 18 columns under 
green bar). These isolates with or without the CNV showing similar pattern of gene expression 
originate from Kilifi and Kisumu populations. The isolates with the CNV showing a different 
expression pattern (last 14 columns under green bar) originate from Sudan. Some of the genes 
showing the CNV effect on expression include 12 genes known to be involved in splicing of 
pre-mRNA and 11 genes that encode chaperones and their regulations 
(http://mpmp.huii.ac.il/). Pre-mRNA splicing has been identified as one of the mechanisms 
utilized by plants to regulate expression of stress responsive genes (Mastrangelo et al. 2012, 
Dubrovina, Kiselev and Zhuravlev 2013). In Arabidopsis, changes in the expression of a gene 
encoding a protein, Sm-like protein 5 (LSm5), involved in mRNA splicing, has been found to 
regulate splicing o f stress-responsive genes which influence the ability of the plant to tolerate 
salt conditions (Cui et al. 2014). In P. falciparum, some of the genes, e.g., heat shock protein 
70, that encode chaperones have been shown to be protective to the parasite under heat stress 
(Pesce et al. 2008, Shonhai et al. 2011). The difference in heat stress response between Sudan 
and the two Kenyan populations (Kilifi and Kisumu) may be due to difference in thermal 
climatic conditions that the human host occupies.
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Figure 5.6. Increased copy number of PF3D7 1248600 gene shown to affect expression of 
genes located on different chromosomes
A heatmap showing the expression values of 183 genes with expression found to be 
significantly affected by cnvl2_413 containing a single gene (PF3D7 1248600) on 
chromosome 12 using linear regression model. 170 of these genes were located on 
chromosomes other than (grey rows) the chromosome on which it was located (pink rows).
The red colour shade indicates expression of greater than 0 while the blue colour indicates 
expression values below 0. The samples with the amplifications are indicated by the columns 
under the green bar, while the samples with normal copy are the columns below the black bar. 
A few samples had missing CGH data for this gene (columns under yellow bar).
5.4 Discussion
The impact of CNVs on gene expression was assessed in light of prior evidence that CNVs
affect gene expression (Gonzales et al. 2008, Mackinnon et al. 2009) and play a role in
phenotypic variation and adaptation (Nair et al. 2008, Chavchich et al. 2010). Forty-one out
of 221 CNV genes were found to exhibit direct dosage effects on gene expression. These CNV
genes showed significant positive and negative correlations between CGH and expression data
in both deletions and amplifications. The positive association between copy number and gene
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expression is expected and commonly reported in studies. However, the observed negative 
correlations are unexpected under a model of direct gene dosage effects on expression 
although have been observed elsewhere (Stranger et al. 2007, Henrichsen et al. 2009). These 
negative correlations may be as a result of the CNV being in linkage with other regulatory 
variants that cause the change in gene expression (Stranger et al. 2007). They may also be 
explained by the presence of a feedback loop whereby the expression of additional copies of a 
gene promotes the expression of a repressor that reduces the level of gene expression or 
reduced copies of a gene induces the expression of a gene enhancer leading to increased 
expression (Henrichsen et al. 2009). The extra copies of a gene may also interfere with the 
steric conformation of the gene disrupting its access to transcription machinery (Henrichsen et 
al. 2009, Sexton et al. 2007). In cases where there was a lack of association between CGH and 
expression data there may be a different regulatory mechanism to gene dosage operating. In 
the case of amplified genes, copies of genes may be located in different regions of the genome 
and hence regulated through a different chromatin environment (Henrichsen et al. 2009): the 
microarray technology cannot distinguish between tandem and non-tandem duplications and 
thus would not detect such transpositions.
Some CNVs were observed to affect the expression of genes neighbouring or at a distance 
from CNVs. These include a large proportion of genes located at distances greater than 30kb 
from the CNVs boundaries and some genes located on different chromosomes. This is 
consistent with previous studies in P. falciparum showing that CNVs affect the expression of 
genes located outside as well as inside CNVs (Gonzales et al. 2008, Mackinnon et al. 2009). 
The observation of CNV effects on genes located at different distances from the CNV implies 
that CNVs may regulate other genes through various mechanisms. First, CNVs may alter the 
chromatin structure that is known to play a role in determining gene transcriptional activity
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through epigenetic mechanisms (Cui and Miao 2010). The chromatin structure can be altered 
through modifications at the histone tails forming histone marks upon which effector proteins 
bind, or through histone variants, or through other chromatin remodellers that influence 
accessibility of DNA to transcription factors (Cui and Miao 2010, Duffy et al. 2012). The 
histone marks enable the recruitment o f chromatin-associated proteins which maintain the 
chromatin active and repressive states. Amplifications or deletions that disrupt the histone 
marks may interfere with transcriptional activity in the chromatin environment. An example of 
this in the human genome is a reduction in copy number of the D4Z4 repeats that interferes 
with chromatin structure through loss of histone marks (Bodega et al. 2009, Zeng et al. 2009). 
In addition, genomic alterations that affect genes encoding proteins that bind to the modified 
histones and those involved in histone modifications may lead to global effects on expression 
(Kleinjan and van Heyningen 2005). In P. falciparum, several genes involved in histone 
modifications (HDACs, HATs) and those interacting with the modified histones (SET1, SET2, 
PjHPI, PF3D7_1141800among others) have been identified and have been associated with 
either repressive or active states of the chromatin (Duffy et al. 2012, Cui and Miao 2010). In 
this study, genes encoding histone deacetylase 1 (HDAC1) and SET9 were observed to be 
copy number variable in both microarrays and sequencing and only microarrays, respectively. 
One of the genes under chromatin-mediated regulation is the pfap2-g (PF3D7 1222600) 
whose expression, by removal of the chromatin silencing histone marks, has been linked to 
reprogramming of the parasite’s transcriptome promoting conversion of asexual forms of the 
parasite to sexual forms (gametocytes) (Kafsack et al. 2014). Some of the observed global 
CNV effects, in this study, may be as a result of alteration in chromatin structure that 
interferes with expression of such master regulator genes.
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Furthermore, CNVs may affect the expression of genes at a distance through other methods 
including perturbation of certain functional pathways that result in changes in expression of 
genes involved in these pathways, interference with long-range interactions among promoters, 
c/s-regulatory elements and their transcriptional units (Kleinjan and van Heyningen 2005) and 
lastly, disruption of interactions that form pockets of repressive and active nuclear 
compartments that control gene transcription (Fraser and Bickmore 2007).
In conclusion, the gene expression variation associated with CNVs may result in phenotypic 
diversity in parasite populations that enable the parasite to survive when environmental 
conditions suddenly change.
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Chapter 6
General Discussion
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6 General discussion
6.1 Study objectives
The malaria parasite is exposed to constantly changing vector and host environments and yet 
is able to thrive under these conditions. The parasite has the ability to respond to these changes 
by possessing multiple variants that have varied responses to environmental pressure in order 
to facilitate its survival. There is limited understanding of the mechanisms that facilitate the 
responsive nature of the parasite that enables it to adapt to its environment. Various factors in 
the parasite have been linked to regulation of genes that interact with the environment in vitro, 
or which are associated with adaptive phenotypes, and therefore may contribute to phenotypic 
plasticity in the parasite’s natural setting. These include genetic variants that are thought to 
affect parasite phenotype, epigenetic mechanisms thought to be involved in expression of 
genes involved in immune evasion (Duraisingh et al. 2005, Freitas-Junior et al. 2005, Lopez- 
Rubio et al. 2007) and erythrocyte invasion (Cortes et al. 2007, Jiang et al. 2010) and the 
presence of master regulators of expression, e.g., the Apicomplexan ap2 gene family of DNA- 
binding transcription factors (Balaji et al. 2005, De Silva et al. 2008). It is possible that the 
parasite has a large number of mechanisms that underlie its adaptability. An understanding of 
the factors, networks and interactions that underlie adaptive parasite phenotypes in their 
natural setting may be useful in development of effective therapeutics and vaccines.
Genetic and phenotypic variation has been widely studied as the basis for understanding
malaria parasite biology. In the process, a vast number of SNPs, indels, CNVs and
chromosome size polymorphism have been identified. Investigations o f the relevance of these
variants have been on the rise over the years. First, experiments involving generation of
artificial mutants have aided in the understanding of various processes in the parasite
including erythrocyte invasion, gametocytogenesis, drug resistance among others (Crosnier et
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al. 2011, Ikadai et al. 2013, Triglia et al. 1998). Second, selection experiments have also 
contributed to identification of variants linked to particular phenotypes (Price et al. 2004,
Singh and Rosenthal 2004, Nzila and Mwai 2010). Since genetic variation is the substrate for 
evolution, plasticity in the parasite genome may well underlie the phenotypic plasticity that 
enables parasites to thrive in variable environments. A number of CNVs have been shown to 
underlie adaptive evolution under drug pressure (Nair et al. 2008, Price et al. 2004, Sidhu et al. 
2006, Singh and Rosenthal 2004, Dharia et al. 2009), and in vitro culture conditions in the 
laboratory (Nair et al. 2010, Biggs et al. 1989, Shirley et al. 1990, Kemp et al. 1992, Ribacke 
et al. 2007, Mackinnon et al. 2009). The study of CNVs in natural populations under variable 
natural selection pressures offers insight into their potential role in adaptation to different 
environments.
The hypothesis that CNVs underlie malaria parasite adaptation to different environmental 
conditions in nature was investigated. The specific aims included detection of CNVs in four 
parasite populations using microarrays, calculation of the CNV frequencies in these 
populations and tests for evidence of selection on them, confirmation of the detected CNVs 
using sequencing, and investigation of the impact of the CNVs on gene transcription levels.
6.2 Key findings
6.2.1 CNVs are prevalent in natural populations of P. falciparum
In this study, a genome-wide scan o f CNVs in 183 field isolates from four populations, with 
different malaria transmission intensities, was conducted using microarrays. Ninety-eight 
different CNVs comprising 225 genes, located in the 14 chromosomes of the genome, were 
detected. The proportion of the genes in the genome targeted by the microarray and found to
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be copy number variable was 4.5% (225/5032 genes). This proportion falls within the range of 
the fractions reported in other P. falciparum CNV studies, using microarrays, of 1.5% - 7% 
(Ribacke et al. 2007, Jiang et al. 2008b, Mackinnon et al. 2009, Dharia et al. 2009, Mok et al. 
2011, Kidgell et al. 2006, Carret et al. 2005, Bozdech et al. 2003a). The difference observed in 
the studies may be due to differences in numbers of isolates studied (2-37 isolates), density of 
the arrays (6000 probes - 4.8 million probes) and stringency measures of CNV detection.
Other studies on different organisms estimated the proportions of genomes with CNVs at 2.1% 
- 4.6% in the cattle genome (Bickhart et al. 2012, Hou et al. 2011), 3.7% - 12% in the human 
genome (Redon et al. 2006, Conrad et al. 2010b) and 2% in Drosophila melanogaster 
(Emerson et al. 2008). The length of the CNVs detected in this study ranged between 400bp 
and 90kb with a median of 6.7 kb. This is comparable to the range of lOObp to 107kb reported 
in previous studies of P. falciparum (Kidgell et al. 2006, Cheeseman et al. 2009).
The CNVs identified consist of amplifications and deletions at a ratio of 1.9:1. A greater 
fraction of amplifications than deletions has been commonly observed in different studies of 
P. falciparum (Ribacke et al. 2007) and other organisms (Redon et al. 2006). This may be as a 
result of stronger purifying selection on deletions that may be more deleterious than 
amplifications, assuming that the rates of formation of deletions and amplifications are similar. 
It may also reflect technical challenges in detecting deletions. CNVs showing both deletion 
and amplifications made up 5% (5/98) of the CNVs identified. This has also been observed in 
other genomes (Hou et al. 2011, Chen et al. 2012, Stranger et al. 2007). If real, these indicate 
that CNVs exist at a wide range of copy number in populations, and reflect high plasticity in 
that genomic segment. Alternatively, these may sometimes be an artefact due to the presence 
of sequence polymorphisms in the population. In this study, data from array probes with 
known SNPs within the probe regions were excluded from the analysis and that lbp mismatch
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out of 70bp probe sequence would not have a great effect on hybridisation intensity (Bozdech 
et al. 2003b) thus making this explanation unlikely.
Some of the CNVs reported in this study have been previously identified. Of all the CNVs 
published so far in P. falciparum, approximately 4% (50/1236 genes) were detected in this 
study. The low concordance with previous studies could be explained by differences in 
technical aspects, CNV calling algorithms, populations and numbers of isolates studied. It may 
also imply that there are many more CNVs yet to be discovered.
An interesting CNV found here, previously identified in only laboratory adapted lines and not 
in field isolates, is the large deletion on chromosome 9 containing 18 consecutive genes. This 
was identified in 13% (24/183) of the isolates studied of which 67% (14/24) originated from a 
single population (Sudan). This CNV appears to be real since its deletion is supported by data 
from probes in a large number of consecutive genes located within the CNV. However, upon 
analysis of this deletion by sequencing (Chapter 4), the region was observed to be covered by 
sequence reads in samples that were found to contain the deletion by microarrays. CNV 
calling using sequence data detected four of the 18 genes in the region as deleted, partially 
supporting the results by microarray, but not for the entire region. A deletion/amplification, in 
the case of sequencing, was defined as a region with coverage that was 1.74 fold (0.8 on the 
log2 scale) lower/higher than the mean sequence coverage of all the samples. The variability 
between genes in sequence coverage, inherent in sequencing data, may therefore have 
obscured the deletions in the other 14 genes. The signal may have been further obscured by 
the presence of subpopulations of parasites with and without the deletion within the isolates. 
Deletion of this region has been linked to loss of cytoadherence (Kemp et al. 1992, Biggs et al. 
1989) and gametocytogenesis (Day et al. 1993). The parasites bearing this deletion are thought
Page 153 o f 191
to have a growth advantage since, so far, they appear to arise only in vitro, an environment 
where they are relieved of the cost that comes with the need for transmission and immune 
evasion. In the parasite’s natural setting inside the host, the occurrence of this deletion in a 
subpopulation in nature may be beneficial for increased growth rate of the parasite in the 
short-term, i.e., within its host, but detrimental in the longer term because of its loss of 
transmissibility. The majority of isolates bearing the deletion were found in Sudan, a 
population with low transmission intensity and immunity. Reduced selection pressure from 
host immunity compared to the other populations may enable existence of parasites that are 
less virulent (Gandon et al. 2001), as characterized by loss of cytoadherence. Alternatively, 
increased selection pressure to prolong the infection through the long mosquito-free dry 
season in Sudan may bring this deletion to the fore.
Fifteen functional gene groups were found to be significantly enriched in the list of CNV 
genes detected. Some of these groups are involved in environmental responsiveness processes. 
The two most enriched groups of genes were those coding for Maurer’s cleft proteins and the 
PHIST family of genes. The Maurer’s cleft proteins consist of proteins that reside in the 
Maurer cleft, a parasite derived organelle in the iRBC cytoplasm, or exported to the iRBC 
membrane through the Maurer’s cleft (Lanzer et al. 2006). PHIST family of genes are also 
thought to be exported to the iRBC surface (Sargeant et al. 2006). These two gene groups are 
exposed to the host immune responses and alteration of their copy numbers may be a 
mechanism for evasion of host immunity. Gain in gene copy number would increase the 
chances of random mutations that increase genetic diversity allowing for immune escape. 
Other enriched groups include those involved in glycolysis, an important mechanism for 
production of energy using glucose obtained from the host to support parasite multiplication 
and growth. Enrichment was observed in genes involved in antioxidative activity that relieves
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the parasite of oxidative stress from processes including digestion of haemoglobin, production 
of energy in the mitochondria and host immune responses (Jortzik and Becker 2012).
6.2.2 CNVs may be under selection
I explored for signs of CNVs under selection by assessing the differentiation in CNV 
frequencies between populations using Weir and Cockerham’s F st estimates. Twenty percent 
of the CNVs (19/ 95) were observed to show high differentiation between populations (F st 
>0.20) and hence may show signs of directional selection that result from population-specific 
pressures. The high differentiation may also be as a result of bottlenecks in the population, 
difference in the effective population sizes leading to variation in genetic drift between 
populations and migration of individuals. The CNVs that are show high differentiation 
between populations contain genes coding for proteins involved in gametocytogenesis, 
transcription regulation, DNA repair and proteins that interact with host immunity. Some of 
the differences in the populations that may contribute to differential selection include host 
genetics, host immunity, vector population densities and genetics, transmission intensities, 
drug use and co-infections. So far in P. falciparum, the only natural selection forces on CNVs 
that have been identified have been anti-malarial drugs (Nair et al. 2008) and host immunity 
(Ahouidi et al. 2010).
An example of a CNV with high differentiation between three population pairs (F st >0.35),
the two Kilifi populations compared to Sudan and Kilifi-Pre compared to Kisumu, was
cnvl2_413 on chromosome 12 containing a single gene PF3D7_1248600. This CNV occurred
at a higher frequency in Sudan and Kisumu than in the Kilifi populations (Chapter 3). The
function of the protein encoded by the gene has not been experimentally tested in the
laboratory. It is inferred to be involved in attachment of glycosylphosphatidylinositol (GPI)
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anchor to proteins, based on its sequence. The GPI anchor is useful for attachment of proteins 
to the extracellular surface of the membranes (Gilson et al. 2006). The gene has also been 
identified to belong to sexual stage Gene Ontology (GO) biological process of response to 
external stimuli (Young et al. 2005). The sexual stage GO is found at 
http://chemlims.com/OPI/MServlet.ChemInfo?module=Go&act=find&act2=viewRecord&GO 
Name LikeSBE 0=%3D&GQ Name TextSBE l=GQ:0009628&DataSet=21 . 
Interestingly, in Chapter 5, this deletion was found to significantly affect the levels of 
expression of 170 genes, both positively and negatively. Thus the existence of copy number 
variation at this locus could conceivably be the consequence of selection pressure on its 
regulatory effect on gametocyte production, a key component of parasite fitness.
Most of the CNVs showed low to moderate differentiation between populations (F st<  0.20). 
The presence of these CNVs could be as a result of neutral evolutionary processes, e.g., drift 
and population separation. These CNVs may be of no immediate relevance to the parasite, but 
might be considered to be on standby for future changes in environment that would render 
them advantageous.
6.2,3 Poor overlap between CNVs identified by microarrays and sequencing
A second technology - whole genome sequencing - that has been widely used for CNV studies
in human genome and a few P. falciparum isolates was adopted to validate the CNVs
identified using microarrays. Sequence data of 18 of the 183 isolates were generated and CNV
calling performed. The CGH data of the 18 isolates were also reanalysed using the same
methods for sequence data with adjustments to certain parameters (fold change, number of
probes within CNV, generally at lower stringency than for CGH) in calling of CNVs in order
to compare the results to those from sequence data. Three percent (21/828) of the CNV genes
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detected using microarrays (GADA software) were confirmed by sequencing (cn.MOPs 
software).
The low concordance in results from the two different technologies could be as a result of 
technical and analytic differences between them. First, the read count data used for CNV 
detection in sequence data is affected by inefficient alignment of reads to the reference 
genome due to presence of sequencing errors, repeat regions, sequence polymorphisms and 
short read length. Second, the type of data analysed differ in the two technologies. CGH data 
are log2 intensity ratios (difference in intensity between test and reference genome) and CNVs 
were defined as regions showing greater or less than absolute log2 intensity ratio of 0.8. By 
contrast, sequencing data are normalised read counts per isolate and CNVs were defined as 
regions with fold-differences corresponding to log2 value of 0.8 from the mean read count. 
Third, microarrays have a cap on the maximum signal intensity that can be detected whereas 
this is not the case for read counts in sequencing. Fourth, microarray hybridization may be 
affected by the presence of sequence polymorphisms in natural populations that were not 
detected and hence not ruled out prior to analysis thus resulting in false positive calls. Given 
these differences between the two technologies, one cannot replace the other in CNV 
detection. Instead, they can be used to complement each other for comprehensive mapping of 
CNVs.
6.2,4 CNVs affect the levels of transcription of genes within and outside CNV 
boundaries
An integrated analysis using CGH data and transcriptome data of 72 isolates was performed to
assess variation in gene expression that could be attributed to CNVs. Significant positive and
negative correlations between genetic content (CGH) and expression (transcriptome) data for
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genes identified to be located within CNVs by CGH. These indicate direct dosage effects of 
CNVs on gene expression. Negative correlations are unexpected and may be attributed to the 
involvement of other gene expression regulatory mechanisms. Amplified genes showed 
significant associations with expression more often than deleted genes suggesting that 
amplifications have greater impact on expression and parasite phenotype than deletions.
The effect of CNVs on the expression of the genes in the rest of the genome (i.e., outside the 
CNV boundaries) was assessed using linear regression models. It was surprising to find that 
most of the variation in gene expression significantly associated with CNVs were of genes not 
located in the CNVs. Significant effects on expression were observed in 5.7% of the 
relationships analysed (95 CNVs and expression of 4797 genes). The genes showing altered 
expression associated with a CNV were located in close proximity, at a distance or on 
different chromosomes from the CNVs. However, from these analyses, it is impossible to 
confidently conclude that the CNVs confer causal effects on CNV expression or are linked to 
other causal variants.
6.3 Future directions
This study has identified CNVs as a major source of variation in naturally occurring parasites.
It has also revealed that CNVs affect phenotype, using gene expression as a proxy to
phenotype, and also appear to be under natural selection. This sets the basis for understanding
parasite adaptation in response to its natural environment (host immunity, vectors, host
genetics among others) and control programmes, e.g., vaccines and therapeutics (Mackinnon
and Marsh 2010, Gandon et al. 2001). The findings provide a lead in to better understanding
of new regulatory mechanisms that might be able to be targeted by drugs or vaccines. For
example the CNV on chromosome 12 (cnvl2_413) that was associated with expression of 170
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genes is a high priority candidate for future study because it may be one of the master 
regulators of gene expression. The candidate CNVs can in future be studied using transfection 
technology, e.g., the introduction of extra gene copy number or a deletion to better understand 
the mechanism through which they contribute to phenotypic variation.
However, most of the CNVs identified using microarrays could not be validated by 
sequencing. To improve this situation, better CNV detection tools for sequence data that are 
suitable for the P. falciparum genome are needed. Second, increased sequencing read length 
would be useful in overcoming problems associated with short reads mapping in repeat 
regions. Third, generation of a representative ‘genome’ of all the naturally occurring isolates 
that could be used to establish unique and conserved regions would improve accuracy of read 
depth calculation and hence CNV calling. Lastly, development of a CNV detection tool that 
could be applied to both sequence and CGH data would enable fair comparison between the 
technologies and pooling of information from different sources in order to improve the 
accuracy and power to detect novel CNVs.
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8 Appendix
8,1 Appendix 1.1. A summary of genome-wide studies of CNVs in P. falciparum  using microarrays and next generation sequencing 
technologies.
Platform No. o f CNVs 
identified
Reference
genome
Size
of
CNVs
Isolates CNV detection criteria Reference
70-mer 
microarray :
4488 genes
144 CNV
genes
3D7 1 lab line 
(HB3)
Probes with difference in red and 
green intensities o f less than 50% 
of total (3D7) signal intensity. 
Exclude VSAs
(Bozdech et al. 2003a).
25-mer
Affymetrix
scrMalaria
array.
5159 genes 
260,596 probes
177 CNV 
genes
37 deleted 
genes
NF54 7 cultured 
isolates
Deletion defined as greater than 
40% reduction in intensity o f test 
relative to reference (NF54)
(Carret et al. 2005).
25 mer
Affymetrix
array
13
amplifications 
(-116 genes) 
33 gene 
deleted
3D7 9 lab lines 
and
5 culture
field
isolates
Amplification detection cutoff at 
log2ratio > 0.7
Deletion detected using MOID 
algorithm.
(Kidgell et al. 2006).
70 mer 
microarray
50 genes 
amplified 
32 genes 
deleted
3D7 980bp
107K
bp
2 fresh 
isolates and 
7 lab lines
2 consecutive probes showing 
similar statistically significant ratio 
difference (B statistics in limma 
(Smyth 2005)). Change in one 
direction (increase/decrease), VSAs 
excluded.
(Ribacke et al. 2007).
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PFSANGER 
GeneChip 
2.2 million 
probes
390 CNV 
genes
3D7 4 cultured 
lines
Segmentation using Partek 
Genomic Suite v6.3 
Segments 1.5 fold signal difference 
relative to 3D7 
Minimum o f 15 probes.
>300bp
(Jiang et al. 2008b).
70 mer 
microarray 
5224 genes
-324 CNV 
genes
3D7 5 short term
culture
isolates
1.5 fold in intensity difference 
between test samples and 3D7. 
Significant variation in log2 
intensity between strains (p<0.001). 
Occurrence o f CNV in at least two 
isolates.
(Mackinnon et al. 
2009).
70-mer array 138 CNV 
genes
3D7 6 fresh 
clinical 
isolates
GADA (Pique-Regi et al. 2010). (Mok etal. 2011).
Custom Tiling 
array
4.8 million 
probes
90% coding and 
60% noncoding 
regions.
79 CNV 
regions
3D7 1.9kb
P-
83kbp
4 lab lines Deletion detected by MOID 
algorithm. 10 unique probes per 
gene. Amplifications detected by 
performing z-test on windows 
testing whether log2 ratio >0. Z- 
score cut off o f 18.
(Dharia et al. 2009).
454 sequencing 2 deletions 
5
amplifications
3D7 2.5kb-
160kb
2 lab lines Read depth analysis (Samarakoon et al. 
2011a).
Illumina
sequencing
5 deletions 
2 amplification
3D7 300bp
-20kb
5 fresh 
isolates
Read depth analysis (Yoon et al. 
2009) and paired end mapping
(Robinson et al. 2011).
*MOID-Match-only Integral Distribution Algorithm
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8.2 Appendix 3.1. Overlap between CNVs identified in our study compared to published studies.
CNV name Gene ID Chromosome Gene name Reference
cnvl_005 PF3D7_0108500 1 Hypothetical protein, 
conserved
(Cheeseman et al. 2009)
cnv2_013 PF3D7 0202000 2 Knob associated 
histidine-rich protein
(Jiang et al. 2008b, Samarakoon et al. 201 la, 
Samarakoon et al. 201 lb, Pologe and Ravetch 
1988, Scherf and Mattei 1992, Mackinnon et al. 
2009, Ribacke et al. 2007, Carret et al. 2005)
PF3D7_0202100 2 Plasmodium exported 
protein (PHISTc), 
unknown function
(Cheeseman et al. 2009, Mackinnon et al. 2009, 
Carret et al. 2005)
PF3D7_0202200 2 Plasmodium exported 
protein, unknown 
function
(Mackinnon et al. 2009)
cnv3_043 PF3D7_0309300 3 N2227-Iike protein, 
putative
(Mackinnon et al. 2009)
PF3D7_0309600 3 60S Acidic ribosomal 
protein P2
(Cheeseman et al. 2009)
cnv3_064 PF3D7_0322700 3 (Samarakoon et al. 201 lb)
cnv4_091 PF3D7_0423400 4 (Samarakoon et al. 201 lb)
PF3D7 0423500 4 (Samarakoon et al. 201 lb)
cnv4_092 PF3D7 0424400 4 hypothetical protein (Samarakoon et al. 201 lb, Jiang et al. 2008b)
cnv5_122 PF3D7_0529100 5 hypothetical protein, 
conserved
(Jiang et al. 2008b)
PF3D7_0529200 5 sugar transporter, 
putative
(Mackinnon et al. 2009)
cnv7_169 PF3D7_0710200 7 hypothetical protein (Samarakoon et al. 201 lb, Jiang et al. 2008b, 
Mackinnon et al. 2009)
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cnv7_181 PF3D7 0721000 7 (Samarakoon et al. 201 lb)
cnv7_193 PF3D7_0730500 7 (Samarakoon et al. 201 lb)
cnv8_201 PF3D7_0804700 8 conserved Plasmodium 
protein, unknown 
function
(Mackinnon et al. 2009)
cnv8_215 PF3D7 0829500PF3D7 08180 
00
8 RNA binding protein, 
putative
(Mackinnon et al. 2009)
cnv9_251 PF3D7_0921000 9 ubiquitin conjugating 
enzyme
(Mackinnon et al. 2009)
cnv9_269 PF3D7_0935400 9 cytoadherence-linked
protein
(Mackinnon et al. 2009, Carret et al. 2005, 
Samarakoon et al. 201 la, Samarakoon et al. 
201 lb, Kidgell et al. 2006)
PF3D7_0935500 9 (Mackinnon et al. 2009, Jiang et al. 2008b, 
Samarakoon et al. 201 la, Samarakoon et al. 
2011b)
PF3D7_0935600 9 (Cheeseman et al. 2009, Mackinnon et al. 2009, 
Samarakoon et al. 201 la, Samarakoon et al. 
2011b, Jiang etal. 2008b)
PF3D7_0935700 9 (Cheeseman et al. 2009, Mackinnon et al. 2009, 
Samarakoon et al. 201 la, Samarakoon et al.
201 lb, Jiang et al. 2008b)
PF3D7_0935800 9 cytoadherence linked 
asexual protein 9 
(CLAG9)
(Cheeseman et al. 2009, Mackinnon et al. 2009, 
Samarakoon et al. 201 la, Samarakoon et al.
201 lb, Jiang et al. 2008b)
PF3D7_0935900 9 (Samarakoon et al. 201 la, Samarakoon et al. 
201 lb, Jiang et al. 2008b, Mackinnon et al. 
2009)
PF3D7_0936000 9 hypothetical protein (Cheeseman et al. 2009, Mackinnon et al. 2009, 
Samarakoon et al. 201 la, Samarakoon et al. 
2011b, Jiang etal. 2008b)
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PF3D7_0936100 9 hypothetical protein, 
conserved
(Cheeseman et al. 2009, Mackinnon et al. 2009, 
Samarakoon et al. 201 la, Samarakoon et al.
201 lb, Jiang et al. 2008b)
PF3D7_0936200 9 hypothetical protein (Cheeseman et al. 2009, Mackinnon et al. 2009, 
Samarakoon et al. 201 la, Samarakoon et al.
201 lb, Jiang et al. 2008b)
PF3D7_0936400 9 hypothetical protein (Cheeseman et al. 2009, Mackinnon et al. 2009, 
Samarakoon et al. 201 la, Samarakoon et al.
201 lb, Jiang et al. 2008b)
PF3D7_0936500 9 hypothetical protein (Samarakoon et al. 201 la, Samarakoon et al. 
201 lb, Jiang et al. 2008b, Mackinnon et al. 
2009)
PFI1770w 9 hypothetical protein (Samarakoon et al. 201 la, Samarakoon et al. 
201 lb, Jiang et al. 2008b)
PF3D7_0936700 9 hypothetical protein (Samarakoon et al. 201 la, Samarakoon et al. 
201 lb, Jiang et al. 2008b, Mackinnon et al. 
2009)
PF3D7_0936800 9 hypothetical protein (Cheeseman et al. 2009, Mackinnon et al. 2009, 
Samarakoon et al. 2011a, Samarakoon et al.
201 lb, Jiang et al. 2008b, Ribacke et al. 2007)
PF3D7_0936900 9 hypothetical protein, 
conserved in P. 
falciparum
(Cheeseman et al. 2009, Mackinnon et al. 2009, 
Samarakoon et al. 2011a, Samarakoon et al.
201 lb, Jiang et al. 2008b, Ribacke et al. 2007, 
Kidgell et al. 2006, Carret et al. 2005)
PF3D7_0937000 9 Hypothetical 
hypothetical protein
(Samarakoon et al. 201 la, Samarakoon et al. 
201 lb, Jiang et al. 2008b, Mackinnon et al. 
2009, Ribacke et al. 2007)
PF3D7_0937100 9 hypothetical protein (Samarakoon et al. 201 la, Samarakoon et al. 
201 lb, Jiang et al. 2008b, Mackinnon et al.
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2009, Ribacke et al. 2007, Cheeseman et al. 
2009)
PF3D7 0937200 9 enzyme, putative (Samarakoon et al. 201 la, Samarakoon et al. 
201 lb, Jiang et al. 2008b, Mackinnon et al. 
2009, Ribacke et al. 2007, Carret et al. 2005)
cnvll_335 PF3D7_1129000 11 spermidine synthase (Mackinnon et al. 2009)
cnvll 344 1/ 
2
PF3D7_1140500 11 myosin heavy chain 
subunit, putative
(Mackinnon et al. 2009)
cnvl1_348 PF3D7_1143400 11 translation initiation 
factor elF-lA, putative
(Mackinnon et al. 2009)
cnvl1_354
i
PF3D7_1148700 11 (Samarakoon et al. 201 lb, Sepulveda et al. 
2013, Jiang et al. 2008b)
PF3D7 1148800PF3D7 11488 
00
11 hypothetical protein Jiang 2008, Samarakoon 2011 A, Cheeseman 
2009
PF3D7_1148900 11 hypothetical protein (Jiang et al. 2008b, Samarakoon et al. 201 lb)
PF3D7_1149000 11 hypothetical protein (Jiang et al. 2008b, Samarakoon et al. 201 lb)
cnvl1_355 PF3D7_1149000 11 antigen 332, putative (Jiang et al. 2008b, Samarakoon et al. 201 lb)
cnvl2_375 PF3D7_1212400 12 Tetratricopeptide repeat 
family protein, putative
(Mackinnon et al. 2009)
cnvl3_434 PF3D7_1313100 13 conserved Plasmodium 
protein, unknown 
function
(Mackinnon et al. 2009)
cnvl3_441 PF3D7_1316800 13 sec20 homolog, putative (Mackinnon et al. 2009)
cnvl3_503 PF3D7_1366400 13 (Samarakoon et al. 2011b)
cnvl4_516 PF3D7_1412400 14 hypothetical protein (Jiang et al. 2008b)
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8.3 Appendix 3.2. Potentially novel CNVs
CNV name Gene ID Description
cnvl_007 PF3D7_0109400 tubulin-specific chaperone a putative
PF3D7_0109500 N-acetyltransferase putative
cnv2_014 PF3D7_0202500 early transcribed membrane protein 2
PF3D7_0202600 conserved Plasmodium protein unknown function
cnv2_016 PF3D7_0203100 protein kinase putative
cnv2_023 PF3D7_0212400 conserved Plasmodium membrane protein unknown function
cnv2_024 PF3D7_0213600 conserved Plasmodium protein unknown function
cnv2_028_l/cnv2_028_2 PF3D7_0215700 DNA-directed RNA polymerase II second largest subunit putative
cnv3_036 PF3D7 0301600 Plasmodium exported protein (hypl) unknown function
PF3D7_0301700 Plasmodium exported protein unknown function
PF3D7 0301800 Plasmodium exported protein unknown function
cnv3_037 PF3D7 0302600 ABC transporter (TAP family) putative
PF3D7_0302700 PFMNL-1 CISDl-like iron-sulfur protein putative
PF3D7_0302800 conserved Plasmodium protein unknown function
PF3D7_0302900 exportin 1 putative
cnv3_051 PF3D7_0315200 CSP and TRAP-related protein
cnv4_073 PF3D7_0407000 conserved Plasmodium protein unknown function
PF3D7 0407100 conserved Plasmodium protein unknown function
PF3D7_0407200 peptidyl-tRNA hydrolase PTH2 putative
cnv4_076 PF3D7_0409500 conserved Plasmodium protein unknown function
PF3D7 0409600 replication protein A large subunit
PF3D7_0409700 conserved Plasmodium protein unknown function
cnv4_078 PF3D7_0411700 conserved Plasmodium protein unknown function
cnv4_092 PF3D7_0424400 surface-associated interspersed gene 4.2 (SURFIN4.2)
cnv5_101 PF3D7 0507900 conserved Plasmodium protein unknown function
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PF3D7 0508000 6-cysteine protein
PF3D7_0508100 SET domain protein putative
cnv5_106 PF3D7_0512600 Rab GTPase lb
PF3D7_0512700 orotate phosphoribosyltransferase
cnv5_108 PF3D7_0514300 aspartyl-tRNA synthetase putative
PF3D7_0514500 conserved Plasmodium membrane protein unknown function
PF3D7_0514600 ribose 5-phosphate epimerase putative
cnv5_109 PF3D7_0515000 RNA recognition motif putative
PF3D7_0515100 rhomboid protease ROM9
PF3D7_0515200 conserved Plasmodium protein unknown function
PF3D7_0515300 phosphatidylinositol 3-kinase
cnv6_125 PF3D7 0602000 conserved Plasmodium protein unknown function
PF3D7_0602100 ATP-dependent RNA helicase putative
PF3D7_0602200 MYND finger protein putative
PF3D7 0602300 conserved Plasmodium protein unknown function
PF3D7 0602400 elongation factor G putative
PF3D7_0602500 geranylgeranyltransferase putative
cnv6_127 PF3D7_0604800 RAP protein putative
PF3D7_0604900 conserved Plasmodium protein unknown function
PF3D7_0605000 mitochondrial ribosomal protein L24 precursor putative
PF3D7 0605100 RNA binding protein putative
cnv6_129 PF3D7_0606200 ubiquitin conjugating enzyme E2 putative
PF3D7_0606300 conserved Plasmodium protein unknown function
PF3D7 0606400 conserved Plasmodium protein unknown function
PF3D7_0606500 polypyrimidine tract binding protein putative
cnv7 185 : PF3D7_0724100 conserved Plasmodium protein unknown function
PF3D7 0724200 immunoglobulin-binding protein 1-related putative
cnv8_201 PF3D7_0805100 conserved Plasmodium protein unknown function
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cnv8_222 PF3D7 0822600 Pfsec23
cnv8_227 PF3D7_0826000 conserved Plasmodium protein unknown function
PF3D7_0825900 conserved Plasmodium protein unknown function
cnv8_233_l/cnv8_233_2 PF3D7_0829500 conserved Plasmodium protein unknown function
cnv9_235 PF3D7 0902900 conserved Plasmodium protein unknown function
PF3D7_0903000 conserved protein unknown function
PF3D7_0903100 retrieval receptor for endoplasmic reticulum membrane proteins putative
cnv9_242 PF3D7_0908000 PI nuclease putative
PF3D7_0908100 conserved Plasmodium membrane protein unknown function
cnv9_249 PF3D7 0915200 conserved Plasmodium protein unknown function
PF3D7 0915300 conserved Plasmodium protein unknown function
cnv9_254 PF3D7_0925400 protein phosphatase-beta
PF3D7_0925500 thioredoxin-like protein 2
PF3D7_0925600 zinc binding protein (Yippee) putative
PF3D7_0925700 histone deacetylase
cnv9_255 PF3D7_0926400 monocarboxylate transporter putative
cnv9_259 PF3D7_0928000 cytochrome c oxidase putative
cnv9_262 PF3D7 0928900 guanylate kinase
PF3D7 0929000 conserved Plasmodium protein unknown function
PF3D7_0929100 conserved Plasmodium protein unknown function
PF3D7_0929200 RNA binding protein putative
PF3D7_0929300 conserved Plasmodium protein unknown function
cnv9_268 PF3D7 0934300 conserved Plasmodium protein unknown function
PF3D7_0934400 transcription factor with AP2 domain(s) putative
cnvl0_270 PF3D7_1001300 Plasmodium exported protein (PHISTa) unknown function
PF3D7_1001400 alpha/beta hydrolase putative
cnvl0_276 PF3D7_1008700 tubulin beta chain
PF3D7_1008800 small subunit rRNA processing protein putative
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PF3D7_1008900 adenylate kinase
cnvl0_279 PF3D7 1012500 phosphoglucomutase putative
cnvl0_283 PF3D7 1016500 Plasmodium exported protein (PHISTc) unknown function
PF3D7 1016700 Plasmodium exported protein (PHISTc) unknown function
cnvll_304 PF3D7_1107300 MIF4G domain containing protein
PF3D7_1107400 Rad51 homolog
PF3D7_1107500 prefoldin putative
cnvl1313 PF3D7_1113800 conserved Plasmodium membrane protein unknown function
PF3D7_1113900 mitogen-activated protein kinase 2
cnvll_316 PF3D7_1114800 glycerol-3-phosphate dehydrogenase putative
PF3D7_1114900 conserved Plasmodium protein unknown function
cnvl1_347 PF3D7_1142600 60S ribosomal protein L35ae putative
PF3D7_1142700 conserved protein unknown function
PF3D7_1142800 conserved Plasmodium protein unknown function
PF3D7_1142900 conserved Plasmodium protein unknown function
cnvl2_359 PF3D7_1201700 conserved Plasmodium membrane protein unknown function
PF3D7 1201800 cytochrome c oxidase assembly protein putative
PF3D7 1201900 conserved protein unknown function
PF3D7_1202000 ATP-dependent RNA helicase putative
cnvl2_360 PF3D7 1202100 conserved Plasmodium protein unknown function
PF3D7_1202200 mitochondrial phosphate carrier protein
cnvl2_364 PF3D7_1205400 conserved Plasmodium protein unknown function
PF3D7 1205500 conserved Plasmodium protein unknown function
cnvl2 3 6 7 PF3D7_1207000 conserved Plasmodium protein unknown function
cnvl2_368 PF3D7_1207200 conserved Plasmodium protein unknown function
cnvl2_377 PF3D7 1214900 conserved Plasmodium membrane protein unknown function
PF3D7_1215000 thioredoxin peroxidase 2
cnvl2_378 PF3D7_1216200 glycerol-3-phosphate dehydrogenase putative
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cnvl2_379 PF3D7_1217500 conserved Plasmodium protein unknown function
PF3D7_1217600 anaphase promoting complex subunit 10 putative
cnvl2_388 PF3D7_1229300 conserved Plasmodium protein unknown function
PF3D7_1229400 macrophage migration inhibitory factor
PF3D7_1229500 T-complex protein 1
cnvl2_398 PF3D7_1238900 protein kinase 2
cnvl2_405 PF3D7_1243700 ubiquitin conjugating enzyme E2 putative
cnvl2_408
cnvl2_408
PF3D7_1244700 conserved Plasmodium protein unknown function
PF3D7_1244800 cytoplasmic translation machinery associated protein putative
cnvl2_409 PF3D7_1245200 conserved Plasmodium membrane protein unknown function
cnvl2_413 PF3D7 1248600 conserved Plasmodium protein unknown function
cnvl3_428 PF3D7_1309000 conserved Plasmodium protein unknown function
PF3D7_1309200 protein phosphatase 2c-like protein putative
PF3D7_1309300 U4/U6 small nuclear ribonucleoprotein putative
PF3D7_1309100 60S ribosomal protein L24 putative
cnvl3_437_l/cnvl3_437_2 PF3D7_1315400 conserved Plasmodium protein unknown function
cnvl3_442 PF3D7_1317300 conserved Plasmodium protein unknown function
PF3D7_1317400 conserved Plasmodium protein unknown function
cnvl3_447 PF3D7_1322300 translation initiation factor EIF-2B subunit related
cnvl3_453 PF3D7_1324900 L-lactate dehydrogenase
PF3D7_1325000 lsm6 homologue putative
cnvl3_457 PF3D7_1329200 conserved Plasmodium protein unknown function
PF3D7_1329300 chromatin assembly factor 1 subunit putative
cnvl3_469 PF3D7_1340400 conserved Plasmodium protein unknown function
cnvl3_473_l/cnvl3_473_2 PF3D7_1344600 lipoate synthase putative
cnvl3_478 PF3D7_1348800 conserved Plasmodium membrane protein unknown function
PF3D7_1349000 conserved Plasmodium protein unknown function
PF3D7 1348900 conserved Plasmodium protein unknown function
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cnvl3_482 PF3D7_1351200 conserved Plasmodium protein unknown function
cnvl4_517 PF3D7_1412500 actin II
cnvl4_541 PF3D7 1431600 ATP-specific succinyl-CoA synthetase beta subunit putative
cnvl4_543 PF3D7 1432200 conserved Plasmodium protein unknown function
cnvl4_549 PF3D7_1438800 conserved Plasmodium protein unknown function
PF3D7_1438900 thioredoxin peroxidase 1
PF3D7_1439000 copper transporter putative
cnvl4_564 PF3D7_1452700 U1 snRNA associated protein putative
PF3D7_1452800 conserved Plasmodium protein unknown function
cnvl4 573 PF3D7_1460700 60S ribosomal protein L27 putative
cnvl4_573 PF3D7_1460800 conserved Plasmodium protein unknown function
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Appendix 4.1. Number and length of CNV segments detected in the six analysis methods of CGH and sequence data
Barplots of the number of CNV segments detected in each of the 18 samples and the distribution of the length of the segments in the A) ‘exome’ 
B) ‘genes’ C) “genome’ D) ‘probome’ E) CGH (cn.MOPS) F) CGH (GADA). The lengths are indicated by red (0-250bp), grey (251-500bp), 
yellow (501-1 OOObp), blue (1001-5000bp), orange (5001-10000bp), green (>10000)
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8.4 Appendix 4.2. Number of CNV genes detected and fraction of gene length identified to be copy number variable.
Barplot of the number of CNV genes identified in the six methods A) ‘genes’ B) ‘genome’ C) ‘probome’ E) ‘exome’ F) CGH (cn.MOPS) and G) 
CGH (GADA) with their corresponding fraction of gene length in CNV segments shown by different colours on bars 0-0.2 (pink), 0.2-0.4 (grey), 
0.4-0.6 (yellow), 0.6-0.8 (green) and 0.8-1 (blue)
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